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ABSTRACT 
The value of genetic test feedback for common conditions is widely debated.  This is principally 
because of the lack of impact on behaviour change of feedback for genes with small effect 
sizes, but also because of concern about the risks of fatalistic responses to positive test results 
or false reassurance from negative results.  This thesis describes research using feedback for 
one gene, FTO, implicated in the development of obesity, as a model to investigate 
motivational and emotional reactions to testing for genetic susceptibility.  It comprises a series 
of six studies examining the benefits and harms associated with genetic test feedback.  They 
incorporated a mixture of qualitative and quantitative methodologies, used hypothetical and 
real genetic feedback, and tested predominantly normal-weight students and overweight/and 
obese individuals from a web panel.   
 
Fatalism or false reassurance in response to FTO genetic test feedback was not observed in 
any of the studies.  Genetic test feedback was consistently perceived as motivating, and 
negative emotional effects of a higher-risk FTO gene result were minimal.   Overweight and 
obese individuals found the test result helpful for alleviating guilt and stigma; although in 
response to an unexpected lower-risk genetic test result, some were disappointed.    
 
University is notoriously a life stage with risk of weight gain but not all students gain weight.  
One study examined associations between genetic risk status and weight gain, and found that 
students with at least one higher-risk allele were more likely to gain weight.  The final study 
was a randomised controlled trial examining the effect of giving FTO feedback alongside 
simple weight control advice to first year students.  Short-term (one month) results showed 
that weight control intentions were significantly higher in those randomised to receive FTO 
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feedback and weight control advice than weight control advice alone, but there was no effect 
on weight or reported behaviour change.  
 
Although the studies in this thesis had many limitations, the findings indicate that people are 
unlikely to misinterpret or overstate the impact of genetic test results, at least in the context 
of a single gene implicated in a multifactorial condition.  However, effects on behaviour 
remained elusive.  This indicates the need for future research to learn how to harness the 
potential of genetic information to promote personalised prevention.  
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Chapter 1:  Obesity, FTO and the environment 
1.1 The Burden of Obesity 
 
Obesity is of major concern for health care providers and policy makers, because it 
raises the risk of serious health conditions such as diabetes, hypertension, 
cardiovascular disease, and certain types of cancer; contributing significantly to 
morbidity and mortality and driving healthcare costs substantially upward (World 
Health Organization (WHO), 2000; James, 2008). 
 
Obesity is defined as excess body fat that impacts on physical constitution, resulting 
from sustained positive energy balance (Martinez & Fruhbeck, 1996).  It is commonly 
assessed using body mass index (BMI), which is the ratio of weight to height, 
calculated by dividing weight (kg) by height (m) squared.   Established cut-off points 
are 25.0-29.9 kg/m2 for overweight and ≥ 30.0 kg/m2 for obesity (WHO, 2000); 
although these are somewhat arbitrary because weight itself is continuously 
distributed in the population assuming a bell-shaped curve.  However, because of its 
easy use and relatively close correlation with body fat at ranges considered as 
hazardous for  health, BMI remains the most widely used measure of weight status 
(Romero-Callo et al., 2008).  
 
Obesity rates have been increasing at an alarming rate over the past 30 years, leading 
the WHO to declare it a ‘global epidemic’ in 2000 (WHO, 2000).  Worldwide an 
estimated 1.46 billion adults are overweight or obese, with numbers in developing 
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countries rising rapidly (International Association for the Study of 
Obesity/International Obesity Task Force, 2010).  In the United Kingdom (UK), the 
latest available figures show that over 60% of adults are overweight or obese (Health 
Survey for England, 2010).  Importantly, to date, no country has demonstrated a 
reversal of the trend despite sustained efforts, highlighting not only the complexity of 
the problem, but also hinting at the prospective burden from ever increasing numbers 
of overweight and obese individuals. 
 
1.2 Genetic and environmental influences in the development of obesity  
 
The diverse causes of obesity are illustrated by the Obesity Systems Map shown in 
Figure 1.1 ( Vandenbroeck et al., 2007) which includes over 100 variables spanning 
macro- and microenvironment, inter- and intrapersonal influences, and their 
interconnections which impact on obesity development. It is beyond the scope of this 
thesis to consider all of these influences, and for the empirical studies the primary 
focus will be on the interaction of one gene (Fat mass and Obesity associated gene, 
FTO) with the university environment in increasing risk of obesity; although I am aware 
that this is an overly simplistic account of the problem. 
Chapter 1: Obesity: Genetic and environmental influences 
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Figure 1.1 Foresight Obesity Systems Map (Vandenbroeck et al, 2007) 
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1.3 Genetic influences on obesity onset 
1.3.1 Twin and adoption studies 
Familial aggregation of obesity is common.  For example, Whitaker and colleagues 
(2010) showed that child obesity levels increased in a graded linear fashion with 
degree of parental overweight. Children of two overweight or obese parents were 
twice and 12 times more likely to be obese than children of two normal weight 
parents.   
 
However, it is difficult to distinguish the effects of shared familial environment, 
lifestyle, and genes in family studies.  Twin studies are especially useful in teasing the 
relationship between genetic and environmental influence apart, because twins share 
either 100% of their genes (monozygotic), or 50% like normal siblings (dizygotic); both 
usually share, however, a very similar environment because they are born at the same 
time.  Adoption studies also provide a powerful strategy for comparing genetic and 
environmental influences of obesity development.  
 
If obesity is genetically determined, then monozygotic twins should show more 
similarities in their weight than dizygotic twins, and adopted children should show 
higher similarities in weight with their biological parents than with their adoptive 
parents.  A recent meta-analysis of all twin and adoption studies confirmed the strong 
genetic effects on BMI in children throughout all age groups until onset of adulthood 
(Silventoinen et al., 2009).  Heritability of obesity was estimated to be about 70%, 
taking into account that changing gene expression patterns across the lifespan may 
cause variation in heritability rates at different ages.  
C 
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1.3.2 Mendelian and monogenic disorders linked with obesity 
Further evidence for a strong genetic component in obesity onset comes from 
Mendelian diseases1.  One example of a Mendelian disorder is Prader-Willi-Syndrome, 
which is, besides other factors, characterized by severe obesity (Ohta et al., 1999).  
Studying this syndrome closely in addition to studying individuals who suffer from 
other rare monogenic diseases has helped to establish a firm evidence base for the 
importance of genes in obesity onset.  In Prader-Willi Syndrome, a deletion of a 
segment of the paternal Chromosome 15 (15q11.2-q12) has been found to cause 
disruption of the pathways responsible for energy homeostasis, leading to severe 
hyperphagia and obesity (Montague et al., 1997; Farooqi & O'Rahilly, 2009).  Another 
example is the disruption of the leptin-melanocortin-pathway, which signals from 
adipose tissue to the hypothalamus to maintain energy balance (Farooqi & O'Rahilly, 
2009; Montague et al., 1997).  Similarly, mutations in the melanocortin-4-receptor 
(MC4R) gene disrupt energy homeostasis leading to increased food intake (Loos et al., 
2008; Farooqi & O'Rahilly, 2005).   
 
                                                          
1 These diseases are characterised by three distinct inheritance patterns that were discovered by the Monk Gregor 
Mendel: 1. dominant, 2. recessive, 3. sex-linked.  In dominant inheritance patterns, a mutation in a single gene is 
sufficient to cause illness.  Recessive inheritance patterns, on the other hand, require the mutation to be present in 
both genes to be expressed. If only one copy is present, the disease can be transmitted, but the individual will not 
fall ill. This is also the case for the sex-linked disorders.  There, the mutation lies on a gene on the X-chromosome.  
As men only have one X-chromosome (they receive a Y from the father), they will be affected by the disease 
regardless of whether it follows a dominant or recessive inheritance pattern; in contrast, women have two X-
chromosomes, one of which will be inactivated, so that they do not fall ill if the disease is X-linked recessive. They 
can however, transmit the faulty gene to their offspring. 
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1.3.3 Linkage studies and genome-wide association studies (GWAS) 
Although studies of Mendelian disorders have been valuable in understanding some of 
the mechanisms responsible for obesity onset, single-gene disorders represent only a 
minority of cases, and therefore cannot account for the high prevalence of obesity in 
the population.  It is now recognised that so-called ‘common obesity’ is a complex, 
multifactorial disorder in which many genes of small effect  and with high population 
prevalence each act to affect weight only marginally, which is known as Common 
Disease/Common Variant Hypothesis (Lander, 1996).  Genes with small effect may also 
interact with one another, other genes, and the environment, to increase 
susceptibility to weight gain. 
 
Previously it was difficult to detect small effects of specific genes because the genome 
was not fully sequenced, and there were no methods available to search it on a large 
scale.  With the development of genetic technologies over the last decade which allow 
for scanning the entire genome, it has become clear that gene variations (alleles) exist 
at many specific locations in the genome.  Genes can now be scanned for Single 
Nucleotide Polymorphisms (SNPs) to find common risk alleles which contribute to 
disease development.  Because effects are so small, large sample sizes are required to 
have sufficient power to detect them and mustering these has become possible only 
relatively recently through decreased sequencing costs. 
 
1.4 FTO and other genes implicated in obesity development 
 
In 2007, Frayling and colleagues reported a common variant in the FTO gene 
(rs9939609), located on Chromosome 16, which leads to an average increase in weight 
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of three kilograms in homozygotes. With one risk allele, individuals tend to be on 
average 1.7kg heavier compared with those having none.  About 37% of the Caucasian 
population carry one higher risk allele of FTO, and 16% carry two. This finding has been 
replicated by several research groups (Cauchi et al., 2009; Haworth et al., 2008; Loos & 
Bouchard, 2008; Scuteri et al., 2007; Dina, 2008) and in other ethnic groups, albeit 
frequency distributions and specific SNPs may vary (Yajnik et al., 2009; Grant et al., 
2008; Tan et al., 2008; MI et al., 2009; Hotta et al., 2008).  
 
In 2008, Loos and colleagues confirmed another locus near the MC4R gene 
(rs17782313) as adding small amounts to weight (about 0.2 kg per allele).  Although 
this is a small increase in body weight per se, it results in an 8% increase for the chance 
of being overweight and a 12% increase in chance of being obese, in individuals 
homozygous for the higher risk allele.  Willer and colleagues (2009) then identified six 
new loci associated with obesity, in addition to replicating the already well-known loci 
for FTO and near MC4R. 
 
A recent study from the Genetic Investigation of ANthropometric Traits (GIANT) 
consortium, an international collaboration that seeks to identify loci that are 
implicated in body size and shape, confirmed 18 new loci implicated in obesity in a 
genome-wide association meta-analysis encompassing 46 studies with close to 
250,000 individuals, (Speliotes et al., 2010).  In total, there have now been more than 
56 genes identified which influence obesity onset;  leading to an estimated BMI 
difference of 2.7 points under the additive model in individuals having 38 or more 
higher risk variants compared with individuals having 21 or less (Speliotes et al., 2010). 
However, despite these new findings, genes discovered to date can only explain about 
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1.45% of the variance in weight (about 2%-4% of heritability) and FTO remains the 
gene with the largest effect size, explaining about 1% of the variance in BMI (Frayling 
et al., 2007). 
 
However, novel methods of genome analysis, such as Genome-wide Complex Trait 
Analysis (GCTA), which estimates the proportion of phenotypic variance in a 
population explained by genome- or chromosome-wide SNPs (Yang et al., 2011) may 
improve heritability estimates, and studies are already beginning to emerge in this 
area.  For example, Llewellyn and colleagues (2013) used GCTA to quantify the additive 
genetic effect of common obesity-related SNPs on BMI SDS scores using data from the 
Twins Early Development study (TEDS) and found that GCTA could explain about 30% 
of the variance in BMI SDS scores; substantially improving estimates attained with 
‘traditional’ analysis methods. 
 
1.4.1 Function of FTO 
FTO’s function (Fto when referred to in animals) is only beginning to be uncovered.  
Although gene expression occurs in many bodily tissues, including adipose tissue, FTO 
and fto expression rates are highest in brain, especially in the hypothalamus and 
adjacent nuclei associated with energy homeostasis and feeding behaviour (Gerken et 
al., 2007; Frayling et al., 2007; Olszewski et al., 2009).  
 
FTO’s structure and resemblance to homologues involved in nucleic acid repair or 
modification, and the preferential binding to single-stranded RNA over double-
stranded DNA of the FTO protein, suggested early on that it may be concerned with 
nucleic acid demethylation (Jia et al.  2008).  This assumption was supported by the 
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presence of FTO in the cell nucleus (Gerken et al., 2007).  More recently, Jia and 
colleagues (2011) confirmed in in vitro experiments that the FTO protein is responsible 
for demethylation of N6-methyladenosine (m6A) in RNA.  
 
FTO expression rates also appear to be sensitive to environmental conditions.  Fto 
expression was up-regulated following food deprivation, but no change in expression 
was observed when animals were fed a hyper-caloric diet over a period of time 
without prior food deprivation (Fredriksson, 2008); further suggesting a role in energy 
homeostasis.  Therefore, attention has turned to investigating the effects of FTO on 
food intake, eating behaviour and energy expenditure to discover whether the 
association of FTO with BMI is mediated by these variables.  The body of literature 
pertaining to animal studies is large, but because the current thesis is concerned with 
FTO’s effects in humans, and evidence from animal studies cannot be directly applied 
to humans, the current review is restricted to studies involving people.  A table of all 
studies reviewed in the following section is included in Appendix 1.  
 
1.4.2 FTO, food intake and dietary preferences 
Fifteen studies investigated associations of FTO with energy or macronutrient intake, 
with only three studies focusing exclusively on energy intake without also investigating 
macronutrient content (Johnson et al., 2009; Wardle, Llewellyn, Sanderson, & Plomin, 
2008; Dougkas, Yaqoob, Givens, Reynolds, & Minihane, 2013). Nine used population-
based cohorts involving several thousand participants (Park et al., 2013; Brunkwall et 
al., 2013; Bauer et al., 2009; Holzapfel et al., 2010; McCaffery et al., 2012; Timpson et 
al., 2008; Sonestedt et al., 2009; Hasselbalch et al., 2010; Johnson et al., 2009). 
Consequently, these studies assessed food intake and food preferences using food 
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frequency questionnaires or diet diaries; in the latter, participants recorded food and 
drink intake over one, three or seven days.  Only three studies measured food intake 
in experimental designs; these are described in detail below.  
 
Cecil and colleagues (2008) measured ad libitum food intake 1.5 hours after ingesting 
a high energy (389kcals), low energy (187 kcals) or no energy (water) preload in a 
sample of 76 schoolchildren aged four to ten years. Foods offered at the test meal 
provided a selection of cold sweet and savoury items adding up to 1900 kcals. Foods 
were weighed before and after consumption, and energy content was determined 
using caloric values provided by the manufacturer.  Children with at least one higher 
risk FTO allele ingested food with significantly higher energy density, but not higher 
weight, than children with the lower risk genotype after receiving the no energy and 
low energy preload, with a similar trend for the high energy preload.  This effect 
remained significant after controlling for age and BMI.  
 
Comparable results were obtained in a study by Wardle and colleagues (2008) who 
focused on the association of FTO and the phenotype known as ‘eating in the absence 
of hunger’ (EAH).  In a home-based study, 131 children aged four to five years received 
a plate of highly palatable food (sweet and savoury biscuits) one hour after consuming 
a meal to satiety. Children were instructed to eat as much as they liked for the 
duration of 10 min and the amount eaten was determined by weighing the plate with 
the biscuits before and after task completion.  Food intake was significantly higher in 
children carrying one or two FTO higher risk alleles than in children homozygous for 
the lower risk allele; following a linear trend.  Results remained significant after 
adjusting for BMI.  
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However, a study by Dougkas and colleagues (2013) failed to show an association of 
FTO genotype and food intake in a sample of 40 overweight men (mean BMI: 27, SD = 
2.0) who had consumed a dairy snack providing 201kcal (either semi-skimmed milk, a 
natural yoghurt, or cheese) or an isovolumetric amount of non-carbonated water 
(depending on treatment condition) 90 min prior to an ad libitum lunch.  It is possible 
that individuals in this study were self-conscious and restrained their food intake 
because of stigma surrounding food intake in the overweight which was overriding any 
genetic tendencies to consume more food.  
 
Studies from population-based cohorts provide mixed evidence for an association of 
FTO with energy intake.  It was reported in the Avon Longitudinal Study of Parents and 
Children (ALSPAC), a cohort of 3641 children for which detailed three day parent 
completed dietary records were available (Timpson et al., 2008), and in a study with 
150 adults aged between 21 and 64 years (54% overweight or obese) who completed 
detailed and verifiable (all food packaging was kept) seven day food records 
(Speakman, Rance, & Johnstone, 2008). However, in other studies it was not evident 
(Hasselbalch et al., 2010; McCaffery et al., 2012; Holzapfel et al., 2010; Bauer et al., 
2009; Park et al., 2013; Brunkwall et al., 2013).  It might be that the association of FTO 
with energy intake varies over the life course in accordance to its association with 
weight and BMI (Hardy et al., 2010), which is stronger in children since findings from 
these studies are largely in agreement.  All but one paediatric study involving a sample 
of 1978 European and African-American adolescents (mean BMI: 22.8, SD not 
reported) using 24h diet recalls (Liu et al, 2010) reported an association of the higher 
risk FTO alleles with higher food intake.  Alternatively, it is possible that under-
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reporting and cognitive factors such as eating restraint are more prevalent in adult 
cohorts.  Under-reporting of dietary intake has been well documented (e.g.Westerterp 
& Goris, 2002; Briefel, Sempos, McDowell, Chien, & Alaimo, 1997), particularly in the 
overweight or obese (e.g. Braam Ocké, Bueno-de-Mesquita, & Seidell, 1998; 
Johansson, Solvoll, Bjørneboe & Drevon, 1998), and may have had an influence in 
cohorts with a significant proportion of overweight and obese individuals.  Several 
studies (but not all) investigated under-reporting and found that AA carriers were 
significantly more likely under-report total energy intake than TT carriers 
(e.g.Brunkwall et al., 2013; Sonestedt et al., 2009).  Although these studies excluded 
the most severe cases of under-reporting, it may still have been widespread, albeit to 
a lesser extent.  
 
However, population-based cohorts consistently report that individuals with AT or AA 
genotypes derive a greater percentage of their caloric intake from fat; irrespective 
whether subjects were adults or children (Sonestedt et al., 2009; Park et al., 2013; 
Timpson et al., 2008). Bearing in mind the limitations of self-reported dietary data, this 
finding is likely to be relatively robust.  
 
1.4.2.1 FTO and eating behaviour  
Nine studies have investigated the effects of FTO on aspects of eating behaviour other 
than energy-or macronutrient intake (Wardle et al., 2008; Ibba et al., 2013; Dougkas et 
al., 2013; Tanofsky-Kraff et al., 2009; Karra et al., 2013; den Hoed, Westerterp-
Plantenga, Bouwman, Mariman, & Westerterp, 2009; Mueller et al., 2012; Jonassaint 
et al., 2011; Cornelis et al., 2013).  Of those, five focused on responses to satiety 
sensitivity (Wardle et al., 2008; den Hoed et al., 2009; Ibba et al., 2013; Karra et al., 
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2013; Dougkas et al., 2013) and four on aberrant eating behaviours such as loss of 
control over eating, emotional eating and cognitive restraint, either in general 
population samples (Tanofsky-Kraff et al., 2009; Cornelis et al., 2013) or in individuals 
with diagnosis of eating disorders (Mueller et al., 2012; Jonassaint et al., 2011).  Five 
studies focused on children or adolescents (Jonassaint et al., 2011; Ibba et al., 2013; 
Wardle et al., 2008; Timpson et al., 2008; Tanofsky-Kraff et al., 2009; Mueller et al., 
2012).  In most studies, samples were from the general population and therefore of 
normal weight; two studies had overweight or obese samples (Dougkas et al., 2013; 
Ibba et al., 2013). Sample sizes ranged from 10 (Karra et al., 2013) to 3852 (Cornelis et 
al., 2013) participants and all studies were cross-sectional. Methods varied between 
studies, from self-reported or parent-reported food intake or eating behaviour to 
standardized laboratory test meal protocols. 
 
1.4.2.2 FTO and satiety sensitivity 
There is strong evidence that FTO influences satiety sensitivity. Wardle and colleagues  
(Wardle et al., 2008) genotyped 3337 children aged 8-11 years from the TEDS cohort 
for the FTO SNP rs9939609, and investigated associations of the higher risk A allele 
with the Child Eating Behaviour Questionnaire (CEBQ), a standardized, validated 
measure of appetite assessing satiety responsiveness and enjoyment of food (Wardle, 
Guthrie, Sanderson & Rapoport 2001).  Weight and height were parent-reported and 
BMI SD scores were derived from the data.  AA homozygotes had significantly reduced 
scores for satiety responsiveness, and this effect remained significant after adjusting 
for covariates including gender, family socioeconomic status (SES), and BMI SD score.  
However, reduced satiety sensitivity was not observed in children with the AT 
genotype; possibly owing to FTO’s small effect size.  Mediation analysis indicated that 
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the association of FTO and BMI was in part mediated by satiety responsiveness, 
although this finding was only borderline significant (p = 0.05).   
 
These findings were replicated in an experimental setting involving 103 adults (66 
women and 41 men, mean age: 31 years, SD = 14 years) of predominantly borderline 
healthy weight (mean BMI 25.0, SD = 3.1; den Hoed et al., 2009).  Participants were 
asked to rate hunger and satiety on visual analogue scales before and after consuming 
a fixed meal in the laboratory (providing macronutrients and calories according to 
individual needs) following an overnight fast.  Individuals carrying at least one higher 
risk A allele were significantly more likely to be classified as ‘high’ in hunger and ‘low’ 
in satiety responsiveness after meal consumption, taking baseline values into account. 
The results remained unchanged after adjusting for age, gender and BMI.  
 
Similarly, the randomised cross-over trial by Dougkas and colleagues (2013) described 
earlier also asked their sample of overweight men to rate hunger and satiety 90 min 
after consumption of preloads with varying energy density.  Mean ratings in hunger 
were 23.9% higher (p =0.019) and satiety was reduced by 17.2% (p = 0.026) in 
participants who had at least one FTO A allele compared with those who had the TT 
genotype. 
 
However, two studies failed to show and association of the higher risk A allele with 
reduced satiety responsiveness.  Tanofsky-Kraff and colleagues (2009) did not detect 
any differences in satiety responsiveness by FTO genotype in a sample of 289 children 
and adolescents aged 6-19 years of predominantly normal weight (BMI TT: 22.85, SD = 
0.8; BMI AT/AA = 25.87, p = 0.002) after consuming an ad libitum lunch.  Ibba and 
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colleagues (2013) used a sample of 412 obese (BMI SDS 2.7, SD = 1.43) Sardinian 
children and adolescents aged 4-20 years using the Satiety Responsiveness subscale of 
the CEBQ (Wardle et al., 2001).  It is likely that the relatively homogenous sample (all 
were obese) did not show sufficient variation in satiety responsiveness to determine 
differences between genotypes.  The wide age range that also included children going 
through puberty may have contributed to the findings, although stratifying the sample 
by age (0-6 n = 30, 7-11 n = 208, 12-15 n = 130, 16-19 n = 46) still did not show 
differences in satiety sensitivity between genotypes, but the sample sizes were small 
in each group.  
 
In a very recent study, Lewellyn and colleagues (in press) created a polygenic risk score 
using 28 well-established obesity SNPs (including FTO), and investigated satiety 
responsiveness and adiposity in a sample of 2258 children (mean age: 9.9 years, SD = 
0.84).  A greater number of ‘obesity genes’ was significantly associated with lower 
satiety responsiveness and greater adiposity, further supporting the hypothesis that 
satiety responsiveness is a valid endophenotype for greater genetic susceptibility to 
obesity.  
 
Recently, one research group provided evidence that secretion of hormones 
influencing hunger and satiety in response to a meal is altered in carriers with the AA 
genotype; providing a biological mechanism whereby FTO may decrease satiety 
sensitivity (Karra et al, 2013).  The sample consisted of 359 males aged 18-35 of 
normal weight (BMI = 22.5, SD = 0.1).  Ten AA and TT participants matched for age, 
BMI, fat mass, and visceral fat area (to avoid any confounding effects of these 
variables) were selected and received a standard test meal consisting of 1840 kcals 
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after an overnight fast and were given 20 min to consume it. Appetite was assessed 
using visual analogue scales before meal ingestion, 20 and 30 min post-meal and every 
30 min thereafter until 180 min after meal termination; simultaneously, blood was 
drawn. AA homozygotes failed to suppress circulating levels of acetyl-ghrelin (the gut 
hormone responsible for sending ‘hunger’ signals to the brain) in response to the test 
meal, and levels remained elevated for the duration of the study period.  
Correspondingly, AA participants also reported significantly higher levels of hunger 
after meal termination and for the remainder of the study period than TT 
homozygotes.  Furthermore, the authors showed that responses to food images 
differed between carriers of the lower-risk (TT) genotype vs. the higher-risk (AA) 
genotype using fMRI data from another group of 24 participants who were closely 
matched for age, gender and BMI.  In contrast to TT carriers, AA carriers exhibited a 
reduced blood-oxygen-level dependent (BOLD) response to food images in the fasted 
state within brain areas related to food reward and goal-directed behaviour 
(hypothalamus, left ventral tegmental area/substanita nigra, left posterior insula, left 
globus pallidus, left thalamus, left hippocampus).  Furthermore, the difference in BOLD 
response to high-calorie vs. low-calorie foods was reduced in AA carriers in the fed vs. 
fasted state; whereas TT carriers showed a greater BOLD response for low-calorie (vs. 
high-calorie) images in the fed (vs. fasted) state.  These findings match emerging 
evidence from a series of in vivo studies by the authors which suggest that Fto 
regulates dopaminergic activity in the brain areas described above by altering 
Dopamine-2-Receptor (D2R) and Dopamine-3-Receptor (D3R) dependent signalling.  
However, it remains to be discovered how these findings link to its role of 
demethylation of N6-methyladenosine (m6A) in RNA.  
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1.4.2.3 FTO and eating disorders 
Evidence for the association of FTO with disordered eating is mixed.  Tanoffsky-Kraff 
and colleagues (2009) discussed earlier also investigated self-reported loss of control 
over eating in their sample of 289 children and adolescents using the Eating Disorder 
Examination (EDE), a well-established self-report questionnaire (Luce & Crowther, 
1999). A significantly higher number of children and adolescents with at least one 
higher risk FTO allele reported having had at least one loss of control eating episode in 
the month preceding assessment (34.7%, n = 66 vs. 18.2%, n = 18) compared with 
those with the lower risk genotype and this difference remained significant after 
adjusting for BMI z-score.  
 
In a more recent study, Cornelis and colleagues (2013) reported on the association of 
FTO and 31 other obesity susceptibility loci with uncontrolled eating, emotional eating 
and eating restraint for each gene individually and for a combined genetic risk score.  
The sample consisted of 3852 individuals in their mid-sixties who were predominantly 
slightly overweight (mean BMI women: 25.9 kg/m2, SD: 5.1; mean BMI men: 25.3 
kg/m2, SD = 3.1).  Participants completed the Three Factor Eating Questionnaire 
(TEFQ), which is a self-report measure with excellent psychometric properties 
(Stunkard & Messick, 1985).  FTO was significantly associated with all three aberrant 
eating behaviours, with each higher risk allele resulting in modestly increased scores 
(~0.12-0.33) on each TEFQ subscale.  However, only the association with cognitive 
restraint remained significant after adjustment with BMI and none of the associations 
survived adjustments for multiple testing. This was also the case for associations of the 
genetic risk score with aberrant eating and for any of the other SNPs investigated.  
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Studies using clinical samples to determine the association of FTO and aberrant eating 
behaviours are also inconclusive.  Jonassaint and colleagues (2011) did not find an 
association of FTO with anorexia nervosa (AN) comparing a sample of 1085 cases with 
677controls, irrespective of subtype (AN with/without bingeing, AN with/without 
purging, AN with bingeing and purging); whereas Mueller and colleagues (2012) 
reported an association of FTO with bulimia nervosa (BN) in a case-control study 
including 477 participants with BN, 689 with AN, 984 non-population healthy controls 
and a population sample of 3951 control participants; although the association was 
only evident in comparison with the non-population-based sample of controls.  
 
Taken together, it appears unlikely that FTO has a strong role in the onset of clinically 
significant disordered eating; although the transition from simple overeating to eating 
pathology may be fluid and FTO may make a minor contribution by influencing 
appetitive traits.   
 
1.4.3 FTO and energy expenditure 
Although there is no evidence for the association of FTO with energy expenditure in 
humans (e.g. Haupt et al., 2009; Berentzen et al., 2008; Speakman et al., 2008; 
Hakanen et al., 2009), evidence for the protective effects of physical activity (PA) in 
individuals carrying higher risk alleles is strong.  A recent meta-analysis including 54 
studies with a total sample of 218,166 adults and 19,268 children confirmed that the 
effect of FTO on BMI is attenuated by 27% in physically active individuals homozygous 
for the A allele (Kilpeläinen et al., 2010).  The meta-analysis included 41 published and 
13 unpublished studies.  Included studies measured PA either using self-report or 
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pedometers. To account for these differences, PA was dichotomized into ‘inactive’ and 
‘active’.  In studies using categorical outcomes, individuals reporting a sedentary 
occupation and less than one hour of light-to-moderate PA or commute per week 
were classified as ‘inactive’; in studies reporting PA as continuous variable, participants 
in the bottom 20% of the sex-specific sample population were deemed ‘inactive’.  
Pooled data analysis indicated that PA significantly attenuated the association of FTO 
with BMI, with the effect of the AA genotype being reduced by 30% in physically active 
adults. Samples were subsequently stratified by region, because of moderate study 
heterogeneity.  Results indicated that the attenuating effect is stronger in North 
Americans than Europeans, with a 59% reduction of the association of FTO and BMI in 
North Americans, but only a 19% reduction in Europeans.  Furthermore, waist 
circumference was significantly smaller and body fat was significantly reduced in 
physically active risk allele carriers (33% and 36%, respectively).  However, differences 
between geographic regions were not significant for any of these variables.  Level of 
physical activity also appeared to be irrelevant.  In children, no significant associations 
with any of the outcome variables were observed.  
 
In summary, studies conducted to date provide strong evidence that the higher risk 
alleles foster overconsumption in the current obesogenic environment by decreasing 
satiety sensitivity but are unlikely to be responsible for clinically relevant eating 
pathology.  However, the effect can be attenuated by being physically active, perhaps 
because physical activity offsets excess energy consumed or because it improves 
satiety sensitivity.  These findings are of clinical relevance because they provide scope 
for behavioural intervention.  Furthermore, although FTO acts by affecting food intake, 
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results show that exercise is a vital component of any weight control program, 
particularly for individuals genetically predisposed to obesity.  
 
1.5 Environmental influences in obesity development 
 
Despite the strong evidence for genetic influences in obesity onset, sceptics often note 
that genes cannot be held accountable for the rapid rise in obesity levels, because the 
genome cannot have changed substantially in such a short time span. Furthermore, 
genes known to date can account only for a fraction of the estimated heritability in 
weight.  Therefore, they conclude, causes for obesity must be rooted in the current 
environment (Gortmaker et al., 2011).   
 
Undoubtedly, the profound technological progress over the past 30 years has created 
an environment that fosters overconsumption of food. Changes in farming practices 
and food production have reduced the ‘time price for food consumption’ and made 
highly palatable, energy-dense food widely and cheaply available. Unintentional, 
regular overconsumption (‘passive overconsumption’) is therefore easy and can add 
substantially to weight gain over time (Swinburn et al., 2011).  Moreover, because lives 
have become increasingly sedentary, excess energy intake is less likely to be 
compensated for by physical exertion, tipping the balance further towards energy 
storage.  
 
However, despite the pressures of this so-called obesogenic environment, not 
everybody exposed to it becomes overweight.  In fact, the weight distribution curve is 
becoming increasingly skewed, indicating that overweight and obese individuals have 
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gained the most weight whereas numbers of lean individuals have not substantially 
changed (Foresight, 2007).  This suggests that the obesogenic environment is 
detrimental predominantly for individuals who have a vulnerability to unhealthy 
weight gain.  The gene x environment interaction model proposes that genes may 
predispose an individual to become overweight, but an environment that fosters their 
expression is needed, i.e. sufficient food availability (‘Genes load the gun, environment 
pulls the trigger’ – Bray, 1998).  Nature and nurture are thus not opponents in the 
obesity epidemic, but jointly drive obesity rates upward.  
 
1.6 The importance of weight gain prevention 
 
In their White Paper, ‘Healthy Lives, Healthy People: Our Strategy of Public Health in 
England’ (2010) the UK government made disease prevention a priority, because 
benefits on a population level are expected to be high: ‘At a population level, it is not 
better treatment, but prevention – both primary and secondary, including tackling the 
wider social factors that influence health – which is likely to deliver greater overall 
increases in healthy life expectancy.’ (Department of Health, 2010).   
 
Although obesity itself is not considered a disease in the UK and has only been 
recently classified as such in the US (which has been widely debated), the catalogue of 
associated chronic, and often severe, health conditions necessitates the reduction of 
its prevalence and is therefore included in the White Paper.  However, although 
effective interventions for weight reduction exist (consisting of behavioural, 
pharmacological and surgical options), sustained weight loss even at the 
recommended level of 10% of body weight which has been associated with significant 
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health benefits, is difficult to achieve except with surgical methods (which have a very 
high success rate), and only a small proportion of individuals who initially lose weight 
succeed (Anderson, Konz, Frederich, & Wood, 2001).  Physiological and metabolic 
changes in response to weight reduction persist long after weight loss and leave 
individuals vulnerable to weight regain and weight cycling (Sumithran et al., 2011; 
MacLean, Bergouignan, Cornier, & Jackman, 2011; Sumithran & Proietto, 2013; Reed, 
Chaput, Tremblay, & Doucet, 2013; Redman et al., 2009).   
 
The high level of commitment required even among individuals who have achieved 
significant weight loss, to avoid weight regain is well documented in the National 
Weight Control Registry (NWCR).  The NWCR consists of over 13,000 participants who 
have lost at least 13.6 kg (30 lb.) and kept it off for the minimum of one year; although 
the average time period since weight loss is 5.5 years.  Comparison of successful and 
unsuccessful weight loss maintainers shows that successful weight maintainers are 
highly physically active (on average one hour of moderate to vigorous activity/day), 
consistently eat a low-calorie, low-fat diet (on average 1800 kcal/day with 24% of 
energy coming from fat), monitor their food intake closely, eat breakfast every day of 
the week, don’t score high on dietary disinhibition (a measure of loss of control over 
eating), weigh themselves frequently (mostly daily), and correct small dietary ‘slips’ 
immediately using compensatory behaviours such as increased physical activity or 
further caloric restriction (Phelan, Wyatt, Hill, & Wing, 2006; Wing & Phelan, 2005).  It 
can easily be seen why maintaining this level of behaviour change over the long-term 
just to prevent weight regain can be difficult. 
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Focusing attention on weight gain prevention appears to be the reasonable next step 
to stall obesity rates on a large scale for several reasons: First, obesity is commonly the 
result of a small, persistent energy imbalance in favour of excess energy of about 
100kcal/day (Hill, 2003).  Correcting this imbalance requires only small adjustments in 
energy intake or expenditure because the aim of weight gain prevention is to create 
equilibrium between energy intake and expenditure.  Weight loss, in contrast, requires 
the creation of an energy deficit which can only be achieved through larger changes in 
energy intake and/or expenditure, which usually necessitate substantial behaviour 
change.  Implementing and maintaining significant behaviour change is in itself a 
challenge, which requires considerable cognitive resources and skills in self-regulation 
such as self-monitoring and stimulus regulation (Mason & Butler, 2010).  In contrast, 
implementing small changes to prevent weight gain should be less cognitively 
demanding and might thus be easier to sustain.   
 
 
1.7 Risk of weight gain in young adults 
 
Although it is sensible to assume that weight gain prevention efforts should begin as 
early as possible and continue throughout life, young adulthood constitutes a time 
where intervention might be particularly beneficial.   
 
Whereas weight gain usually occurs gradually over a number of years (Hill, Wyatt, 
Reed, & Peters, 2003), some life stages have been associated with increased risk of 
rapid weight gain.  One of these periods is the transition from late adolescence to 
adulthood.  Evidence from epidemiological studies indicates that weight gain is most 
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pronounced between the ages of 18 and 35, with obesity onset usually occurring 
before the age of 30 (Gordon-Larsen, The, & Adair, 2010).  Importantly, weight gained 
within this period is not lost over time, and thus leads to a significant increase in the 
proportion of young adults being classified as overweight or obese (Lewis, 2000).  This 
is problematic because younger age of obesity onset is associated with more severe 
health outcomes for associated diseases, such as diabetes mellitus type 2 and 
cardiovascular disease, younger age of mortality, as well as less favourable social and 
economic status (Gortmaker, Must, Perrin, Sobol, & Dietz, 1993; Dietz, Gortmaker, 
Sobol, & Wehler, 1985; Ryan, 2009).   
 
Moving out of home, going to university, starting work (which often leads to a more 
sedentary lifestyle), cohabitation, and pregnancy have all been identified as 
contributing to disproportionate weight gain during this period (Poobalan, Aucott, 
Precious, Crombie, & Smith, 2010).  Perhaps the best studied phenomenon is the 
transition from school to university and the remainder of this review will focus on this 
contributor to weight gain because of the study population used for most of the 
studies in this PhD.  
 
The transition from home to the university environment instigates a distinct life stage, 
associated with independence, yet without the major responsibilities of working adult 
life.  Moving to a new environment and living independently allows for experimenting 
with different worldviews and lifestyles, developing and refining personality and self-
identity (Nelson, Story, Larson, Neumark-Sztainer, & Lytle, 2008).  The development of 
self-identity is crucial from a health promotion perspective, as self-efficacy and 
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identity have been important components in successful behaviour change and 
maintenance (Elfhag & Rossner, 2005).   
 
Furthermore, as young adults are able to make the lifestyle choices they deem 
suitable, lasting lifestyle behaviours may be established within this period which may 
facilitate or hamper weight gain prevention.  Therefore, the start of university offers a 
unique window of opportunity for weight gain prevention (Nelson et al., 2008). 
 
Unfortunately, it appears that the college environment is not conducive to the 
formation and maintenance of health promoting behaviours.  A substantial proportion 
of young adults gain disproportionate amounts of weight within the first three to four 
months of starting university (Mihalopoulos, Auinger, & Klein, 2008; Serlachius, 
Hamer, & Wardle, 2007).  Anecdotally, it has been said that young people gain about 
15lbs of weight after leaving for university (the so-called ‘Freshman 15’), although this 
is probably an overestimate.  The body of research has generally shown that actual 
weight gain is on average closer to 5 lbs (e.g. Holm-Denoma, Joiner, Vohs, & 
Heatherton, 2008; Anderson, Shapiro, & Lundgren, 2003).   
 
Work carried out mainly in the United States (US) indicates that college life is marked 
by frequent consumption of fast-food (sometimes because no healthy options are 
available in the vicinity), late night eating, and heavy drinking.  Furthermore, perceived 
work load limits the time for physical activity, which, alongside with stress, further 
contributes to weight gain (Lowry et al., 2000; Furia, Lee, Strother, & Huang, 2009; 
Nelson, Kocos, Lytle, & Perry, 2009).  Environmental factors, such as lack of cooking 
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facilities and large distances to shops, lead students to keep considerable amounts of 
non-perishable food items in their dormitory rooms, which may lead to overeating.   
 
Nelson & Story (2009) conducted an observational study and counted the food kept in 
dormitory rooms of 100 students at a large US university.  Each existing item of food 
and beverage was classified into one of ten categories.  Calorie and fat content was 
also recorded for each item that belonged to the student, as well as for shared foods 
and beverages.  In addition, participants completed a survey about eating patterns.  
The authors found that 85% of students were on a campus meal plan.  Nevertheless, 
number of food items and drinks kept in rooms ranged from zero to 208, with a mean 
of 47 items.  This equalled an average calorie count of over 22,000 calories.  As 
mentioned above, the specific setting of many US universities, which are campus 
universities, often in isolated areas, may contribute to students ‘hoarding’ food in their 
rooms.  Therefore, these findings may not fully apply to Europe, where universities are 
commonly integrated within cities, and amenities are relatively easily accessible.  
 
Studies examining weight gain in European students are rare.  Serlachius and 
colleagues (2007) investigated the association of lifestyle changes and stress with 
weight change in 268 first-year university students at a British university.  Health 
behaviours, weight, weight change and stress were self-reported.  Over half of the 
sample (55%) reported weight gain, although 12% reported weight loss.  Participants 
reporting weight change reported significantly more stress than those who remained 
at a stable weight.  Students overall reported sleeping less, drinking more alcohol, 
exercising less, and eating fewer meals per day than in the last year of secondary 
school, although snacking frequency did not differ.  This was consistent among all 
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groups.  Mean reported weight gain was 1.53 kg, which is less than observed in the US.  
This difference may be because of differences in culture and university environment; 
alternatively it may be possible that selection bias contributed to the findings as the 
survey was voluntarily.  However, these findings show that trends for weight gain in 
European university students may be in the same direction, even if not as pronounced.   
 
1.7.1 Weight gain prevention interventions in young adults 
In comparison with the literature on weight loss, weight gain prevention interventions 
occupy only a small niche in obesity research to date, with 858 entries in Pubmed as of 
August 2013 (compared with 6086 entries when searching for ‘weight loss 
interventions’).   
 
Preventive interventions often use equivalent methods to those aimed at weight loss; 
namely improving dietary quality, increasing physical activity, and teaching 
behavioural skills such as self-regulation and goal setting to enable individuals to 
implement and maintain behavioural changes.  Two recent reviews have assessed the 
efficacy of weight gain prevention interventions in young adults (Hebden, Chey, & 
Allman-Farinelli, 2012; Laska, Pelletier, Larson, & Story, 2012). Hebden and colleagues 
(2012) conducted a systematic review and meta-analysis of randomised controlled 
trials (RCTs) for weight gain prevention.  In addition to being RCTs, studies had to be 
published between 1980 and August 2011, and explicitly focus on young adults aged 
18 to 35, who were free of chronic diseases (e.g. eating disorders, obesity-related 
diseases), studies should not be primarily concerned with weight loss or designed 
exclusively for the obese, and should focus on ‘lifestyle’ changes (rather than 
medication adherence) and should use mean weight change as outcome variable.  
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Databases searched included PubMed, MEDLINE, PsychINFO, ERIC, CINHAL, the 
Cochrane Library, Embase, Science Direct, Web of Science, Scopus and several others 
using a variety of keywords referring to the study population, intervention and 
outcomes.  Of the nine studies identified, only eight were included in the meta-
analysis, because one study (Matvienko, Lewis, & Schafer, 2001) did not report the 
precise mean change in body weight over the intervention period.  
 
Laska and colleagues (2012) had identical exclusion criteria, but did not restrict their 
search to RCTs and also accepted studies who used measures other than weight/BMI 
change as primary outcome variables (although their paper discusses only studies in 
detail which included weight/BMI change).  Their review was limited to studies 
conducted in the US or Canada that were published between 1985 and July 2011.  
Databases searched included PubMed, MEDLINE, PsychINFO, ERIC and CINHAL, using a 
variety of keywords referring to the study population, intervention and outcomes 
described above.  In addition to the nine studies identified by Hebden et al (2012), 
Laska et al (2012) identified 28 further interventions which did not include weight/BMI 
change as outcome variables but focused on improvements in nutrition knowledge, 
physical activity and mastery of behavioural skills to prevent weight gain.  The present 
review discusses findings from these 37 studies (43 publications) below.  
 
Similar to interventions aimed at other age groups, studies with young adults focused 
on improving dietary quality, increasing physical activity and teaching skills to limit 
food intake above caloric need or a combination of those.  With the exception of three 
studies which used convenience samples of young adults from the general population 
(Gokee LaRose, Tate, Gorin, & Wing, 2010; Klem, Viteri, & Wing, 2000; Kirk et al., 
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2009) or from a group with one overweight parent (Eiben et al. 2006), all were 
conducted in a university/college setting and were designed for students.   
 
1.7.1.1 Dietary interventions 
Sixteen studies (discussed in 19 publications) attempted to exclusively improve dietary 
quality in young adults (Peterson, Duncan, Null, Roth, & Gill, 2010; Matvienko et al., 
2001; Finckenor & Byrd-Bredbenner, 2000; Ha & Caine-Bish, 2009; Ha, Caine-Bish, 
Holloman, & Lowry-Gordon, 2009; Ha & Caine-Bish, 2011a; Chu, Frongillo, Jones, & 
Kaye, 2009a; Skinner, 1991; Shive & Morris, 2006; Brinberg, Axelson, & Price, 2000; 
Davis-Chervin, Rogers, & Clark, 1985; Freedman & Connors, 2011; Hekler, Gardner, & 
Robinson, 2010; Levy & Auld, 2004a; Clifford, Anderson, Auld, & Champ, 2009; 
Richards, Kattelmann, & Ren, 2006; Nitzke et al., 2007; Park et al., 2008; Poddar, 
Hosig, Anderson, Nickols-Richardson, & Duncan, 2010).  Although only one study 
included weight change as outcome variable (Matvienko et al., 2001), and one 
assessed weight only at baseline but not follow-up (Ha et al., 2009), the framing of the 
papers often alluded to the assumption that better dietary quality would lead to 
avoidance of unhealthy weight gain and overweight in the long-term.  Furthermore, 
studies targeted areas related to weight gain prevention such as knowledge about 
healthy food and eating, information about benefits of healthy eating and cooking 
skills.  
 
Twelve interventions were designed to improve overall diet quality and seven sought 
to improve intake of one specific food group or dietary component.  Of these 
interventions, most targeted fruit or vegetable intake (Ha & Caine-Bish, 2009; Richards 
et al., 2006; Nitzke et al., 2007; Park et al., 2008), two focused on dairy foods (Poddar 
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et al., 2010; Ha et al., 2009), one on fibre (Brinberg et al., 2000), one on whole grains 
(Ha & Caine-Bish, 2011b) and, one on fat (Finckenor & Byrd-Bredbenner, 2000).  
 
Methods used varied, including  distributing pamphlets and leaflets with information 
and tips about healthy eating around campus or sending them to students by email 
(Richards et al., 2006; Nitzke et al., 2007; Park et al., 2008), giving out free fruit and 
vegetables (Shive & Morris, 2006), providing cooking classes (Levy & Auld, 2004b), 
watching a cooking TV show (Clifford et al., 2009), providing calorie information for 
dishes sold at food outlets around campus (Chu et al., 2009a; Peterson et al., 2010; 
Davis-Chervin et al., 1985), and introducing a label that signified which foods were 
‘healthy’(Freedman & Connors, 2011).  However, most interventions were nutrition 
courses, taught either face-to-face (Matvienko et al., 2001; Hekler et al., 2010; 
Finckenor & Byrd-Bredbenner, 2000; Skinner, 1991; Ha & Caine-Bish, 2009; Ha et al., 
2009; Ha & Caine-Bish, 2011b) or online (Poddar et al., 2010)for which students 
received course credit.  
 
Study duration ranged from four weeks (Park et al., 2008) to 16 months (Matvienko et 
al., 2001), with an average duration of 5 months (median: 4 months).  Only two studies 
included one-year follow-up (Finckenor & Byrd-Bredbenner, 2000; Nitzke et al., 2007) 
and two further studies ran for more than one year (Matvienko et al., 2001; Evans & 
Sawyer-Morse, 2002) 
 
The total combined sample size of all studies was 5505 participants.  Sample sizes 
ranged from 65 (Levy & Auld, 2004a) to 2024 (Nitzke et al., 2007), with a mean sample 
size of 348 individuals; although four studies failed to report exact sample sizes 
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(Freedman & Connors, 2011; Brinberg et al., 2000; Davis-Chervin et al., 1985; Chu, 
Frongillo, Jones, & Kaye, 2009b).  Attrition rates were often not reported; where they 
were reported, retention rate was over 80%.  Only eight out of the 17 studies were 
trials, and of those, two did not use random group allocation (Finckenor & Byrd-
Bredbenner, 2000; Hekler et al., 2010).  Trials usually had two arms (intervention vs. 
control); only one study had three arms (Finckenor & Byrd-Bredbenner, 2000) 
 
Results from these studies were mixed with some finding improvements in students’ 
dietary intake and others being less successful.  The one study including weight gain as 
outcome variable (Matvienko et al., 2001) found no change in BMI; although students 
with higher BMI in the intervention group made more beneficial changes than those 
with higher BMI in the control group and maintained these for at least one year.  
Because of the diversity in study designs and reliance on self-report for all outcomes, it 
is difficult to discern ‘active’ ingredients of interventions.  Furthermore, the small 
number of studies that ran for more than one semester limits conclusions about 
efficacy regarding long-term dietary changes.  
 
1.7.1.2 Exercise interventions 
Twelve interventions (reported in 13 publications) focused exclusively on improving 
physical activity to achieve weight gain prevention (Cardinal, Jacques, & Levy, 2002; 
Sallis et al., 1999; Donnelly et al., 2003; DeVahl, King, & Williamson, 2005; Cholewa & 
Irwin, 2008; Boyle, Mattern, Lassiter, & Ritzler, 2011; Claxton & Wells, 2009; Jung & 
Heald, 2009; Parrott, Tennant, Olejnik, & Poudevigne, 2008; Ornes & Ransdell, 2007; 
Calfas et al., 2000; Jackson & Howton, 2008; Kirk et al., 2009); although only five 
assessed changes in weight, BMI or per cent body fat (Cholewa & Irwin, 2008; Kirk et 
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al., 2009; DeVahl et al., 2005; Donnelly et al., 2003; Boyle et al., 2011).  Studies that 
did not report anthropometric changes most commonly assessed changes in levels of 
physical activity (8/13), either using self-report (4/8), pedometers (2/8) or using proxy 
measures such as resting energy expenditure (1/8); one study reported on changes in 
intentions to exercise as assessed by self-report (Jung & Heald, 2009).   
 
Exercise was prescribed and carried out in the research setting in three studies and 
self-directed, with weekly goal recording in six studies.  Type, frequency and intensity 
of physical activity were often not specified.  In the four studies where it was reported, 
walking (no. of steps) or running were the most frequently mentioned activities, and 
one study specifically focused on resistance training.  
 
Study duration varied across studies from two weeks (Parrott et al., 2008) to 18 
months (Sallis et al., 1999), with only two studies running for more than 1 year 
(Donnelly et al., 2003; Sallis et al., 1999).  Mean duration of interventions was 21 
weeks (median: 12 weeks).  Main outcomes were usually assessed at the end of the 
intervention period; although one study reported follow-up results at three weeks 
(Parrott et al., 2008), and another at 2 years (Calfas et al., 2000).  
 
The combined total sample size of all studies was 2344.  Individual sample sizes ranged 
from 39 (Kirk et al., 2009) to 540 participants (Cardinal et al., 2002), with a mean 
sample size of 195 participants.  Studies usually randomly assigned participants to one 
of two arms (intervention or control); only one study had three arms and in this study 
participants could choose which group they wanted to be assigned to (Cholewa & 
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Irwin, 2008). Levels of non-attendance or attrition was frequently not reported (8/13 
studies); and where it was mentioned, around 50% of participants were retained.   
 
Overall, the efficacy of these interventions was mixed; eight studies were successful in 
increasing exercise intentions, or levels of physical activity.  Anthropometric markers 
improved in four studies in at least some of the intervention participants.  Limited 
information about the interventions in the majority of studies discussed here makes it 
difficult to assess whether any specific features may have contributed to the varied 
outcomes.  
 
1.7.1.3 Behavioural skills 
One publication reported on two studies which focused exclusively on self-monitoring 
in the form of daily weighing to prevent weight gain (Levitsky, Garay, Nausbaum, 
Neighbors, & DellaValle, 2006).  In the first study, 32 female freshmen were randomly 
assigned to intervention or control groups after weights were recorded by the 
researchers.  The intervention group emailed self-recorded weights (taken in the 
morning immediately after rising) daily to the research team.  After the first seven 
days which were used to calculate a regression line of their weight change, they 
received daily reports about the slope of weight change for 10 weeks.  In the second 
trial, intervention participants ( n = 16) also reported self-recorded daily weights, but 
received feedback on caloric modification required to maintain weight after the first 
seven days which were used to calculate average weight for 10 weeks.  Results from 
both studies were positive, showing no significant weight gain in intervention groups 
over the intervention period (0.1 kg ± 0.99 kg and -0.82 ± 0.56 kg) compared with 
controls who gained 3.1 kg ± 0.51 kg and 2.0 ± 0.65 kg, p < 0.01, respectively.   
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1.7.1.4 Combined interventions 
Nine studies were designed to include a combination of dietary, exercise and 
behavioural components (Gokee-LaRose, Tate, Gorin, & Wing, 2010; Stice, Orjada, & 
Tristan, 2006; Gow, Trace, & Mazzeo, 2010; Klem, Viteri, & Wing, 2000; Eiben & 
Lissner, 2005; Hivert, Langlois, Berard, Cuerrier, & Carpentier, 2007; Boyle, Mattern, 
Lassiter, & Ritzler, 2011; Werch et al., 2008; Leermakers, Jakicic, Viteri, & Wing, 1998).  
All these interventions were delivered as structured programmes, comprised of 
lectures, seminars and small group discussions.  One study (Gow et al, 2010) also 
included online materials that participants were asked to complete in their own time, 
sometimes for course credit (2/8 studies).   
 
All studies used BMI/weight change as main outcome; self-reported in seven studies 
(Gokee-LaRose et al., 2010; Hivert et al., 2007; Eiben & Lissner, 2005; Gow et al., 2010; 
Hebden, Chey, & Allman-Farinelli, 2012; Leermakers et al., 1998) and measured by a 
researcher in two studies (Stice et al., 2006; Klem et al., 2000).  Only one study (Gokee-
LaRose et al., 2010) compared two different intervention approaches without a ‘no-
treatment’ control group; all others included a ‘wait-list control’ group. 
 
Course content was similar in all interventions; although the focus varied slightly:  
Gokee-LaRose et al (2010) included lessons on nutrition and dietary change. Gow et 
al(2010), Hivert et al (2007), Klem et al(2000) and Stice et al (2006) included 
information about causes and prevalence of obesity, the physiology of obesity, healthy 
eating and physical activity, and techniques required to maintain energy balance. 
Werch et al (2007) focused on the importance of goal setting in weight maintenance 
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(although this component was also covered in the other studies) and also included 
seminars on other behaviours (alcohol intake, smoking) into their programme. Eiben 
et al (2005) adjusted information based on individual needs, and Leermarkers et al 
(1998) included prescribed exercise sessions at the end of each weekly group meeting.  
 
With the exception of three studies (Leermarkers et al., 1998; Klem et al., 2000; Gow, 
et al., 2010), in which one intervention arm was assigned to completing the 
programme entirely online after initial personal consultation, all interventions were 
delivered face-to-face.  
 
Study duration varied considerably among studies from six weeks (Gow et al., 2010) to 
two years (Hivert et al., 2007) with a mean duration of 14 weeks (median: 12 weeks).  
Reported main outcomes were usually taken immediately after the end of the 
intervention period; although three studies also included follow-up data at six and 12 
months.  
 
Most commonly, studies had two or three intervention arms.  In all interventions, 
sample sizes were small to medium, ranging from 40 to170 participants, with a mean 
of 91 participants.  Levels of non-attendance and attrition varied, with most studies 
retaining 81% of initial participants.  Study duration did not appear to influence 
attrition because the study with the two-year follow-up retained participants at a 
comparable level to studies with shorter duration (83% completed the two-year FU). 
 
Efficacy of these studies was high.  All studies reported small but significant weight 
loss or weight stability (~ - 0.83kg to -1.3 kg) in intervention groups in comparison with 
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control groups at the end of the intervention period. This difference was maintained in 
at six month follow-up in studies which included this time point.  Although results have 
to be viewed with caution because of study heterogeneity and small effect sizes, if 
weight differences were maintained over the long-term, it would lower the risk of 
obesity and its associated conditions substantially.  However, study durations were 
usually too short to make any predictions about long-term efficacy; the one study who 
included a two-year follow-up did not find any lasting effects of the intervention.  
 
Taken together, the results from all studies included in the meta-analysis of RCTs by 
Hebden et al (2012) show comparable outcomes, with small positive effects for weight 
gain prevention or weight loss. Small sample sizes in some trials and short-follow-up 
periods limit the generalizability of the findings, especially with regard to long-term 
efficacy.  However, these results demonstrate that complex interventions targeting 
multiple components are more successful at preventing weight gain than those 
focusing only on improving a single outcome.  
 
1.7.1.5 Evaluation of studies aimed at weight gain prevention in young adults 
The high level of intensity employed in the interventions discussed above, regardless 
of specific focus, is striking.  Considering that most individuals in these studies are 
normal weight or only slightly overweight, one would expect that the processes 
required for energy balance should function reasonably well or that individuals already 
possess behavioural skills required to maintain energy balance.  Efforts needed to 
maintain weight might therefore be expected to be modest.  However, no study has 
investigated the efficacy of a low-impact intervention on the prevention of weight gain 
among students and therefore, evidence for this hypothesis is lacking.  Although a 
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number of studies were successful in preventing weight gain, with the exception of the 
online studies, intervention format and delivery limit the applicability and cost-
effectiveness on a large scale.  Furthermore, these studies required a high level of 
commitment from students, which makes it likely that only highly motivated 
individuals participated which is evident in the high retention rates.  However, 
students who are less concerned about weight gain may also be at risk, but those 
might be unlikely to take part in an intervention that requires high levels of 
commitment.  Therefore, a low-intensity, low-cost intervention that could easily be 
applied to a large number of students might be a more feasible option to try to engage 
students with weight gain prevention.   
 
1.8 Chapter Summary 
In summary, this chapter discussed that genetic and environmental influences act in 
concert to drive obesity levels upwards.  The physiological adaptations that are 
occurring in the overweight/obese state make long-term weight loss difficult to 
achieve.  Therefore, weight gain prevention should be a priority.  Young adults are 
especially vulnerable to unhealthy weight gain because many of the life stages 
associated with higher risk of disproportionate weight gain occur during young 
adulthood.  Weight gain prevention interventions for this age group have focused 
predominantly on college students, with mixed success.  Although the most intense 
interventions usually demonstrate efficacy, their labour intensity and high 
participation burden limits their applicability for the student population at large.  
Developing a personalized, low-intensity intervention to raise awareness about risk of 
unhealthy weight gain may be one way to engage less motivated students with weight 
gain prevention.  
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Chapter 2:  Could genetic test feedback be a novel way to stimulate 
behaviour change?  
 
Completion of the sequencing of the Human Genome a decade ago constituted a major 
achievement in scientific discovery.  Subsequent technological advances have led to 
increasingly reliable information about alleles implicated in disease development for a 
reasonable cost.  Genetic discoveries made since have caused paradigm shifts in the 
understanding of health, pathogenesis, disease classification, and treatment approaches.  
To date, tests for nearly 2300 genetic conditions exist, 2028 of which are already available 
in clinical practice (NCBI, 2011). 
 
However, despite the multitude of novel findings and enormously improved technology, it 
has become clear in recent years that the ‘genomic hype’ left many promises unfulfilled, 
at least in the short-term (Evans et al., 2011).  This is partly because the emerging picture 
of the genetic basis of disease is far more complicated than expected.  Only about 2% of 
diseases follow clear Mendelian inheritance patterns; the remainder are caused by a 
complex array of gene x gene and gene x environment interactions, as well as epigenetic 
changes in DNA (Fraser, 2009). Therefore, translation of research findings from genomic 
studies into the clinic is still in its infancy.   
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Even with the greatest efforts, translation of new discoveries from ‘bench to bedside’ 
usually takes several decades, with benefits and costs becoming visible only after a certain 
period of time.  Figure 2.1 schematically displays past and expected achievements in 
genomic research, with different colours representing the density of discoveries in each 
area.  Harnessing the full potential that genomic medicine has to offer is not expected to 
occur for at least another decade.   
 
Nonetheless, the field is under enormous pressure because of the high expectations 
placed on it.  The persistent media attention, presumably resulting from the ‘sensed’ 
potential that genomic medicine may hold for health, is evidence for this.  Funding bodies 
are keen to see this perceived potential turning into reality, which places demands onto 
those working in the discipline to (perhaps sometimes prematurely) translate findings into 
clinical applications. This led to a situation where the ‘genomic bubble’ is perpetuated by 
the speed technology moves forward whereas the broader infrastructure as well as the 
evidence base for its effects lags behind (Evans, Meslin, Marteau, & Caulfield, 2011; Burke 
et al., 2010). 
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Figure 2.1. Schematic representation of accomplishments across five domains of genomic research 
 
E D. Green et al. Nature 470, 204-213 (2011) doi:10.1038/nature09764          
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2.1 Practical considerations and challenges 
 
Before predictive genetic testing can be implemented on a large scale, multiple 
challenges need to be overcome.  One important consideration is whether the quality 
of individual genetic tests2 is sufficient to be used in clinical practice.  The US Centre 
for Disease Control and Prevention developed a framework to address this question, 
called the ACCE model (Haddow & Palomaki, 2004).  The acronym stands for analytic 
validity (including sensitivity, specificity, positive predictive value (PPV) and negative 
predictive value (NPV)), clinical validity (incorporating scientific validity and clinical test 
performance), clinical utility (assessing whether the test improves health outcomes) 
and the ethical, legal and social implications (ELSI). Currently, genetic tests for complex 
conditions face challenges in all but the first of these domains.  The model is shown in 
Figure 2.2.  
 
  
                                                          
2
 genetic test in this context refers to a test to detect (1) a particular genetic variant (or set of variants), 
(2) for a particular disease, (3) in a particular population and (4) for a particular purpose, Zimmern et al. 
2007 
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Figure 2.2 ACCE framework for evaluation of genetic tests 
 
 
 
 
2.1.1 Challenge: Improving clinical validity 
Probably the biggest challenge to date is improving clinical validity.  Currently, the 
predictive value of genes implicated in common complex conditions is low because the 
effect sizes of most identified individual gene variants are small and penetrance3 does 
not usually exceed 5% (Holtzman & Marteau, 2000).  Furthermore, despite high 
                                                          
3
 Penetrance refers to the likelihood that the disease is expressed. If a disease has 5% penetrance it 
means that in 5% of the pop the gene will be active and thus the trait/disease will be expressed. In 
conditions with < 5% penetrance it is difficult to distinguish environmental and genetic effects. 
Retrieved from: http://www.cdc.gov/genomics/gtesting/ACCE/ 
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heritability estimates, even in combination, genes known to date can only explain a 
fraction of common phenotypes such as weight or height.  The gap between known 
heritability estimates and the contribution from known genetic variants to a trait is 
known as ‘missing heritability’ (Manolio et al., 2009).  It is likely that multiple genes of 
small effect, combined with gene x gene and gene x environment interactions as well 
as epigenetic effects account some of the discrepancy between heritability and 
variance explained by known genes.   
 
The evolutionary advantage is self-evident:  Having many genes of small effect for a 
certain trait results in less damage if errors in transcription and translation occur than 
if few genes were responsible for it because these genes would be more likely to be 
selected against in the course of evolution.  Furthermore, existence of mechanisms to 
respond to environmental changes on a molecular level (epigenetic effects) yields 
greater flexibility and adaptive capacity of the organism (Manolio et al., 2009).  
 
The importance of these additional factors for genetic risk prediction becomes clear 
when studying causes of mortality of monozygotic twins.  Despite being identical 
genetic copies of one another, they usually do not die from the same disease; 
although they are far more likely to do so than two unrelated individuals (Roberts et 
al., 2012).  This example highlights the fact that risk prediction based solely on 
underlying genetics is inherently limited.  However, it has also been debated whether 
better understanding of genetic interactions could really improve risk prediction, or 
whether ‘random’ factors that cannot be accounted for, such as unique combinations 
of environmental exposure, would always constrain predictive value (Janssens & van 
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Duijn, 2008).  Although there may be some conditions for which this may be the case, 
it is difficult to foresee outcomes for all complex conditions.  
 
2.1.2 Challenge: Establishing clinical utility 
The issue of uncertain clinical validity of genetic test feedback is entwined with that of 
clinical utility.  Clinical utility, in this context, refers to the successful application of 
genetic test feedback in clinical practice to improve health outcomes.  One problem is 
to define what this constitutes because ‘health outcomes’ may vary and can be 
difficult to quantify, especially with respect to psychological variables (Haga, Khoury, & 
Burke, 2003).  Moreover, because clinical validity is suboptimal at present, it is unlikely 
that the test can meaningfully distinguish between those who require intervention and 
those who do not, as others who are cautious of using genetic test feedback for 
complex conditions to stimulate behaviour change have repeatedly pointed out: ‘If all 
would benefit from a healthy diet, exercise, smoking cessation or prudent alcohol 
intake, regardless of genotype, the added value of the test is unclear unless it can be 
shown to motivate compliance in those who test positive without reducing compliance 
in those who test negative.’ (Haga et al., 2003) 
 
Because the evidence base for the premise that predictive genetic testing for complex 
conditions would lead to health benefits is thin at present, research efforts need to 
focus on establishing clinical validity using a variety of measures and rigorous 
methodology to which this PhD aims to contribute.  
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2.1.3 Challenge: Ensuring privacy and management of incidental findings 
The inherent individuality of genome sequences (except in the case of monozygotic 
twins) raises issues of anonymity in clinical and research contexts (Javitt, 2006).  
Concerns about discrimination based on genetic risk by insurance or employers led to 
the development of laws to protect individuals even before the genome was fully 
sequenced; although it was not fully implemented until 2008.  Since then, the Genetic 
Information and Nondiscrimination Act (GINA) is in place in the US, which prohibits 
insurers to charge higher premiums and employers to discriminate against individuals 
based on genetic risk alone (http://www.govtrack.us/congress/bills/110/hr493/text )   
 
However, genetic testing not only concerns the individual but also allows inferences 
about family members.  This can pose problems when one family member seeks 
genetic testing and issues within the family influence sharing of their genetic test 
result (Corpas, 2012; Forrest, Delatycki, Curnow, Skene, & Aitken, 2010; Forrest et al., 
2003).  The question remains whether there is a ‘duty to warn’ family members of 
potential risks, possibly even at the expense of patient confidentiality, and, if there is, 
who should be informing them: Their General Practitioner (GP), family member, 
genetic specialist (Offit, 2004).  Furthermore, relatives may not wish to know of their 
genetic risk status (exert the right not to know) which may cause conflict within the 
family and distress for relatives who sought testing because they may feel a 
responsibility to persuade others to seek testing (D’Agincourt-Canning, 2001; Foster, 
Eeles, Ardern-Jones, Moynihan, & Watson, 2004).  However, because research to date 
has focused on families affected by severe conditions such as Huntington’s disease and 
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hereditary cancer syndromes, effects on more common, complex conditions may be 
less pronounced.  
 
A further difficulty is that genes rarely code only for a single trait and may be 
detrimental in combination with certain genes but protective when paired with others 
(Williams, 2001). Therefore, it is highly likely that genetic feedback for one condition 
will simultaneously reveal risk status for another (for example Apolipoprotein E (APOE) 
is implicated heart disease and Alzheimer’s disease (Wilson, Schaefer, Larson, & 
Ordovas, 1996).  This means that information about risk for conditions may become 
available for which the individual has not sought testing.  Once again, the issue of duty 
of care to inform individuals about these ‘incidental findings’ must be resolved before 
genetic testing can become widely available in clinical practice, especially considering 
the prospective introduction of whole-genome sequencing where these issues will 
become commonplace (Berg, Khoury, & Evans, 2011; Tabor, Berkman, Hull, & 
Bamshad, 2011).   
 
Recently, the American College of Medical Genetics (ACMG) released 
recommendations on how to best manage incidental findings for whole-genome 
sequencing (Table 2.1, Green et al., 2013), including conditions for which return of 
results should be mandatory.  The European Society of Human Genetics followed up 
with similar, if slightly more conservative recommendations focusing on informed 
consent (Ayuso, Millan, Mancheno, & Dal-Re, 2013).  However, it is difficult to predict 
at this point which issues will become most pressing once genetic testing is introduced 
on a large scale, so that these recommendations have to be viewed as flexible.  
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Table 2.1 ACMG recommendations on the return of incidental findings (Green et al, 
2013) 
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2.2 The Promise 
2.2.1 Health maintenance and early intervention 
 
The vision of genomic medicine is not only to individualize medical treatment, but also 
to reduce risk and prevent illness by making personal recommendations for screening 
adherence, and lifestyle modifications based on the individual’s genetic profile (Haga 
et al., 2006).   
 
Genetic test feedback was hypothesised to motivate the initiation and maintenance 
behaviour change by providing the ultimate personalized message for several reasons.  
One was that assumptions about the beneficial impact of genetic testing are rooted in 
its historical use (mainly for reproductive decision making) in family groups afflicted by 
conditions with an underlying genetic contribution (Wright, 2011). In the case of 
chromosomal disorders with Mendelian inheritance patterns or genetic disorders with 
high penetrance, risk for illness can be predicted with high accuracy.  Therefore, it has 
been assumed by many writers that knowledge of the full genomic sequence would 
reveal underlying genetic effects of similar magnitude in common conditions.  
Furthermore, it was thought that insights into genetic disease associations would be 
rapidly followed by translations into novel approaches to prevention and treatment 
(Khoury & Wegner, 1995, Collins, 1999).    
 
Thirdly, individuals are usually optimistically biased with respect to their disease 
susceptibility and commonly perceive themselves to be less likely to fall ill than others; 
increasing risk of engaging in health-compromising behaviour (Weinstein, 1980). 
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Providing evidence for their ‘true’ susceptibility in the form of genetic test feedback 
was thought to serve as a ‘wake-up call’ to initiate health protecting actions before 
problems arise. 
 
Lastly, there is also substantial evidence that ‘tailoring’ a message to the audience will 
improve outcomes, because it increases personal relevance and therefore salience 
(Petty & Cacioppo, 1981).  Noar, Benac & Harris (2007) conducted a systematic review 
and meta-analysis of 57 studies on the effects of tailored print behaviour change 
interventions.  Studies were included if they were randomised or non-randomised 
trials comparing effects of tailored print behaviour change interventions (as opposed 
to web-based or telephone interventions) with a ‘non-tailored’ or ‘less tailored’ 
condition.  Health behaviour change was the main outcome variable. All included 
studies were published between 1989 and 2005.  The total sample size in the meta-
analysis was 58,454 participants (median N = 535 per study) of predominantly 
Caucasian origin and a mean age of 45 years. Behaviour change interventions focused 
on dietary change, improving physical activity, improving cancer screening behaviour, 
smoking cessation, vaccination behaviour and condom use, with durations from one 
week to 18 months. The results showed that tailored messages were modestly but 
significantly more successful in changing behaviour than non-tailored messages (Effect 
Size = 0.047); although there was considerable heterogeneity among studies. Further 
analysis revealed that interventions with the largest effect sizes were those that 
focused on preventive and screening behaviours (e.g. pap-smear), that generated 
newsletters, pamphlets or magazines, were theory-based, tailored on several concepts 
including demographics, included multiple time points, and had shorter-follow-up 
Chapter 2: The utility of genetic test feedback for behaviour change 
 
68 
 
periods.  Findings from a meta-analysis of web-based interventions match those from 
print messages (Krebs, Proschaska & Rossi, 2010). Genetic testing could be regarded as 
the ultimately tailored/personalised information, although in the case of single gene 
testing, there are of course a limited number of possible outcomes.  However, genetic 
test results from an individual biological sample have a personal salience and 
relevance that is not present when people are given general health behaviour advice. 
 
In summary, the expected information value of genetic testing, reduction of optimistic 
bias, and personal nature of genetic test results have all contributed to expectations 
that personal genetic testing would be effective in engaging individuals with beneficial 
health behaviour change (Collins, 2006; Bowen, Battuello, & Raats, 2005; Gollust et al., 
2012; Barns, Schibeci, Davison, & Shaw, 2000).  
 
 
2.3 The Pitfalls 
2.3.1 Fatalism and false reassurance 
Enthusiasm for the beneficial prospects of genetic testing is not shared unanimously. 
Those cautioning against the use of predictive genetic testing argue that it has the 
potential to cause harm by inducing fatalism in the case of a higher risk result and false 
reassurance in the case of a result indicating no raised risk (Marteau & Croyle, 1998).  
This latter response would be particularly problematic for conditions such as obesity 
where prevention and treatment depend primarily on behaviour modification.  
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Much of this concern originates from the notion that, in contrast to other biomarkers, 
genes are unchangeable.  In addition, early clinical genetic testing, which was almost 
exclusively performed for diagnostic and reproductive purposes, focused on 
monogenic or highly penetrant, severe diseases (Wright et al., 2011).  Assumptions 
about the psychological impact have been extrapolated to genetic testing for low-risk 
common conditions; although it is currently unclear whether they hold true in the 
same way.  
 
2.4 Predictions from Health Behaviour Models about psychological and behavioural 
outcomes of genetic test feedback for common, complex conditions 
 
Theoretical models of health behaviour have attempted to capture the complex influences 
that lead to behaviour change, and have some application for assessing utility of genetic 
testing for behaviour change.  Two of the most commonly cited models in the literature on 
genetic test feedback for common, complex conditions are the Health Belief Model 
(Rosenstock, 1974), and Leventhal’s Illness Perception Model (Leventhal et al., 1997).  
Although there are alternative models of health behaviour that have been applied in studies of 
reactions to genetic test feedback (e.g. the extended parallel processing model by Witte and 
colleagues (1992), or protection motivation theory, Rogers, 1975), the study design in the 
current thesis was guided by the concepts and constructs discussed in the Health Belief Model 
and Leventhal’s Illness Perception Model because they seemed most suited for the main 
outcomes investigated in this thesis (motivation to change behaviour, fatalism and false 
reassurance), and the type of genetic test feedback given (a single gene for a common, 
complex condition).  Lastly, much work about fatalistic reactions to genetic test feedback has 
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been based on Leventhal’s Illness Perception Model, and it seemed therefore sensible to use it 
in the current thesis.  
 
2.4.1 Health Belief Model 
Application of the Health Belief Model suggests that individuals may use predictive genetic 
test results indicative of personal risk to make beneficial behavioural changes to prevent 
adverse health outcomes. Perception of susceptibility to the specified condition and its 
perceived severity make up the ‘perceived threat’ from that condition (Figure 2.3).  According 
to the model, these perceptions are modified by demographic factors and ‘cues to action’, for 
example through messages in the media.  According to the HBM, high-risk results from 
predictive genetic testing for weight gain susceptibility should therefore increase perceived 
risk of gaining weight, which in turn would motivate lifestyle changes to minimise risk so long 
as they believed in the efficacy of that action (perceived benefits) and the perceived barriers 
were not too high.   
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Figure 2.3 Schematic representation of the Health Belief Model 
 
 
 
 
2.4.2 Self-regulation Model of Health and Illness 
There are other theoretical perspectives. The Self-Regulation Model  Leventhal, 1997,  
 
Figure 2.4) proposes that risk-reducing actions are taken in accordance with perceived causes 
of illness.  According to this model, individuals incorporate various aspects when thinking 
about an illness: symptoms (illness identity), causes, consequences, the extent to which it is 
controllable, and the duration and/or symptom change over time (timeline).  So if someone 
Retrieved from http://nnlm.gov/evaluation/pub/witte/ 
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believes that weight gain is caused by modifiable factors, such as sedentary lifestyle or 
unhealthy diet, they will act accordingly and make the required behavioural changes.  If 
however, causality is assumed to be non-modifiable (e.g. genes are assumed to be entirely 
determining), a high-risk genetic test result could lead to a fatalistic attitude.  Likewise, 
assumed genetic causality could cause a false sense of immunity when the result indicates no 
raised genetic risk for the condition in question 
 
Figure 2.4 Self-regulation Model of Health and Illness 
 
 
2.5 The evidence to date 
2.5.1 Psychological impact of genetic testing for common, complex conditions 
A table of all studies reviewed in this section is included in Appendix 1.  
Retrieved from Munro, Lewin, Swart & Volmink (2007), http://www.biomedsearch.com/nih/review-health-
behaviour-theories-how/17561997.html#fullText  
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2.5.1.1 Fatalism  
The majority of studies investigating fatalism and false reassurance were conducted 
during the early applications of genetic testing.  The body of literature that emerged is 
large, but studies are diverse in methodology and samples are often small and drawn 
from family groups afflicted with rare and severe genetic conditions.  Therefore, it is 
very difficult to synthesize the information and draw more general meaningful 
conclusions, especially for predictive genetic testing for common, low-risk conditions. 
 
One of the most frequently cited studies in support for potentially fatalistic response 
to testing is a qualitative study by Senior, Marteau & Peters (1999), cited 138 times on 
Google Scholar.  The authors investigated parents’ response to neonatal screening for 
familial hypercholesterolemia in semi-structured interviews with 24 parents of 
children aged between 15 and 30 months who had received positive screening results 
for their child and had been invited for re-testing. Interviews took place before a 
definite diagnosis of FH was made. Interview questions were based on Leventhal’s 
Illness Perception Model (1997). Senior and colleagues found that parents felt the 
condition was more dangerous and less controllable when they thought of the result 
as genetic rather than related to the mother’s diet during pregnancy.  This is an 
important finding although the sample was small and from a very special population 
subgroup so it may not generate to the adult population.  The qualitative design of the 
study excludes the generalizability of the findings a priori, and the authors themselves 
clearly caution against doing so, so it might be somewhat surprising that this study 
builds the foundation for the argument that genetic test feedback would result in 
fatalism. 
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Findings from this study also contrast with a RCT that was conducted by Marteau et al 
(2004).  Individuals suffering with Familial Hypercholesterolemia (FH) (n = 341) and 
their relatives (n = 128) were randomly assigned to receive either a routine clinical 
diagnosis or the routine diagnosis and genetic test results.  Affected participants were 
tested directly, and mutation searching was performed for unaffected relatives.  
Primary outcomes were perceptions of control over FH, cholesterol and heart disease, 
and fatalism about FH, which were assessed with the respective scales of the Illness 
Perception Questionnaire-Revised (Moss Morris, 2002), and scales devised especially 
for the study.  In addition, risk-reducing behaviour, perceptions of diagnosis and 
emotional state were investigated.  However, relatives for whom no mutation was 
found had lower perceived control over FH and heart disease one week after 
disclosure of results; this was no longer evident at the six-month follow-up. There was 
also no difference observed in risk-reducing behaviours.  As this study was a RCT, 
which is the gold-standard for investigating causal relationships, results can be 
assumed to be relatively robust.  This is also one of the few studies which were 
sufficiently powered, although the results are limited by the special population 
investigated who were aware of their potentially increased risk, and thus may have 
already taken action to minimise risk.  The participants in this study may have sought 
confirmation of what has been a private assumption about FH risk.  When the 
mutation search was unsuccessful, this may have resulted in disappointment and 
insecurity about causes of FH. 
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Families affected by Huntington’s disease are another frequently studied population 
group for assessing outcomes of genetic testing.  Huntington’s disease is a severe 
neurological condition caused by a mutation in a single gene, for which to date no cure 
exists (Vonsattel, 1985).  For example, a study by Wiggins et al (1992) investigated 
psychological impact of genetic testing in 135 members of the Canadian Collaborative 
Study.  Eligible participants had to have at least a 50 % chance of having inherited the 
Huntington gene.  About a quarter of participants (26%, 55 individuals) withdrew 
before testing or after learning that results could be uninformative.  The remaining 
participants were split into ‘increased-risk’ group (those whose risk prediction 
increased from 50% after testing), ‘decreased risk’ group (those whose risk prediction 
decreased to 25 % or less after testing) and the ‘no-change’ group (those who declined 
the test or those for whom the test was uninformative but did not withdraw).  
Participants filled in several self-report questionnaires on anxiety, distress, depression 
and well-being, and were followed up one week, six months and one year after genetic 
result disclosure.  The results showed a significant decline in distress in individuals 
with a test result indicating decreased risk, but no change in symptoms in those 
receiving an ‘increased-risk’ result.  Both groups showed an increase in well-being 
compared with the ‘no-change’ group.  Similar results were shown in a review 
investigating the impact of testing for Huntington’s disease (Meiser & Dunn, 2001), 
with higher risk individuals being slightly negatively affected in the short-term which 
was, however, no longer evident after one year follow-up.  Certainty about disease 
status and increased sense of control has been cited as the main reasons for the 
‘positive’ effects (Gooding et al., 2006).  Lack of increase in suicide rates after testing 
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became widely available is also a crude, but objective indicator of the absence of 
major detrimental effects after testing. 
 
Evidence for lasting negative impact was also not found after testing for cancer, such 
as BRCA1/2 for breast cancer (Watson et al., 2004), or genes for hereditary colorectal 
cancer (Croyle & Lerman, 1993), or for Alzheimer’s disease (Cassidy et al., 2008).  A 
systematic review by Heshka et al. (2008) focusing on the psychological effects of 
genetic testing for nonpolyposis colorectal carcinoma, hereditary breast and ovarian 
cancer, and Alzheimer’s disease included 30 studies discussed in 35 articles.  The 
literature search was restricted to five databases (MEDLINE, EMBASE, Cochrane 
Central Register for controlled trials, CINHAL and PsychINFO) and encompassed 
articles related to genetics, genetic testing and psychological impact.  Articles were 
included if they were published in English, were concerned with adults, focused on the 
psychological and/or behavioural impact of genetic testing and reported separate 
results for carriers and non-carriers.  Studies were excluded if they only assessed 
screening intentions, assessed impact of single-gene disorders, or included samples 
with already affected individuals.  The final set of studies spanned the following topics:  
affective outcomes (general distress, test-related distress, anxiety, depression, worry) 
behavioural outcomes (screening behaviour, prophylactic surgery, use of 
chemotherapeutics and other health-related behaviours) and perceived risk.  The 
authors concluded that there was no difference in psychological distress, anxiety or 
depression after disclosure of the test result in those carrying a genetic mutation and 
those who do not.  This was found to be the case regardless of method of assessment.  
Although there was a trend for distress immediately after individuals received their 
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result in some of the studies (Broadstock et al., 2000; Cassidy et al., 2008; Murakami et 
al., 2004; Tibben et al., 1993), this was modest in magnitude and disappeared with 
follow-up.  Interestingly, risk perception was not related to risk status, although 
screening behaviour increased slightly in individuals with high-risk results. 
 
However, distress over potential disease status in those samples may have occurred 
long before a decision for a genetic test was taken, as members of these rare 
population groups undoubtedly had a family history of illness.  Testing may have 
simply acted to confirm what was already anticipated, acting as catalyst to relieve 
distress from uncertainty.  It is also possible that individuals rationalized negative 
emotions towards the test result in retrospect, in an attempt to cope with the 
outcome.  Moreover, the actual uptake of genetic testing has been found to be much 
lower than anticipated, which hints that there are factors which may hold individuals 
back from getting tested (Bernhardt et al., 2009). 
 
It is uncertain whether findings from these studies are applicable to the population at 
large.  Finding out about a genetic disease without family history may hold entirely 
different connotations and outcomes for affected individuals.  Negative emotional 
impact would be expected to be much higher, and the potential for fatalism much 
greater, because of the life-changing impact such a result holds.  Investigating how 
adopted individuals react to their genetic test result may potentially help gain an 
understanding of how individuals cope with adverse health-related information where 
no (known) family history exists. 
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2.5.1.2 False reassurance 
Disengaging from health protective behaviours because of a false sense of immunity 
from a genetic test result showing decreased, risk of disease is the other reason 
commonly cited by those who favour test regulation.  This concern is also based on the 
assumption that individuals adopt a deterministic attitude towards genetics, and will 
thus ignore other, non-genetic, determinants of illness development.  Little empirical 
research has focused on this aspect; the majority of studies were concerned with 
fatalistic responses to genetic testing. 
 
Sanderson & Wardle (2005) explored factors associated with a motivated or a 
complacent reaction to genetic testing for risk of heart disease or cancer in a survey 
including 186 smokers.  The vignette included information about genetic testing and 
stated clearly that the test would only show a predisposition to illness, and not a 
definite outcome.  Anticipated reactions were assessed with a single statement for 
each reaction of interest (motivation, complacency, and depression). In addition, the 
authors measured perceived family history, dispositional pessimism, desire to quit 
smoking, level of nicotine addiction, and understanding of genetic testing.  The 
majority of smokers anticipated finding a high-risk result more motivating for smoking 
cessation than a result showing no increased risk.  However, the predicted false 
reassurance was observed, with over one third of the sample (39%) thinking that it 
was safe to carry on smoking if they received a negative result.  Out of those 
participants, a higher percentage had less formal education and less understanding of 
genetic testing, in addition to a lower desire to quit.  However, in multivariate 
analyses, only the effect of age and level of education were maintained.  Shortcomings 
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of the study were the small sample so that power issues may have impaired validity of 
the findings.  Furthermore, as the authors noted, the potential misunderstanding of 
the test result in their study (it was framed as a ‘positive’ result if the susceptibility of 
lung cancer was increased and ‘negative’ if this was not the case) is a major 
shortcoming.  Respondents may have reversed the meaning of the test results which 
may have rendered the current results inaccurate. 
 
However, similar results were obtained by Frosch et al. (2005) in a vignette test 
scenario, for risk of obesity, which will discussed in detail below.  The authors found 
that individuals who scored low on perceived behavioural control imagining not having 
the high-risk gene combination for obesity reported less intention to eat a healthy 
diet, although again, the sample was not powered to investigate interactions, and 
results should therefore be viewed with caution.  Furthermore, both studies assessed 
only anticipated and not actual reactions to genetic testing.  Individuals often 
overestimate their reaction in a hypothetical situation, and actual testing may have 
yielded less complacent responses.  The number of studies conducted so far on the 
subject is by far not large enough to draw definite conclusions on complacency in 
reaction to a test result not indicating increased risk. 
 
2.5.2 Impact on behaviour change 
2.5.2.1 Smoking cessation 
Decreased cost of genetic testing has made it possible to investigate potentially 
adverse psychological reactions after testing for common conditions.  The paucity of 
research to date is noteworthy, considering that the commonly cited reason in favour 
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of predictive genetic testing is the subsequent adoption of a healthier lifestyle.  
Smoking cessation is the only area of behaviour change that has received reasonable 
attention over recent years with respect to utilizing genetic feedback.  Early discovery 
of the link between genes coding for enzymes that reduce risk for lung cancer (GSTM1 
and CYP2D6) may have led several groups to begin exploring the impact feedback may 
have. 
 
Lerman and colleagues (1997) were one of the first groups to study the impact of 
genetic test feedback on smoking cessation in a sample of 427 individuals.  Genetic 
test feedback for the CYP2D6 gene was incorporated into a minimal contact quit 
smoking counselling.  Participants were assigned to receive counselling only, 
counselling and biomarker feedback or counselling, biomarker feedback and genetic 
test feedback.  Feedback was successful in elevating perceived risk, perceived quitting 
benefits but also increased worry about lung cancer.  There were no differences 
between groups in cessation rates and number of cigarettes smoked per day at the 
two-month follow-up.  After one year, however, participants receiving genetic test 
feedback in addition to counselling had made more quit attempts and were more 
motivated to quit than those only receiving counselling, although no differences in 
actual quit rates emerged (Audrain et al., 1997). 
 
Increases in actual quit rates were observed in another RCT (McBride et al., 2002), 
which used genetic feedback in addition to a smoking cessation intervention in a 
sample of 316 African-American smokers.  In this study, quit rates nearly doubled at 
the six-month follow-up.  (19% versus 10%), respectively; at 6 months but not at 12 
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months There were no increases in perceived risk or distress among participants.  
However, quit rates were high regardless of ‘high-risk’ or ‘low-risk’ genetic status for 
the GSTM1 gene. Considerably more support during the intervention was given to 
participants who also received genetic feedback.  Therefore, increases in quit rates 
cannot be clearly attributed to test feedback, although it is possible that individuals 
used feedback as motivator for behaviour change, regardless of the actual test result. 
 
More recently, Sanderson and colleagues (2008) conducted a RCT including 61 
participants and found that smoking cessation rates increased significantly one week 
after providing individuals with feedback for the GSTM1 gene, compared with control 
participants (35 % vs. 0%).  However, the effect was no longer evident after the two-
month follow-up.  In addition to smoking-related outcomes, perceived risk and self-
efficacy were also assessed.  There were no differences in those variables found at 
two-week follow-up, although perceived risk and worry about lung cancer was slightly, 
albeit not significantly, higher at the two-month follow-up in the control group.  This 
may have been, as the authors suggest, because participants enrolling in the study 
may have participated to have certainty about their risk status (albeit the risk increase 
is very small), and not receiving a result may have led to disappointment and slight 
distress.  However, this study was underpowered, which limits the reliability of the 
findings. 
 
The overall effect of genetic testing for smoking cessation, and other risk-reducing 
behaviours, was recently investigated in a Cochrane review by Marteau et al (2010).  
Only studies qualifying as RCTs or quasi-RCTs were included.  In addition, feedback had 
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to be given for conditions for which risk-reducing actions could be taken. The three 
studies discussed above were included in the analysis, in addition to two studies from 
Japan (Hishida, 2010; Ito, 2006). 
 
Hishida and colleagues (2006) allocated 562 employees of a bank to either gene 
feedback group (n = 286, n = 257 agreed to genetic testing) or no intervention.  At one-
year follow-up fewer people in the intervention arm had quit than in the control group 
(15 vs. 22 participants).  However, negative outcomes of gene feedback were also not 
reported.  
 
Ito and colleagues used a sample of 617 smokers attending a local cancer centre and 
allocated them to receive either gene feedback or no intervention.  Follow-up smoking 
status was collected at three and nine months.  There were no significant differences 
in quit rates between the groups; neither at three-, nor at nine months; although there 
was a trend for quit rates to be higher in participants receiving gene feedback.  Pooled 
data analysis from all clinical studies showed no statistically significant effect of 
incorporating genetic feedback results into smoking cessation programs, neither in the 
short term (two weeks), nor the longer term (six months).  However, studies were very 
heterogeneous in sample size, assessment methods, and interventions used to aid 
smoking cessation.  Confidence intervals for the pooled effect size estimates were 
wide, which indicates considerable variation in results.  Furthermore, the past 10 years 
during which the studies were conducted were marked by rapid development and 
change in the genetic testing field; participants in the earlier studies may have viewed 
genetic testing differently from those who participated more recently.  Although lack 
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of a positive effect is discouraging, there was also no evidence for a negative effect, 
which is encouraging as it suggests that it is safe to carry real genetic test feedback 
forward. 
 
2.5.2.2 Diet and exercise attitudes, intentions and behaviours 
Studies that looked at the utility of genetic testing for modifications in diet and 
exercise are fewer than those for smoking cessation.  In fact, there are only two RCTs 
that gave actual genetic test feedback.  One study gave feedback but did not include a 
control group, and three studies were based on hypothetical scenarios. 
 
The first study to give real genetic test feedback specifically for obesity was conducted 
by Harvey-Berino (Harvey-Berino et al., 2001) who tested whether genetic testing 
would diminish self-efficacy and feelings of control over eating.  This study gave 
feedback on the beta-3 adrenergic receptor gene (b3AR, thought to be implicated in 
obesity) to thirty postmenopausal obese women.  Participants were informed that the 
gene increased risk for obesity, but no information was given on how the gene would 
act.  Diet self-efficacy was measured with the Eating Self-Efficacy Scale (Poston, 1997), 
and four statements assessed potential responses and beliefs about the effect of 
having an ‘obesity gene’.  Diet and weight history were assessed via self-report.  
Feedback status had no impact on diet self-efficacy, confidence in the ability to lose 
weight, or attitudinal variables.  Contrary to expectations, individuals who tested 
positive for the b3AR gene reported more confidence in the ability to overcome 
genetic predispositions with the right lifestyle choices.  Individuals in this study were 
already obese and presumably had a history of struggling with their weight, so that the 
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findings cannot necessarily be translated for obesity prevention.  Although the small 
sample size diminishes validity of the results, the findings indicate that individuals do 
not use genetic testing as an ‘excuse’ to disengage with weight loss efforts and 
become negatively affected or complacent.  However, this study did not assess 
behaviour change, so inferences about potential benefits of testing cannot be made. 
 
Hicken and Tucker (2002) addressed the question of whether a positive test result for 
the fictitious ‘Asch syndrome’ would affect individuals’ dietary behaviour.  The 115 
participants read a pamphlet about the ‘Asch syndrome’ in which it was stated that it 
is an inherited condition and that the risk for its occurrence could be minimised by 
lowering the amount of fat in the diet and consuming soy products. Individuals gave 
information on family history for the symptoms of ‘Asch syndrome’ (fatigue, 
headache, and stomach pain), health behaviours, and perceived risk for falling ill with 
the disease.  One experimenter ‘reviewed’ the individuals’ family history.  Participants 
whose pedigree supported the family history were retained, and divided into three 
groups: the experimenter informed one third that their risk was solely due to family 
history.  The remaining participants were offered a ‘gene test’ for the disease.  Half of 
the gene test group was misled to believe that the test was positive.  After filling out 
the follow-up questionnaire, which included an assessment of intended fat reduction 
and soy consumption, participants were fully debriefed about the purpose of the study 
and the fictitious nature of the disease.  Participants who received a high-risk result 
(either through family history or genetic test) perceived themselves to be at a higher 
risk for ‘Asch syndrome’. However, no differences between the groups emerged in 
intended soy consumption or dietary fat reduction. Clearly, this study suffered from 
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major ethical shortcomings. Although participants did not display negative reactions 
after debriefing, letting someone believe they are at high-risk for a genetically 
transmitted disease, even if it is only for a short time, is highly questionable. 
Furthermore, the sample size was small which may have limited the validity of the 
findings. 
 
The first study with a larger sample (n = 249) used a hypothetical scenario 
methodology (vignette) to assess the anticipated consequences of genetic test 
feedback for obesity risk (Frosch et al., 2005). It used a 2x2 factorial design, with two 
test conditions (hormone test vs. genetic test) and two levels of risk (higher-risk vs. 
lower-risk result).  Participants were randomised to receive one of the four vignettes.  
Measures were chosen according to the Theory of Planned Behaviour (Ajzen, 1991) 
and included intentions to eat a healthy diet, attitudes, perceived behavioural control, 
perceived social norms, and expectations about benefits of eating a healthy diet.  
Higher-risk feedback led to increased intentions to eat a healthy diet, regardless of 
whether feedback was given for gene-or hormone-status; although dietary intentions 
were overall relatively low (mean = 2.0 (SD = 1.0) for higher-risk feedback vs. 1.7 (SD = 
1.2) for lower-risk feedback on 4-point Likert scale).  However, the interaction 
between feedback type (hormonal vs. genetic) and control beliefs was significant: 
individuals receiving higher-risk genetic test feedback felt less in control than those 
receiving lower-risk test result, whereas in the hormone group the opposite pattern 
emerged (individuals given higher-risk hormone test feedback felt more in control 
than individuals receiving lower-risk hormone test feedback).  Intentions to eat a 
healthy diet were high when control was perceived to be high, independent of risk 
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status or feedback type.  There was no significant interaction of BMI and feedback 
type on intentions to eat a healthy diet.  These results contrast with those obtained by 
Harvey-Berino et al (2001) in terms of some evidence for a demotivated and fatalistic 
attitude in response to a genetic test result.  Frosch et al interpret the lack of effect for 
feedback, and low dietary intentions for those who a higher BMI themselves, as a sign 
for fatalism.  However, it may be that the lack of motivation for dietary change was 
due to a belief that a larger size was natural for them; which is subtly different from a 
fatalistic attitude.  Furthermore, the study provided individuals with risk increase of 
50% in the high-risk conditions.  This is far higher than any real genetic effects known 
so far, and may have led individuals to (falsely) assume that overweight would be 
inevitable.  As this study was only hypothetical, it is difficult to predict reactions to 
‘real’ feedback.  Lastly, the study did not employ a pre-post design, so conclusions 
about changes in attitudes cannot be made.  
 
The meta-analysis by Marteau et al (2010) included the trial by her and her colleagues 
(2004) discussed in 2.3.1 and a study by (Chao, 2008) who looked at dietary change 
following disclosure of ApoE 4 status for risk of Alzheimer’s disease in a sample of 162 
individuals.  Participants were asked three questions pertaining to behaviour change 
(changes in diet, exercise and changes in medication/supplements) in response to 
Apo-Lipoprotein E (a gene implicated in Alzheimer’s disease, APOE) disclosure one 
year after learning about their results.  In comparison with either control or lower risk 
participants, those receiving a higher risk result were significantly more likely to have 
made changes in one of the three healthy behaviours.  Most commonly, participants 
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changed their medication/vitamin use, despite being explicitly informed that there 
was currently no effective prevention for AD.  
 
Results from the meta-analysis of the clinical studies indicate that feedback is effective 
for dietary change.  However, as only two studies were included in the analysis, one of 
which returned results for a highly debilitating disorder for which to date no cure 
exists, results have to be viewed with caution. 
 
Two RCTs have been published since the meta-analysis became available, one aimed 
at encouraging smoking cessation and the other at diabetes prevention (Hollands et al, 
2012; Grant et al, 2012). 
 
Grant and colleagues investigated whether returning genetic feedback about diabetes 
risk to a sample of 102 overweight participants at high risk for diabetes would improve 
outcomes in a 12-week validated diabetes prevention programme.  Assessed 
outcomes were weight loss (> 5%), programme attendance and motivation to lose 
weight.  When either high-risk or low-risk participants were compared with control 
participants, there were no significant differences in programme attendance, weight 
loss or motivation between participants; suggesting that genetic feedback may have 
little impact in motivated individuals.  These results also lend further evidence to the 
hypotheses that genetic test feedback is ‘safe’ to administer and would not decrease 
individuals’ motivation to engage in behaviour change.  
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Null-findings were also reported in the RCT by Hollands and colleagues (2012).  Here, 
497 first-degree relatives of patients with Crohn’s disease who were smokers received 
information on their personal risk of developing Crohn’s disease based on either family 
history alone or in conjunction with genetic risk information.  The main outcome was 
smoking cessation for at least 24 hours, assessed at 6 months and differences between 
groups were not significant, again suggesting that adverse outcomes of genetic test 
feedback are unlikely.  However, there were several limitations to this study:  First, risk 
recall was poor: Only 57% (124/219) remembered their DNA test results correctly, and 
this fell to 34% (137/209) at six months.  Therefore it is likely that some participants 
misinterpreted their test result, or acted with the (incorrect) result in mind.  Secondly, 
increases in absolute risk were small (5% or lower for Crohn’s disease) and it is 
possible that this was not sufficient to change perceived risk, particularly given that 
the participants had a family history of Crohn’s disease and may thus have had 
established risk perceptions.  Lastly, the number of individuals who received higher 
risk results was relatively small (n = 50), and the study was under-powered to detect 
differences in quit rates by risk status.   
 
2.5.3 Beyond ‘objective’ clinical utility: The potential for reduction of stigma 
Despite the risks of fatalism and false reassurance, genetic testing specifically for 
obesity risk may yield positive effects, because obesity is still perceived by the wider 
society as resulting from a lack of self-control; it is a highly emotionally charged 
problem, stigmatizing and instilling guilt into individuals who suffer from it (Puhl, 
2009).  Guilt and self-blame may be significantly reduced by the notion that the 
condition is not solely in the control of the individual, leading to a more realistic 
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understanding of its origins, and thus to more effective strategies for weight 
management.   
 
Conradt and colleagues (2009) included genetic information on obesity in a 
consultation with 147 obese individuals.  Measurements included restraint eating, 
body acceptance, feelings of guilt, self-efficacy, and affect.  Sessions were provided by 
consultants trained in genetics.  The inclusion of genetic information led to a 
significant increase in genetic causal attributions of obesity in individuals, and those 
who also had a family history of obesity suffered from less negative affect after six 
months.  Feelings of guilt were also reduced in the short-term, although this had 
disappeared at follow-up. This indicates that individuals who see their genetic test 
result reflected in their family history may be most likely to benefit from genetic 
testing. 
 
However, findings from two recent randomized controlled trials by Lippa and 
Sanderson (2013) did not support the hypothesis that providing information about the 
genetic contribution to obesity would decrease internalized weight stigma in self-
identified overweight/obese individuals (n = 655), or obesity stigma (in self-identified 
normal weight individuals, n = 396).  Participants were randomized to receive 
information on obesity as being either caused by genes, environment, or gene x 
environment interactions in form of a short news article.  In addition, they were 
randomized to receive behavioural advice about options to reduce obesity risk, or not.  
Subsequently, participants were asked to rate the information they just read 
(relevance, ease of understanding, perceived relevance), and to complete the Fat 
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Phobia Scale-Short form (FPS-S, Bacon, Scheltema & Robinson, 2001) if they self-
identified as normal weight, or the Weight Bias Internalisation Scale (WBIS, Durso & 
Latner, 2008) alongside demographic information, eating attitudes, and a measure of 
self-esteem.  Although significantly more participants in the genetic condition agreed 
that ‘a person’s genes’ were a cause of obesity, there were no differences in obesity 
stigma, or internalized weight stigma, between the genetic and the non-genetic 
conditions.  However, as this study did not assess obesity stigma or internalised weight 
stigma before the intervention, it is unclear whether the study was effective in 
changing causal beliefs about obesity.  It is also possible that the brevity of the 
intervention (a short news article) was not powerful enough to change longstanding 
causal beliefs about obesity; which would explain the discrepancy between the current 
findings and those by Conradt et al (2009) who found that genetic information relieved 
stigma and self-blame in overweight individuals attending a weight loss programme.   
 
However, it is noteworthy that none of the studies on obesity stigma to date have 
shown an increase in obesity stigma after providing genetic casual information which 
is reassuring in the light of concerns about possible adverse effects of genetic 
information.  
 
2.5.4 Consumer-based genetic tests 
Sometimes termed ‘genetic horoscopes’ or ‘recreational genomics’, direct-to-
consumer (DTC) genetic tests have frequently been criticized, mainly for their low 
clinical utility and lack of oversight (Hogarth, 2008; Grosse et al., 2009; Annes, 2010).  
The FDA has recently responded to these concerns and placed restrictions on 
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advertising (FDA, 2010).  However, there is still little distinction in internet advertising 
between tests without much scientific credibility such as intelligence, tests about 
physical characteristics such as the texture of a person’s earwax or eye colour (which 
are already apparent to the individual), and tests for severe genetic diseases with 
firmly established evidence base and life changing consequences such as Huntington’s 
disease.  Carrier status for recessive diseases, pharmagenomic profiles (genetic 
differences in the ability to metabolise medications), and ancestral lineage 
determination, is also part of the DTC landscape.  In fact, results from all the above 
categories are commonly returned online together with those for severe illnesses, 
without the presence of a genetic counsellor.  
 
2.5.4.1 Psychological and behavioural reactions to DTC testing 
How individuals take in and process multiple genetic risk information and its 
consequences is only beginning to be understood.  One of the first studies to assess 
effects of DTC test results was published by Bloss and colleagues in 2011.  They 
investigated psychological (anxiety and distress after testing) as well as behavioural 
changes (dietary fat intake, exercise levels, intended or real use of screening tests) 
after testing.  Discussion of the results with a physician or genetic counsellor was also 
examined. Participants in the Scripps Genomics Health Initiative obtained the 
Navigenics Health Compass at a reduced rate in return for being followed up 
longitudinally.  The Navigenics Health Compass is a DTC genetic test, assessing risks for 
a wide range of traits and medical conditions as well as providing pharmacogenomic 
profiles.  Test-related anxiety, distress, fat intake and exercise behaviour were 
measured with standardized questionnaires at baseline and after 3-6 months.   
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Initially, 3639 participants took part, but only 2037 completed the three to six months 
follow-up (mean = 5.6 months, SD = 2.4).  The sample was demographically no 
different from regular Navigenics costumers.  The majority of the non-completers 
(44% in total) accessed their results but did not respond to the survey.  Among the 
responders, genetic test results had no effect on anxiety, dietary fat intake, exercise 
levels, or any of the test-related distress variables at follow-up, regardless of whether 
they indicated increased or decreased risk for disease.  No significant difference 
between baseline and follow-up was found in the number of screening tests 
completed since genetic testing; although intended use of screening tests was 
significantly increased.  Just over a quarter (26.5 %) of participants shared their result 
with a physician, but only 10.4 % made use of the free genetic counselling service 
offered by Navigenics. 
 
These results are the first to demonstrate that genetic testing for multiple conditions is 
relatively unlikely to result in harmful effects.  Although the possibility remains that 
non-completers of the questionnaire had more pronounced negative effects, it is 
unlikely as they did not differ in any of the variables at baseline and distress might 
have been expected to moderate study participation.  The lack of effect on behaviour 
may be discouraging at first sight; however, it is likely that ‘early adopters’ of genetic 
testing are already health conscious, and engage in as many of the recommended 
behaviours as they can which could have caused a ceiling effect for the follow-up 
results.  Unfortunately, ‘health consciousness’ was not assessed at baseline, so this 
explanation remains speculative.   
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Potentially, the time frame of investigation may have been to narrow, and beneficial 
effects may become apparent only in the longer term.  Intentions to undergo more 
screening was mainly due to a small number of individuals planning to utilize a large 
number of screening tests, which may have artificially skewed the results.  These 
individuals may differ from the overall sample in their personality or in health-anxiety 
related traits; at this stage it is too early to draw conclusions about actual screening 
uptake.   
 
It is also difficult to extrapolate findings from this study to a group that undergoes 
genetic testing specifically because they feel at an increased risk for disease, as 
perceived relevance may influence the results.  DTC tests provide individuals with a 
large amount of risk information for a wide range of conditions.  Inevitably, risk will be 
raised for some conditions, and will be lower for others.  It is unknown how this affects 
the overall health risk perception of individuals, and whether this differs from 
receiving feedback for several risk markers for a single condition, or a single risk 
marker for a single condition.  More research is needed to understand the ways in 
which individuals take in and process genetic information.  
 
Motivation to change is a central factor to achieve behaviour change, and if the 
majority of the sample underwent testing for reasons other than utilizing feedback to 
motivate behaviour change, results may not have enough impact to tip people 
towards change.  Nonetheless, they may bring change of lifestyle more to the 
forefront of consciousness, with potential for future impact. 
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Concern about potential harm caused by receiving medical test results appears to be 
widespread and is not restricted to genetic testing.  Results from any blood or 
screening test always have to be returned by a healthcare provider.  So the call for 
regulation of returning genetic test results is not surprising.  At the same time 
however, there is a push towards achieving a better informed, more autonomous 
patient population and a need for minimization for use of healthcare services to 
reduce healthcare costs.  It is not clear at this stage that the evidence base of adverse 
effects for testing justifies the request for stringent regulation.   
 
Although results from clinical studies have shown no lasting negative effects (e.g. 
Dougall, 2009;Watson, 2004 ;Broadstock, 2000), the assumption of potential for harm 
from genetic tests remains.  Fatalism on the one hand, and false reassurance on the 
other, in response to the test result are of special concern for obesity prevention, 
because certain coping strategies, such as overeating in response to negative events, 
or passive reactions to problems, have been associated with poorer weight 
management (Elfhag & Rossner, 2005).  Behavioural means such as exercise or 
sensible eating are crucial for successful weight control.  At the same time, potential 
positive effects of genetic testing may outweigh the risks, particularly in the area of 
obesity prevention.  As McBride and colleagues (2010) note, it is important that 
research into potentially positive outcomes of testing is not hampered by fear of 
potential harm. 
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2.6 Chapter summary and discussion 
 
This chapter reviewed the latest developments in the area of genetics and discussed 
the challenges that would need to be overcome if genetic test feedback was to be 
introduced on a large scale.  Demonstrating any ‘added value’ from genetic test 
feedback to already established methods of disease prevention without causing harm 
by creating false beliefs about inevitability of, or immunity to, disease are of particular 
importance; as is the careful consideration of ethical implications.  Impact appears to 
differ among different domains of health behaviour change ; although the evidence 
base for the likely impact of genetic test feedback is slim at present, and conducting 
studies focusing on genetic test feedback for common, complex conditions are 
needed.  Returning genetic test feedback for susceptibility to unhealthy weight gain 
serves as a good model for this endeavour because of its well-defined genetic and 
behavioural influences.  
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Chapter 3:  Thesis Aims 
 
3.1 Aims of the current thesis 
 
As discussed in the previous chapters, genes interact with obesogenic environments, leaving 
some individuals more vulnerable to weight gain than others; testing for these genetic risk 
variants has recently become affordable.  However, studies investigating the psychological and 
behavioural effects of genetic testing for common conditions, where effect sizes are very 
small, are only beginning to emerge.  Particularly with respect to obesity genetic testing, the 
literature is scarce.   
 
As genetic testing becomes more popular, there is a need to increase our understanding of 
how individuals ‘make sense’ of genetic risk and how it might affect behaviour.  To date, 
studies into psychological and behavioural effects of genetic test feedback have mainly 
focused on ascertaining that there are no harmful effects.  This is in line with 
recommendations for complex interventions by Campbell et al. (2000) which outline the 
exclusion of harm as the first stage when implementing complex interventions to improve 
health.  The next step is now to build on the early literature to discover whether providing 
genetic risk feedback could be used to motivate healthy individuals to engage with disease 
prevention.  FTO genetic feedback for risk of weight gain serves as a good model because of 
the scope for effective weight gain prevention through behaviour modification. 
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The overall aim of the PhD was to investigate the motivational, affective and behavioural 
responses to FTO genetic test feedback in young, healthy individuals, as well as in already 
affected individuals of varying ages to discover whether i) genetic feedback is ‘safe,’ and ii) it 
could be an aide in initiating behaviour change; although it is important to note that in clinical 
practice, feedback would never be given for only one gene, but a whole gene panel, or 
possibly even the whole-genome, so that findings from this PhD should be regarded as proof-
of-principle only.   
 
3.2 Research Questions  
This thesis aimed to answer the following questions:  
1. ‘What is the psychological impact of anticipated and ‘real’ genetic test feedback for risk of 
weight gain? Will genetic test feedback cause fatalism (with a higher-risk result) or false 
reassurance (with a lower-risk result)? Will responses differ by weight status?’ 
I explored these questions in a vignette study to gauge anticipated responses by avoiding the 
potential for harm to participants (Study 1), in two small and selected samples of 
predominantly normal weight and overweight participants, receiving ‘real’ feedback (Studies 
2a and 2b), and quantitatively in a larger sample in participants immediately after they 
received ‘real’ genetic test feedback (Study 4b).  
 
2. ‘What is the impact of genetic test feedback for weight gain susceptibility on motivation to 
avoid weight gain or to lose weight? Does it enhance or decrease motivation to control 
weight? Does the effect depend on genetic risk status? Does the effect depend on current 
body weight?’ 
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I attempted to answer these questions in the vignette study (Study 1) and a RCT by giving 
weight control advice with or without genetic test feedback to a sample of young adults with 
low motivation to control weight (Study 4a). 
 
3. Is FTO status associated with weight gain at university? Will returning genetic test 
feedback alongside weight control advice be effective at diminishing weight gain during 
this time period?  
I explored these questions in an association study (Study 3) and the RCT (Study 4). 
 
4. Will awareness of genetic risk status result in behaviour change? 
I explored this question in the RCT (Study 4).  
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Chapter 4:  Study 1 – Psychological Responses to Genetic Testing for 
Weight Gain: A Vignette Study 
4
 
 
4.1 Background 
 
Chapter 2 reviewed the most recent developments in the field of genetic testing which make it 
important to establish the evidence base for its effects on the general population.  The current 
obesity epidemic calls for novel ways to engage individuals in weight gain prevention. 
Supporters of the genetic testing movement claim that the personalized nature of the result 
will constitute one of those ways.  For example, in his recent book on personalized medicine, 
the head of the National Institutes of Health describes how finding out about his raised risk of 
diabetes from such a genetic test motivated him to make changes in his lifestyle: “The DNA 
test result has forced me to face up to this part of my unhealthy lifestyle. […] I’ve embarked on 
a more disciplined exercise program, I’m paying more attention to what I eat, and I have shed 
about 15 pounds” (Collins, 2010).  
 
As discussed in Chapter 2, the debate about potentially harmful vs. beneficial effects of 
genetic test feedback held in other areas of behaviour change equally applies to weight gain 
prevention and weight loss. Following the Health Belief Model (Rosenstock, 1974), genetic 
feedback should be effective in the prevention of overweight because of its ability to raise 
perceived risk; however, following Illness Perception Models (e.g. Leventhal, 1993), the 
                                                          
4
 A version of this chapter has been published in Obesity
4
:  Meisel, S. F., Walker, C., & Wardle, J. (2011). 
Psychological responses to genetic testing for weight gain: a vignette study. Obesity, 20(3), 540-546. 
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unchangeable nature of genes may lead individuals to assume genetic determinism in the case 
of a high-risk result, or complacency when faced with a low-risk result.    
 
4.2 Study aims and contribution to the literature 
 
The aim of Study 1 was to explore anticipated psychological and behavioural reactions to 
higher risk and lower risk FTO gene results in two populations: i) a general student sample, and 
ii) overweight/obese individuals.  Investigating the effects of genetic testing in overweight and 
obese individuals may have implications for treatment, whereas investigating the effects of 
testing in a predominantly ‘normal’ weight sample may have implications for prevention of 
weight gain.   
 
Outcomes included anticipated motivation to make healthy lifestyle choices, fatalism, negative 
affect, and the perceived value of genetic information in ‘explaining’ current weight status.  I 
also asked questions about interest in taking a real genetic test.  Based on predictions from the 
Health Belief Model (Rosenstock, 1974) and findings from Frosch et al (2005) and Conradt et al 
(2009), I hypothesised that higher risk feedback compared with lower risk feedback, would 
increase motivation for behaviour change, but would also increase negative affect among 
‘normal weight’ individuals. I also expected that women would show more negative affect 
than men in response to a higher risk test result because of higher societal pressure placed 
onto women to be slim. More fatalistic responses among those who were already obese were 
expected, based on predictions from Illness Perception models (Leventhal, 1997), but I also 
expected this group to place more value on having an explanation for their body weight.   
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Several shortcomings of the literature discussed in Chapter 2 are addressed.  The study begins 
to fill the void in the literature investigating the use of genetic test feedback specifically for the 
prevention of weight gain and as aid for weight loss, it uses two large samples which provide 
sufficient power to draw meaningful conclusions, assumptions are based on theoretical 
models of health behaviour, and the vignette was designed in accordance with 
recommendations by Persky and colleagues (2008) to increase validity of the results.  
 
4.3 Methods and Procedure 
 
4.3.1 Participants 
Student sample  
A convenience sample of students from a university in London, UK, was recruited through a 
mass mailing to all students.  
 
The obese ‘Panel’ sample  
Members of a nationwide online ‘user panel’, set up and supported by the charity Weight 
Concern, consisting of adults who are or have been overweight/obese, were invited to 
participate.  
 
Sample size estimations were based on evidence from Conradt et al. (2009) which showed that 
a sample of 300 people would have sufficient power to detect a small effect size difference in 
motivational responses to different genetic test results in a within-subjects design.  
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4.3.2 Procedure 
The study design was cross-sectional.  The email invitation to participate, which included a link 
to the online survey, was sent out to all students and panel members.  Potential participants 
were informed that consent would be presumed from filling out the questionnaire and clicking 
the ‘submit’ button.  The introduction to the survey included brief information about the FTO 
gene, and before proceeding further, participants had to confirm that they had understood 
the information.  The information given was piloted before inclusion in the questionnaire.  
Several details were dropped from the original piece of information for the sake of 
conciseness, clarity and to reduce complexity.  For example, references to allelic variation in 
individuals were not included in the final version because participants in the pilot appeared to 
have difficulties with the concept without further explanation.  Also, references to workings of 
the gene were not included as research in this area is still emerging.  The final version included 
the following four statements about the FTO gene: ‘1.One of the first genes linked with weight 
(called the FTO gene) was discovered in 2007. 2. About 1 in 6 people have the two high-risk 
variants of FTO. 3. Having the high-risk variants of FTO makes a person more likely to put on 
weight. 4. Having the high-risk variants of FTO increases your chance of becoming obese at 
some point in life by 20 %.’  The final version was perceived as very clear, unambiguous and 
easy to understand by participants in the pilot.  Participants responded to both vignettes with 
order of presentation randomised.  
 
4.3.2.1 The vignettes 
Vignettes were developed according to the five criteria outlined by Persky et al (2008) 
which are as follows:  
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1. Dichotomous scales should not be used as response scales, as these do not 
provide opportunities to assess an individual’s true opinion.   
2. Mention should be made of the test occurring in the immediate future.   
3. Length of text can be variable, and depends on the specific group studied.  
4.  Hypothetical scenarios should be pilot tested and build on appropriate theoretical 
foundations. 
5.  Rigorous study design should be employed in order to avoid methodological and 
statistical problems.  It is sensible to develop overarching criteria for using vignette 
designs as this will increase reliability and validity considerably and make it easier 
to compare vignette studies across populations.  This will allow for drawing more 
general conclusions regarding potential reactions to genetic test uptake. 
 
Several versions of the vignette were piloted before arriving at the final version. Mentioning 
that the saliva would be analysed at a special laboratory was dropped after the pilot, as 
participants felt that it was unimportant. The final version read the following:  ‘Imagine you 
have taken a gene test for FTO. It was done by getting saliva (spit). Imagine receiving your 
genetic test result in a letter from your doctor.’ In one scenario, participants were asked to 
imagine that their result showed increased susceptibility to overweight (higher risk condition) 
and in the other they were asked to imagine that they received a result not indicating 
increased risk (lower risk condition).  Individuals on whom the vignette was piloted (n = 35; 
members of the general population) perceived the vignette as clear, sufficient to explain the 
scenario, and easy to understand.  
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Participants were asked to think how the result would affect them by indicating their level of 
agreement to 16 statements broadly relating to the following constructs: motivation to 
counteract weight gain, fatalism, negative affect and having an explanation for their current 
body weight  Each statement was preceded with: ‘If I received a genetic test result which [did 
not] put me at a higher risk for gaining weight I would …’ and responses were on a 5-point 
Likert scale, from ‘strongly disagree’ to ‘strongly agree’.  Mean scores for responses in each 
category were calculated to obtain a composite score on a 5-point scale (‘strongly disagree’ to 
‘strongly agree’) that was comparable across groups and risk conditions.  
 
4.3.3 Measures 
Because no published questionnaire covered all domains of interest, statements used to 
assess the anticipated psychological and behavioural impact of genetic testing were in part 
based on previous research as well as self-developed.   
4.3.3.1 Participant characteristics 
Participants were asked to provide basic information (age, course and year of study for 
students, employment status and educational attainment for Panel members) and to report 
height and weight for BMI calculation.  For all analyses, BMI was dichotomized into 
underweight/normal weight( BMI ≤ 25.0 kg/m2) and overweight/obese.(BMI > 25.0 kg/m2), 
according to WHO criteria (WHO, 2000).   
 
4.3.3.2 Principal component analysis 
Principal component analysis (PCA) was carried out on data from both samples and in both 
conditions to explore whether the individual statements could be categorized according to 
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overarching themes.  Grouping several statements according to underlying constructs was 
thought to improve reliability of the results. Another option would have been to use 
exploratory factor analysis, but PCA has been shown to be as psychometrically sound, but be 
less mathematically complex than factor analysis (Field, 2005).  
 
PCA using Oblimin rotation with Kaiser Normalization confirmed that 16 of the 23 statements 
fell into five domains: Motivation to control weight, Negative Affect, Fatalism (which remained 
assessed through a single item), Information Seeking and the ‘Explanatory Value’ of the 
genetic test result.   Table 4.1 displays the statements used and their respective factor 
loadings.  Scale scores were derived by adding scores for the individual items loading on that 
factor, and then deriving the average.   This made scores fall onto a five-point scale allowing 
for comparison across groups. Crohnbach’s alphas were as follows: Motivation (six items) = 
0.89; Fatalism (one item) = 0.46; Negative affect (four items) = 0.70; Explanation (two items) = 
0.69; Information Seeking (three items) = 0.58. 
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 Table 4.1 Statements used to assess the anticipated psychological and behavioural reactions to FTO feedback and their factor loadings 
If I received a genetic test result which [did not] put me at higher risk for weight gain… Motivation Fatalism Negative 
Affect 
Explanation Information 
Seeking 
   I would be more conscious about the amount of physical activity I do 0.80     
   I would take steps to prevent myself from gaining weight 0.87     
   I would try to change my lifestyle to prevent weight gain 0.87     
   I would want to take some action to prevent weight gain (Sanderson et al. 2008) 0.83     
   I would be more conscious of my diet 0.77     
   I would take up exercise 0.80     
   I would feel that there is nothing I can do to prevent weight gain  0.64    
   I would regret having taken the test     0.83   
   I would be glad that I knew about the genetic test result (reversed)   - 0.71   
   I would feel angry about the test result     0.73   
   I would feel depressed     0.57   
   I would be glad that I have an explanation for my body weight    0.72  
   I would feel that this confirms what I have always thought of as the reason for my weight    0.75  
   I would want to discuss my result with a health professional     0.54 
   I would go to the Internet to find out what the result means     0.86 
   I would like to know more about how the gene acts     0.72 
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4.3.3.3 Interest in and predicted uptake of genetic test feedback 
After completing the vignette component, participants were asked how interested they would 
be to in obtaining a free genetic test within the next six months to test their susceptibility to 
overweight (response options: ‘not interested at all’, ‘slightly interested’ and ‘very 
interested’).  They were then asked whether they would take up an offer of the test (‘no, 
definitely not’; ‘no, probably not’; ‘yes, probably’; ‘yes, definitely’).   
 
4.4 Statistical Analyses 
 
Analyses were carried out using the Statistical Package for Social Sciences (SPSS) version 14.0.  
Descriptive information was based on frequency tables and cross-tabulation.  T-tests were 
used to assess the influence of condition order on the results, and they were non-significant. 
Categorical variables were investigated with chi-square tests.  The influence of BMI and 
gender as predictors of test interest and anticipated uptake was examined with one-way 
analysis of variance (ANOVA).  Repeated-measures analysis of variance (ANOVA) was used to 
determine whether there were significant differences in responses across conditions.  Where 
significant interactions were found, I tested effects of each BMI/gender group individually with 
one-way ANOVA.  Age was included as a covariate in all analyses.  I did not include education 
as covariate as there was very little variation in both samples, so that no meaningful 
differences would emerge. Sidak correction was applied to control for potential alpha inflation 
of multiple testing without losing power to detect significant effects, and the level of 
significance was set at α = 0.05.  
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4.5 Results 
4.5.1 Participant characteristics 
A summary of the characteristics of the two samples is displayed in Table 4.2. 
 
Table 4.2 Participant characteristics 
Participant characteristic Students 
(n = 395) 
Panel 
(n = 306) 
 
Age (years; mean ± sd) 
 
24.7 ± 6.1 
 
44.4 ± 11.5 
Gender % (n) 
     Male 
     Female 
 
29.4 (116) 
70.6 (279) 
 
10.0   (32) 
90.0 (274) 
BMI % (n) 
     Underweight/Normal weight (BMI≤ 25 kg/m2) 
     Overweight (BMI 25.01-30.0 kg/m2 ) 
     Obese (BMI ≥ 30.01 kg/m2 ) 
 
80.0 (316) 
15.2   (60) 
  4.8   (19) 
 
9.2     (27) 
20.7   (66) 
70.1 (213) 
 
Student participants 
Out of 28,000 students registered on the email system, 395 undergraduate and postgraduate 
students took part in the study (1.4 % response rate).  Of the students who took part in the 
survey, the age range was from 18-61 years (mean = 24.7 years, SD = 6.1).  Over two thirds 
(71%) of respondents were female, and they were studying a variety of subjects, ranging from 
arts and humanities to medical and biological sciences.  For the majority (69%), self-reported 
height and weight placed them in the ‘normal weight’ category, with a mean BMI of 23 kg/m2; 
15% were classified as overweight and 8% as obese. 
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Panel participants 
Out of 1119 panel members, 306 individuals took part, yielding a response rate of 27%. 
Participants’ ages ranged from 21 to 82 years (mean = 44.4, SD = 11.2).  The majority were 
female (90%) and employed (70%).  Over two thirds of the sample held at least A-level 
education (64%) with half having completed university level education (52%).  Self-reported 
heights and weights resulted in BMIs from 20 kg/m2 to 75 kg/m2, with a mean of 35 kg/m2.  
Relatively few respondents were ‘normal weight’ (9%) or overweight (20%), and 71 % were 
obese.  Most (93%) perceived themselves to be overweight or very overweight, and 87% were 
either ‘very’ or ‘fairly’ dissatisfied with their current body weight.    
 
4.5.2 Interest in and predicted uptake of the genetic test  
Almost half the student sample (46%) indicated that they were ‘very interested’ in a genetic 
test for prediction of weight gain, and 78% said they would probably or definitely take up the 
offer of a free test.  Interest in testing was significantly higher in the Panel sample than in the 
student sample (difference: χ2 (1) = 56.45 p<0.001), with 75% of the Panel reporting that they 
were ‘very interested’ in obtaining a genetic test.  Almost all Panel respondents who were 
interested (93%), indicated that they would ‘probably’ or ‘definitely’ take up an offer for a free 
test, which was significantly different from the students (χ2 (1) = 29.67, p < 0.001).  There were 
no gender differences in interest in testing in either sample.   
 
Respondents who were overweight or obese were significantly more interested in a genetic 
test for obesity susceptibility than those who were ‘normal weight’ in both samples: (F Students 
(1, 390) = 7.42, p = .007, η2 = 0.019; F Panel (1, 300) = 5.72, p = 0.017, η
2= 0.019).  In the student 
sample, those who were overweight or obese were more likely to intend to have the test (F (1, 
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390) = 12.21, p =0 .001, η2 = 0.030).  There was also a significant interaction between gender 
and weight status in the student sample; with overweight females being more likely to take up 
a test offer than overweight males (F (1, 390) = 4.12, p = .043, η2 = 0.010).   
 
4.5.3 Vignette results in the student sample 
The complete results of the repeated-measures ANOVA for the student sample, including 
mean scores of the outcome measures, are shown in Table 4.3. All analyses included gender 
and BMI as covariates. 
 
Motivation There was a significant difference in motivation to make behaviour changes 
between average risk and higher risk conditions.  As displayed in Figure 4.1, mean scores were 
2.57 in the average risk condition and 4.02 (η2 = 0.153) in the higher risk condition.  The 
interaction with gender was not significant.  
 
Fatalism scores were slightly higher in the higher risk condition (2.01) than the average risk 
condition (1.74), but both means indicated disagreement with the fatalism statement.  10% of 
students agreed or strongly agreed with this statement in the higher risk condition, versus 1% 
in the lower risk condition, χ2 (1) =12.69, p < 0.001.  There were no significant interactions with 
gender or BMI.  
 
Negative Affect scores were higher (mean score: 2.28) after a higher risk than after an average 
risk result (mean score 1.88).  However, the effect size of η2 = 0.025 indicates that this increase 
was modest.  Interactions between condition and either BMI or gender were not significant. 
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Having an explanation for body weight did not differ significantly by feedback condition (p = 
0.413).  However, the interaction of risk condition and gender was significant.  Women 
reported significantly more relief about having an explanation for their body weight in the 
higher risk than in the lower risk condition, F (1, 300) = 6.26, p = 0.013, η2 = 0.016.   
 
Information seeking A higher risk result led to more anticipated information seeking, as shown 
in Figure 4.2.  Gender and BMI did not predict the extent to which individuals would seek 
information about the FTO gene.  
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Table 4.3 Results of the repeated-measures ANOVA for the Student and the Panel sample 
 
Outcome 
(range 1-5) 
Risk condition 
 
 
 
F(df, error) 
 
 
p-value 
 
 
lower risk 
mean ± sd 
 
higher risk 
mean ± sd 
 
Partial eta 
squared 
 
Students (n = 395)      
     Motivation 2.99 ± 0.57 3.97 ± 0.55 0.13 62.99  (1, 300) < 0.001 
     Fatalism 2.16 ± 0.90 2.54 ± 1.00 0.02   9.97  (1, 300)    0.002 
     Negative Affect 2.18 ± 0.72 2.24 ± 0.66 0.03 13.56  (1, 300) < 0.001 
     Information Seeking 3.49 ± 0.80 4.19 ± 0.58 0.02 10.37  (1, 300) < 0.001 
     Explanation 3.09 ± 0.86 3.79 ± 0.78 0.01   0.67  (1, 300)    0.413 
      
Panel (n = 306)      
     Motivation 2.57 ± 0.67 4.02 ± 0.65 0.16 60.99   (1,390) < 0.001 
     Fatalism 1.74 ± 0.04 2.01 ± 0.06 0.01   1.18   (1,390)    0.279 
     Negative Affect 1.88 ± 0.55 2.29 ± 0.72 0.01   0.37   (1,390)    0.545 
     Information Seeking 3.29 ± 0.79 4.08 ± 0.68 0.07 23.09   (1,390) < 0.001 
     Explanation 2.70 ± 0.82 3.00 ± 0.97 0.02   6.19   (1,390)    0.013 
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4.5.4 Vignette results for Panel respondents 
Mean scores of the composite scales for both conditions and complete results of the 
repeated-measures ANOVA are shown in Table 4.3.  
 
Motivation to change behaviour was high in the Panel sample regardless of test feedback, but 
was even higher when anticipating a higher risk result, displayed in Figure 4.1 (mean scores: 
2.99 lower risk vs. 3.97 higher risk). This effect was independent of BMI or gender.  
 
Fatalism did not differ between the different risk conditions for Panel members, as shown in 
Figure 4.1.  As indicated by the relatively low mean scores (2.16, SD = 0.90 lower risk and 2.54, 
SD =1.00 higher risk), few respondents believed that there was nothing they can do about 
further weight gain.  BMI or gender did not significantly affect the results.  
 
Negative Affect likewise was not affected by risk condition.  The mean score of 2.18 (lower 
risk) and 2.24 (higher risk) out of 5 for both conditions shows that respondents did not expect 
to be depressed or upset by a result placing them either at average or higher risk for weight 
gain.  There was also no significant interaction with BMI or gender. 
 
Having an explanation for body weight was endorsed more strongly following a higher risk test 
result, regardless of BMI or gender.  
 
Information seeking: Panel members anticipated informing themselves more about genetics 
and FTO following a high than a lower risk result. This effect was secondary to the significant 
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interaction of risk condition and gender, with men being slightly more interested than women 
in the higher risk condition F (1, 300) = 5.26, p = 0.022, η2 =0.017.  BMI did not predict 
information seeking.  
 
Figure 4.1 Motivation, Negative Affect and Fatalism in both samples 
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Figure 4.2 Value of Explanation and Information Seeking in both samples 
 
4.6 Discussion 
The present study investigated anticipated psychological and behavioural responses to genetic 
test feedback for susceptibility to weight gain in a panel sample of overweight/obese 
individuals and a general student sample.  In both groups, higher risk test feedback elicited 
increases in anticipated motivation to adopt a healthier lifestyle or lose weight. This is 
consistent with social cognition models such as the Health Belief Model (Rosenstock, 1974) 
which identify perceived risk as a determinant of motivation.  However, higher-risk feedback 
also resulted in increased negative affect for some participants; although these effects were 
mild.  Overweight and obese individuals anticipated to derive a greater explanatory value from 
a higher risk genetic test result than normal weight individuals.  
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4.6.1 Study limitations 
The study had several limitations.  First, the hypothetical scenario precludes inferences 
regarding actual behaviour, because intentions do usually not translate fully into actions 
(Sheeran, 2005).  Secondly, although all individual items used to assess anticipated reactions 
to genetic test feedback were based on the literature and their factor structure was confirmed 
by Principal Component Analysis, they were not taken from a validated questionnaire.  
Therefore, they may have not been sensitive enough to capture the nuances in psychological 
affect, particularly if reactions were mild.  However, findings allow for gauging any potential 
reactions, while avoiding at the same time the potential for harm.  A further limitation is that 
samples are not representative of the population from which they were drawn.  Spam filters 
and non-use of the university email address may have contributed to the low response rate in 
the student sample.  Furthermore, individuals with more positive attitudes towards genetic 
testing and who anticipated reacting more positively to genetic feedback, would have been 
more likely to choose to take part in the study (Sanderson & Wardle, 2008), which could lead 
to an underestimation of potential adverse reactions if test feedback was given to individuals 
who were not in a position to choose whether or not to receive it.  However, in the real world, 
genetic testing for disease susceptibility is voluntary and so the same situation would hold.  
Nonetheless, to forestall adverse emotional reactions in individuals who might be more 
affected than they anticipate, offering the option of professional advice alongside the test 
result might be sensible.  Thirdly, the FTO information provided was referring to risk of future 
weight gain, and not to losing weight. This may have had a different impact for those 
individuals who are already overweight or obese.  Negative outcomes may have been more 
severe if the risk information was framed to include the difficulty in losing weight.  Lastly, the 
current study gave information on only one gene with modest effect size to assess obesity risk.  
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In clinical practice, this scenario would be highly unlikely as returning feedback for gene panels 
is now feasible and cost-effective, and whole-genome sequencing is expected to follow in the 
foreseeable future.  Therefore, reactions to results from panel-or whole-genome sequencing 
may differ because participants may assign more meaning to these results.  
 
4.7 Conclusion 
Results from this vignette study indicate that anticipated personalized feedback about raised 
genetic risk for weight gain increased motivation for change with only modest adverse 
emotional effects in both a student sample and a clinical group.  These results provide some 
confidence in taking forward research using real FTO feedback as part of a package of 
personalized risk information and behaviour change advice. 
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Chapter 5:  Study 2 – Reactions to FTO genetic test feedback for weight 
gain – a qualitative exploratory investigation
5
 
 
5.1 Background 
 
The findings of Study 1 indicate that genetic test feedback for weight gain susceptibility may 
be motivating, and is unlikely to result in pronounced harmful effects.  However, hypothetical 
responses can provide only an impression of likely outcomes in the real situation; although, 
the lack of anticipated major adverse effects gave confidence in setting up a study to examine 
effects of giving real genetic test feedback to individuals.  
 
5.2 Study aim and contributions to the literature 
 
The aim of the current study was to explore reactions to real FTO feedback in a small number 
of interested individuals to establish potential benefits and harms associated with this 
technology.  The study addressed the following shortcomings of the existing literature:  
Reactions to genetic test feedback could be studied instead of relying on assumptions made 
on the basis of hypothetical studies by returning ‘real’ genetic test feedback to individuals.  
Furthermore, it provided in-depth qualitative data in this area of research, which was used for 
hypothesis development for further quantitative research.  
                                                          
5
 A version of this chapter has been published in the Journal of Genetic Counseling Meisel, S. F., & 
Wardle, J. (2013). ‘Battling my Biology’: Psychological Effects of Genetic Testing for Risk of Weight Gain. 
Journal of genetic counseling, 1-8. 
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5.3 Methods 
5.3.1 Development of the FTO information leaflet 
A short information leaflet was developed for participants.  The leaflet gave a brief overview 
about the FTO gene, its mode of inheritance, and magnitude of influence on body weight 
(Appendix 1).  Readability was assessed with the Flesch Reading Ease formula and the Flesch-
Kincaid Grade Level formula, and received a score of 70.0, which translates to the reading level 
expected in grade 6 (age 12).  The leaflet was piloted in a number of individuals not familiar 
with genetics and wording and design were adjusted according to their feedback.  
 
5.3.2 Participants 
The sample consisted predominantly of interested individuals who responded to 
advertisements for Study 3 (p. 146), but whom we had to exclude because they did not match 
the inclusion criteria.  They were offered to have their details added into a database so that 
they could be contacted at a later stage.  The sample was therefore doubly self-selected by 
participants first opting to participate in the association study (Study 3, p. 146), and then 
agreeing to participate in the interview.  Participation was voluntary, and participants did not 
receive remuneration for their time.  Although the sample is not representative of the 
population at large, this is not a requirement for qualitative studies (Ritchie et al., 2003).  At 
this stage it was unknown whether actual reactions would differ from anticipated reactions to 
test feedback for weight gain; therefore, we thought it as important to choose individuals who 
were comfortable with the idea of genetic testing for weight gain, and who would be able to 
talk openly about their experience.  We included the first 18 volunteers because saturation of 
themes was reached after 15 interviews and further interviews felt unjustified.  Ethical 
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approval was granted by the UCL Ethics Committee for non-NHS research (ID Number 
2471/001).  The approval letter is included in Appendix 2.  
 
5.3.3 Procedure 
Participants were sent an email with the invitation to receive a free genetic test for their 
obesity risk status in exchange for being interviewed about the experience.  The invitation 
email stated clearly that pseudonyms would be used and that all personal information would 
remain confidential and included the FTO information leaflet.  After replying to the initial 
invitation, participants received an information sheet with further details about the study, 
were invited to provide saliva for genotyping.  Before saliva collection, the procedure was 
explained in detail and participants were given a consent form to sign.  Saliva flow was 
stimulated with a small amount of sugar placed onto the participant’s tongue and 1.5-2 ml of 
saliva was collected by drooling into the collection tube.  Participants were asked to refrain 
from eating, drinking (other than water), smoking or brushing their teeth in the hour 
beforehand.  Samples were coded with a unique identifier number so that they were 
anonymous but could be linked back to the interviews.  
 
5.3.3.1 Genotyping 
Saliva samples were collected for genotyping and anonymised before further analysis.  DNA 
was isolated and extracted from saliva as described in Chapter 7: .  Genotyping of rs9939609 
was done using TaqMan as previously published (Wardle et al., 2008).  Participants were 
contacted by email to accept or decline receiving the result, and to arrange an interview 
appointment.  Results were sent by email one day before the interview to give participants 
time to think about the test result before the interview while ensuring that responses were 
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still vivid.  The FTO information leaflet was included again in the email to refresh participants’ 
memories.  
 
5.3.3.2 Interviews 
I conducted semi-structured, face-to-face exploratory interviews at University College London.  
Prior to the interview, permission was sought to record it to avoid the need to write.  The 
interview guide consisted of a small number of open-ended questions (see Table 5.1), which 
were principally to keep the conversation flowing and not necessarily rigidly followed.  
Questions were chosen on the basis that they would lead to sharing of thoughts and feelings 
experienced before and after testing, and reveal the narratives that participants had 
constructed about weight and genetics.  Participants’ answers largely established the direction 
of the conversation and I only moved on to the next topic when it was felt that no new 
answers were acquired.   
 
Participants were told that pseudonyms would be used and all personal information would be 
confidential.  They were invited to a meeting where the procedure was explained in detail and 
they were given the opportunity to consent.   
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Table 5.1 Core questions of the interview guide 
Interview question 
What made you interested in the study? 
Can you remember your test result? Can you explain what it meant? 
Were you concerned in any way before you decided to take part? 
Can you take me through your thoughts from when you heard about the study to when you 
received your result? 
How did you feel when I told you your test result was ready and when you received your result? 
Did you tell anyone that you took the test? 
Is there anything else that you would like to tell me that we have not covered?  
 
5.4 Data analysis 
 
Interviews were transcribed verbatim and analysed with Framework Analysis, which allows 
analysis by case and by theme (Ritchie, 2003).  This method was appropriate, because areas of 
investigation were chosen a priori, based on predictions of health behaviour models.  For 
example, interviews were searched for evidence of perceived susceptibility, perceived 
severity, benefits, barriers, and cues to action that make up the Health Belief Model 
(Rosenstock, 1974), and illness identity, cause, consequences control beliefs, and timeline that 
comprise the Illness Perception Model (Leventhal, 1997).  
 
Interviews were coded by me, Jane Wardle and an independent researcher (Katriina 
Whitaker).  Triangulating data in this manner ensured high reliability and validity of the current 
results.  At first, statements were loosely coded until common themes emerged that were 
extracted to develop overarching categories.  These categories were refined and subdivided by 
coding and recoding the interviews.  As new themes arose, previously coded interviews were 
re-analysed.  Quotes were organized to represent the same themes:  for example, ‘reactions 
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to FTO feedback’ at first included all reported emotions or behaviours after receiving the 
genetic test result; this was then further subdivided into positive and negative reactions, with 
immediate and future implications.  Data coding followed an iterative process, revisiting the 
interviews until no new themes emerged, as described.  Constructs from the Health Belief 
Model and Illness Perception Model discussed in Chapter 2 were kept in mind when interviews 
were coded.  For example, I After coding was complete, the research team met to discuss 
results.  Agreement of the researchers for extracted themes was very high; where minor 
discrepancies arose they were discussed until agreement was reached.   
 
5.5 Results 
 
5.5.1 Participant Characteristics 
Of the 18 participants who took part in the study, two thirds were women (n = 12), and the 
average age was 27 years (SD = 8.40; Median: 25 years).  Eight participants worked or studied 
in fields allied to health or genetics.  Self-reported heights and weights resulted in a mean BMI 
(kg/m2) of 23.1 (SD = 3.9), with one person classified as underweight, three as overweight, one 
obese, and the remainder as healthy weight.  Eight participants had at least one overweight or 
obese parent.  
 
5.5.2  FTO status and recall of the test result 
All participants chose to know their result and receive it by email, and all came to the 
interview.  All but one remembered their test result correctly, and all were able to give a 
correct explanation of the meaning of the result.  All said that they would remember their test 
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result in the future.  Four participants had the TT genotype (22%), 10 AT (56%) and four AA 
(22%); approximating to the population distribution in larger studies.  
 
5.5.3 Interviews 
Interviews lasted on average 27 min (range: 20-38 min). Every effort was made to create a 
relaxed atmosphere for participants by establishing rapport and offering refreshments on 
arrival.  All participants seemed in a positive mood and keen to share their thoughts on their 
experience.  
 
5.5.4 Themes 
Eleven themes were extracted from the data which are described in detail below. Quotes were 
included where appropriate to illustrate findings. Participant number and weight status are 
included in brackets to add some context. Themes are presented in descending order of 
prevalence. 
 
Theme 1: Curiosity as driver for participation 
Without exception, participants cited ‘curiosity’ as the main reason for participation.  The 
prospect of ‘uncovering something about myself that I don’t already know’ (P4, TT, normal 
weight) that would otherwise be ‘completely hidden’ was seen as intriguing and exciting.  
There was a perception that ‘most people probably go through their life and will never know 
anything about their genetic make-up.’ (P16, AT, underweight), and as such, learning about 
one’s FTO genotype was perceived as a unique opportunity.   
 
Theme 2: Weight is a salient issue  
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Weight regulation was seen as an important personal issue for most participants.  For some, 
this was because they felt they only maintained weight by ‘being fairly controlled about what 
we eat’ (P4, TT, normal weight); for others, because of on-going difficulties with weight 
control:  ‘I have struggled so much with my weight probably since about the age of eight […]’ 
(P11, AA, overweight).  Regardless of current weight status, the desire to know whether 
maintaining body weight was a result of ‘self-control or because of genes’ (P4, TT, normal 
weight) was a strong motivator for participation. 
 
Theme 3:  No consideration of potential negative outcomes before taking the test 
Despite the reported importance of body weight regulation for most participants, none 
considered the potential implications of their genetic test result beforehand.  For example, 
one participant reported that ‘it was only when you sent me the email invitation for the 
interview to talk about the implications then I started to think: oh wow, are there 
implications?’  (P16, AT, underweight).  Similarly, another said ‘I kind of just did it, I didn’t think 
too much about the outcome of it, or how it would affect me really’ (P12, AT, normal weight).   
 
Participants frequently explained their lack of concern about negative effects retrospectively 
by ‘ranking’ the severity of obesity relative to other conditions.  The ultimate decision to get 
tested appeared to be a function of perceived susceptibility to and severity of obesity.  For 
example, one participant explained that ‘if you’d tell me you’d test me for an Alzheimer’s gene 
then I would say no, but for weight gain […]’ (P3, AT, normal weight), whereas another would 
have been more enthusiastic about genetic testing for a gene for a more ‘severe’ condition:  
‘[...] Alzheimer’s or Huntington’s Disease or something, then I would probably be more jumping 
at the chance because it would feel like more applicable to me’ (P5, TT, normal weight).  
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However, both appeared to use a more severe disease and perceived relevance as ‘anchors’ 
onto which to base their decision to participate.  
  
Theme 4: Weight gain is perceived as interplay of genes and environment 
Weight gain and obesity were consistently understood as due to a complex interplay of 
genetic and environmental factors by all participants, and not seen as caused by a single 
agent.  Recognition of family differences in the propensity to gain weight were frequently 
cited as a reason for reaching the conclusion that weight gain must be governed by factors 
other than willpower: ‘I think as someone who can eat whatever I want – at least I thought 
that – and didn’t put any weight on, with a sister that is the complete opposite – she eats and 
she puts on weight – I have always been very intrigued by why that is [...]’ (P16, AT, 
underweight).  Another woman observed that similar eating traits were displayed within the 
family which left her wondering about heritability of appetite ‘[…] I just also see with my niece 
and nephew, 5 and 3, that they have these similar kinds of eating traits that we all, me, my 
sister and my mother have […] they are just obsessed by food […] so I have always wondered 
whether it was genetic or not’ (P6, AT, overweight). 
 
Theme 5: Personal responsibility for control over food intake 
Although participants acknowledged genetic differences in the propensity to gain weight, 
personal responsibility was perceived to be more important: 'I don't think the gene actually 
contributes 100% to weight gain, because it happens with food differences and normal 
lifestyle, you know, so that's not an excuse [...]' (P2, TT, normal weight).  The notion of 
controllability of weight surfaced repeatedly across all weight groups and regardless of 
genotype; expressed by one woman as ‘whatever I am made up of, if I eat a lot and don’t 
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exercise then I’m gonna get fat’ (P4, TT, normal weight).  Weight gain and overweight 
appeared intertwined with beliefs about behavioural efforts and personal control, extending 
even to the biological forces: ‘[…] I think [having a genetic tendency to gain weight] is not 
applicable to me; it is maybe there but I can override it’ (P7, AT, normal weight).  Beliefs were 
formed by personal experience: ‘[...] my experience with weight throughout my life and it’s 
definitely, I don’t blame it all on that [genetic factors], a lot of it is what I did and didn’t for a 
number of different reasons’ (P11, AA, overweight), leading to the conviction that weight 
management is ultimately a matter of personal control.   
 
Theme 6: Feedback affirms private constructs of weight gain 
Regardless of actual risk status, receiving genetic test feedback often affirmed private 
constructs of causal agents of weight gain, which was apparent in the reactions to the test 
result.  Those who felt that they were struggling with weight, either by exerting too much or 
too little control, felt relieved and reassured by their test result: ‘[…] although it wasn’t, like 
AA, the strongest, I still had one risk allele and that was kind of reassuring to me in a sense 
because I always suspected that my kind of appetite [pause] I mean, I have always struggled to 
control my appetite and if I kind of had been like TT and it was completely behavioural, that 
would have been [pause] I would have found that quite hard to deal with in a way because you 
know I feel like, ok it’s a combination of both, but it is in part biology and I am in a sense 
battling against my biology[…]’ (P6, AT, overweight).  A similar view was evident in the 
following quote: ‘[…] I still feel that I gain weight more quickly than other people do and its 
very reassuring to have that knowledge that I don’t necessarily have that condition, that I do 
naturally put on weight while eating just normally, so for me that’s a big reassurance to just 
know that I can be a healthy person if I adjust my diet to a normal standard’ (P14, AT, normal 
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weight).  The former quote was from an overweight woman who was actively trying to lose 
weight and the latter from a woman with a history of anorexia nervosa (now recovered); 
nonetheless, the quotes were strikingly similar.  Both reflected the perception of differing 
from the ‘norm’, and the desire to understand the reasons for their struggles.  Receiving an AT 
personal result was concordant with their private constructs of weight gain, which appeared 
sufficient to resolve internal conflict. 
 
Theme 7: Evidence for relief of guilt and self-blame by the test result 
The relief that overweight participants felt from having a partly biological explanation for their 
problem was evident again when asked about the personal meaning of the result: ‘[…] it would 
just help understand yourself really.  Kind of [pause] it makes me feel better that I have AT, if I 
had TT I think I’d be a bit upset, because it would be like, oh my gosh I’ve got [pause] it’s all 
me, it’s me [pause] but as it’s AT, at least it’s got something to do with my genes and it’s not 
just me being a pig’ (P17, AT, obese).  In addition to the stigma stemming from perceived loss 
of control as the cause for overweight, this participant clearly expressed how much self-blame 
and guilt is attached to this perception.  Similar to the previous comment by P6, this suggested 
that a result indicating no increased genetic risk (TT) could have led her to be negatively 
affected by affirming her perceived personal shortcomings.   
 
Theme 8: No evidence for adverse or fatalistic responses 
Confirmation of private assumptions was also evident in those receiving an ‘AA’ (higher risk) 
result.  However, no-one expressed fatalistic reactions.  Most participants responded by 
asserting that the contribution to weight gain is only small:  ‘I thought bad luck, but then I was 
like, oh well, it doesn’t mean much’.  Another woman focused on how she was motivated by 
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her test result to take on the battle against her biology: ‘If I’m thinking I want to go to the gym 
or thinking about oh yeah I’ll just eat what I want this weekend and not bother, it will give me 
a bit of a push in the right direction to just think no actually, you know you need to be a bit 
careful.’ (P11, AA, overweight).  Test feedback appeared thus to act as motivator and catalyst 
to shift attention to modifiable aspects of weight gain. 
 
Similarly, TT (lower risk) participants were not surprised by their result because they already 
attributed their body composition to factors other than solely their eating behaviour.  
However, as one woman (P4, TT, normal weight) explained with a smile:  ‘This has deprived me 
of the chance to say, well look at me, I have it [the gene] and I still managed to stay lean for 
most of my life’.  In none of the narratives was there any sign that TT participants thought of 
themselves as protected from becoming overweight.  This may be because they were aware 
that the contribution of FTO to weight gain is only small, or because it did not ‘fit’ with their 
preconceived beliefs about weight gain; either way, there was no evidence for complacency.  
 
Theme 9: Evidence for a motivational effect of the result 
Many participants thought that knowledge of the result would help them to maintain weight 
control activities in the future by alerting them to their genetic predisposition, and to ‘be more 
careful in the future, especially when you get older and you get fatter more easily’ (P1, AA, 
normal weight).  Participants who thought that their result would not change their behaviour 
in the near future justified this by explaining how they were already taking action against 
weight gain by eating ‘already reasonably healthy and go[ing] to the gym, and I don’t think it is 
a huge problem for me.  If I was overweight, it would have a sort of bigger, you know, 
significance’ (P3, AT, normal weight).  The themes of taking personal responsibility and being 
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in control of weight gain were again central to the conversation, as participants seemed 
compelled to justify why they felt they could disregard potential implications of the test result. 
 
Theme 10: Inducing an overly restrictive attitude – a concern for genetic test feedback 
Several participants raised a concern about inducing an ‘overly restrictive’ attitude to food or 
fuelling anorectic tendencies: ‘yeah, I don’t know, if someone got AT or AA they might be like, 
oh god, I really shouldn’t eat this, or they might go a bit, a bit too far, but then you probably 
need to have these kinds of tendencies anyway’ (P9, AT, normal weight).  However, the young 
woman with a history of anorexia nervosa did not confirm this fear.  She explained why, in her 
opinion, receiving genetic test feedback would be beneficial:  ‘[…] because when it’s kind of 
scientifically objective you are able to see whether that’s just your genetic condition and it 
helps to deal with it the best way possible […] to be able to address these things and not to 
make it into some sort of taboo that can’t be talked about’ (P14, AT, normal weight).  Once 
again, the theme of a ‘scientifically objective’ result alleviating guilt, stigma and shame 
attached to disordered eating emerged.  Confirmation of a partly biological explanation for 
weight problems appeared to increase, not decrease, perceptions of control by shifting the 
focus away from it being a personal shortcoming towards being a ‘condition’.  The test result 
was sought to remove the ‘taboo’ that surrounds disordered eating by permitting dialogue 
about it. The other participants who raised the issue of potential adverse effects noted that 
the risk would be minimal if accurate information about the genetics of weight gain was given 
alongside the genetic feedback. 
 
Theme 11: Sharing genetic test results 
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There were no concerns about sharing their genetic test results with friends or family, and in 
many instances participants had already done so.  However, opinions were split on the subject 
of genetic testing being part of routine healthcare, or test results being on the medical record.  
Concerns centred predominantly on potential discrimination by employers or insurance: ‘[…] if 
you have to produce a medical record for insurance purposes or for a job or a high stress 
environment […] you might not get that job, but you might have been managing your condition 
your whole life and be healthier than someone who has got no disposition but is eating donuts 
every day’ (P16, AT, underweight).  Interestingly, this participant not only acknowledged 
potentially negative future implications of genetic testing, but at the same time implicitly 
supported the assumption that awareness of genetic risk would positively influence health 
behaviours. 
 
5.6 Discussion 
 
Results from 18 interviews, carried out after respondents had received feedback on genetic 
susceptibility to weight gain, indicated that feedback is likely to have beneficial motivational 
and psychological effects with little risk of negative affect; supporting findings from Study 1 
and the hypothetical study by Frosch and colleagues (2005).  This suggests that, at least in this 
instance, hypothetical studies served as a good model to gauge outcomes of giving ‘real’ 
genetic feedback.  The reported reasons for positive responses to the test result varied 
depending on current weight status and test result.  Normal weight participants with an AT or 
AA result described the result as ‘little warning bell’ that would help them to be more 
conscious of their weight and monitor weight gain in the future.  Participants struggling with 
weight control described reassurance and relief of stigma, guilt or self-blame as benefits of 
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receiving the test result, which has so far received limited attention in the literature.  
Constructs discussed in the Health Belief Model (Rosenstock, 1974) were all evident in the 
interviews.  There was less support for the Illness Perception Model (Leventhal, 1997) with 
respect to fatalistic responses or false reassurance; however none of the participants 
appeared to have had representations of obesity that relied exclusively on genetics, and 
therefore the Illness Perception Model would not strictly speaking have anticipated either 
fatalism or false reassurance in response to the test result.  
 
5.6.1 Study limitations 
However, this study had many limitations.  As in all qualitative studies, reliability and validity 
of the current results have to be viewed with caution.  The sample was highly selected 
because participants were drawn from a pool of educated individuals who had previously 
expressed interest in genetics and weight control and therefore, findings may not generalise 
beyond the sample studied here.   However, the aim of the study was to explore potential 
benefits and problems of testing for risk of weight gain, and not to draw general conclusions.  
Furthermore, we tried to increase reliability by constantly comparing cases with one another, 
following suggestions by Glaser & Strauss, 1967.  Social desirability bias cannot be excluded; 
although the interview questions were open-ended, some answers may have been intended to 
make a good impression on the interviewer.  Obesity is stigmatized, and a ‘moral imperative’ 
to fight against it is prevalent (Townend, 2009; Saguy, 2005).  Participants may therefore have 
felt compelled to exaggerate the beneficial effects of their test result.  However, because they 
were participating out of personal interest and did not think deeply about the implications of 
their result beforehand, this seems likely to be a modest effect.  In addition, we had no 
‘mismatches’ between genotype and phenotype in the sample (i.e. no slim AAs or overweight 
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TTs), and responses may differ in these individuals which should be explored in further 
research.  Finally, the present study focused only on responses the day after receiving the 
result, and the long-term effects of receiving genetic feedback need to be investigated in 
future research.   
 
 
5.7 Conclusion 
This qualitative study indicated that real genetic test feedback did not engender fatalistic or 
complacent responses, and most respondents reported increased motivation towards healthy 
lifestyles and relief of stigma and self-blame.  The findings provide a strong foundation for 
further research to investigate the clinical utility of FTO feedback as part of weight control 
advice.  
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Chapter 6:  Study 2b – Affective responses to genetic test feedback for 
obesity in a sample of overweight individuals: An Interpretative 
Phenomenological Analysis 
6
 
 
6.1 Background 
 
Findings from the previous study indicate that FTO feedback may have positive psychological 
effects, especially for individuals struggling with weight control.  However, there was also 
some indication that overweight and obese participants had been disappointed if they had 
received a lower risk genetic test result; but because there were no ‘mismatches’ between 
genotype and weight status (no very slim AAs or overweight/obese TTs), this emerging theme 
could not be further investigated.  The literature on genetic test feedback has almost 
exclusively focused on the impact of receiving higher risk results.  However, it is important to 
understand the impact of a ‘mismatch’ between the manifestation of a condition in the 
absence of tested genetic markers, particularly because the low predictive ability of most 
genetic markers for common conditions will make this scenario a common occurrence. 
 
 
 
 
                                                          
6
 A version of this chapter has been published in Genes & Nutrition:  Meisel, S. F., and J. Wardle. 
"Responses to FTO genetic test feedback for obesity in a sample of overweight adults: a qualitative 
analysis." Genes & nutrition 9.1 (2014): 1-4. 
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6.2 Study aims and contribution to the literature 
 
Therefore, this study explored the impact of receiving FTO feedback in a small sample of 
overweight/obese individuals to explore the process by which individuals make sense of their 
genetic test result.  Using a sample where some individuals would be expected to have the 
lower risk genotype (TT) despite being overweight (being ‘discordant’ for gene status and 
condition) also allowed me to explore how this discrepancy is resolved cognitively.  This study 
will contribute to the understanding of how affected individuals ‘make sense’ of genetic risk 
and offer insights into coping strategies used to come to terms with an unanticipated genetic 
test result.  
 
6.3 Methods and Procedure 
 
6.3.1 Participants 
Participants were seven volunteers drawn from the ‘Big Panel’, which was also used in the 
vignette study (Study 1, p. 99).  An invitation email was sent to the 306 panel members who 
had taken part in the vignette study and had expressed interest in participating in other 
studies.  Sixty-eight individuals (22%) were interested in the current study and we selected the 
first seven female respondents because the analysis method used (Interpretative 
Phenomenological Analysis, IPA) requires the sample to be small and homogenous.  
6.3.2 Procedure 
The invitation email included the information materials used in Study 2 and 3 (Appendix 3).  
Briefly, the information sheet explained that feedback would be given only for FTO, that 
associations with weight gain are small and that DNA samples would be destroyed on 
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completion of the study.  Participants were mailed a saliva collection kit, the FTO information 
leaflet (Appendix 1), a consent form, instructions on how to collect saliva, a pre-paid return 
envelope, and a telephone contact number.  Ethical approval for the study was granted by the 
UCL Research Ethics Committee for non-NHS research (ID Number 2471/001).   
 
6.3.3 DNA analysis and genetic test feedback 
DNA was extracted from saliva as previously described (Wardle et al., 2008) and FTO 
rs9939609 was genotyped using TaqMan at the Institute of Metabolic Sciences, Cambridge, 
UK.  Participants were notified by email once their result was available, and could choose to 
receive it by providing a date and time for a telephone interview or decline to receive it.  We 
included this step to ensure that participants still wanted to receive their genetic information 
(which they all did).  Result letters were attached to an email, so participants could choose 
when to access them and were sent one day before the interview to allow some time for 
reflection but to be recent enough to be memorable.  
 
6.3.4 Interviews 
I conducted semi-structured telephone interviews which were recorded with the participant’s 
permission.  We chose telephone over face-to-face interviews because we wanted to avoid 
participants feeling self-conscious about their weight, or the researcher’s appearance 
influencing their responses; although we recognised that some contextual information was 
lost by being unable to see facial expressions and body language (Holt, 2010).  The interview 
guide included open-ended questions adapted from Study 2a (Table 5.1, p. 122), broadly 
covering thoughts and feelings before, during and after genetic testing, causal attributions of 
weight gain, and feelings of being ‘at risk’.  Care was taken to let participants tell their ‘story’ 
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while still steering the conversation towards the main points of interest using prompts and 
follow-up questions.  The interview was concluded when the conversation reached a natural 
end and further probing did not reveal new insights.  
 
6.4 Data analysis 
 
Interviews were analysed using Interpretative Phenomenological Analysis (IPA).  IPA focuses 
on exploring in detail the ‘lived experience’ of individuals in all its complexity and is therefore 
particularly suited for the use in studies of novel aspects of the human experience (Smith, 
2009; Chapman & Smith, 2002).  For this study, we felt that IPA’s emphasis on the process by 
which individuals understand their experience of genetic testing fitted well with the aims of 
the study.   
 
Transcripts were read and reread to extract broader topics, which were then further refined 
into themes following an iterative process.  Frequent discussions among the research team 
ensured high agreement on extracted themes and avoided researcher bias.  All transcripts 
were coded by a researcher not involved in the study to ensure reliability.  Inter-rater 
agreement was high, and any minor discrepancies were discussed until agreement was 
reached. 
 
6.5 Results 
6.5.1 Participant characteristics 
Table 6.1 shows demographic characteristics for each participant.  Participants were white 
British or European women, all of whom were currently overweight or obese.  The age ranged 
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from 34 to 54 years (mean age = 45, median age = 44), and BMIs from 25-39 (mean BMI = 32.6 
kg/m2, median BMI = 34.6 kg/m2).  
 
Table 6.1Participant characteristics 
Participant FTO 
status 
Age 
(years) 
BMI Weight 
Satisfactio
n 
Education Self-rated 
understanding 
of genetics  
P1 AT 54 34.6 Very 
dissatisfied 
Postgraduate Higher than 
other people 
P2 AT 53 26.7 Very 
dissatisfied 
Postgraduate About the 
same as other 
people 
P3 TT 37 28.7 Very 
dissatisfied 
Postgraduate Much higher 
than other 
people 
P4 AA 34 25.4 Very 
dissatisfied 
Degree Higher than 
other people 
P5 AT 46 38.6 Very 
dissatisfied 
Degree Higher than 
other people 
P6 TT 43 36.7 Very 
dissatisfied 
A-level About the 
same as other 
people 
P7 TT 45 37.4 Very 
dissatisfied 
Degree About the 
same as other 
people 
 
6.5.2 FTO status and recall of the test result 
One participant was homozygous for the higher risk A variant (AA), three were heterozygous 
(AT), and three were homozygous for the lower risk variant (TT).  All participants correctly 
recalled their test result and could explain its meaning in their own words.  
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6.5.3 Interview characteristics 
Interviews lasted on average 33 min (Range: 26-42 min).  Efforts were made to establish 
rapport, so that participants felt comfortable enough to talk openly. All of them seemed keen 
to share their experience and gave elaborate answers without much prompting. 
6.5.4 Themes 
Five overarching themes were extracted from the data and are described in detail below.  
Illustrative quotes are used throughout the text where appropriate and genotype is provided 
in brackets to add context.  Themes described were common to all interviews.  
 
Theme 1:  In search of an explanation  
All participants took part to help understand their condition; as one participant put it‘[…] to 
find another piece in the jigsaw’.  The quest to find out ‘whether there are genetic reasons why 
I find it extremely difficult to lose weight or why I am larger than other people, is there a 
reason why, other than the fact that I do love food?’ (P7, TT) was described as a ‘life-long 
curiosity’.  Feeling different from people who did not struggle with their weight despite 
apparent similarities in behaviour, and finding explanations for the difference was the main 
driver of participation. One woman explained that she was interested ‘[...] from a selfish point 
of view. I do understand that having these genes, that’s not the whole picture, there’s a lot of 
other stuff going on, but I am still interested to find out whether that might be, you know, a 
contributing factor to why I was struggling.’ (P3, TT).  
 
Theme 2:  Early origins of weight control problems 
The descriptions participants used to for their experiences with body weight regulation 
revealed the difficult emotions that underlie this issue.  For all participants, weight control had 
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been a ‘continuous battle’ since childhood, many recalling that ‘[...] even from being quite 
young I’ve always been on some diet or another’ (P2, AT).  Weight gain was gradual yet 
continuous.  The trajectory described by this woman is not unusual: ‘I was slim up to the age 
of about 10 and then I was a chubby kid until I was about 14 and then I slimmed down a bit. 
Well, I’ve never been skinny and then weight started to come on again after I got married, 
which is 21 years ago, and even more so with childbirth.’ (P7, TT).  All had tried to lose weight 
many times in the past with varying success.  However, because they could not prevent weight 
regain, they were left ‘defeated’.  ‘I just think, what’s the point now, you have done everything 
under the sun [...]’ (P6, TT).  Alternatively, they tried to ‘make peace’ with their bodies by 
adjusting their body image, which proved to be a struggle in itself, ‘because it’s something that 
can be difficult to accept’ (P7, TT).  
 
Theme 3: Guilt and stigma  
Regardless of their test result, many participants were quick to note that they never intended 
to use it an as ‘excuse’ for their weight status; perhaps reflecting acceptance of broader 
societal attitudes towards obesity as a personal shortcoming for which the individual is to 
blame.  Instead, having a genetic ‘explanation’ helped confirm the perception that forces 
beyond personal responsibility contributed to their difficulties with healthy body weight 
maintenance:  ‘I understand that genetics and the things that we are likely to choose as a 
result of our genes or how we are likely to feel means that we can’t always help the fact that 
we eat what we eat, if that makes sense’ (P4, AA).   
 
Knowledge of the underlying genetics was seen as able to alleviate some of the guilt and 
stigma associated with overweight.  In this context, some participants also mentioned that 
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there might be value in popularizing the message that genetics is a contributor to overweight, 
because ‘it could make some people more understanding, it would perhaps make the medical 
profession more understanding’ (P7, TT).  Considering these expectations, surprisingly little 
thought was given to the possibility of not having the higher risk variant of FTO before testing 
and no participant had considered the potential impact of this possibility.  
 
Theme 4:  Emotional reactions  
Participants described feeling brief, but intense, emotions upon learning their FTO gene status.  
All of them assumed they would be a carrier of the higher risk variant.  Those with one or two 
higher risk alleles (AA or AT) often felt ‘pleased with the result’, although it came as ‘no 
surprise, because it just confirmed what I felt anyway’ (P4, AA).  One participants described her 
AT result as ‘normal’ genotype and explained that she was ‘living that result’ (P1, AT); perhaps 
reflecting the understanding that overweight is caused by a combination of genes and 
environment.   
 
A ‘lower risk’ status was unexpected in all cases and resulted in disappointment.  However, 
participants described rallying quickly, as in this example:  ‘I felt disappointed. I suppose deep 
down you hope there is a reason for being overweight but for me there isn’t apart from I must 
be eating too much and not exercising enough. So I suppose in that respect it was a bit of a 
disappointment because [pause] I don’t know [pause] maybe if there was a reason you are 
more likely to say, oh well, it’s not totally all my fault. But, I’m glad I know. Yeah.  You know it’s 
not that, so, okay, what is it? (P7, TT). Once again, the desire for an explanation that absolves 
individuals from some of the responsibility for their weight status became apparent.  However, 
those getting a TT result were not left hopeless, but reported that initial emotional reactions 
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were short-lived, as this participant explained: ‘I just thought, ‘Oh well, I haven’t got the fat 
gene, and I guess carried on with life’ (P6, TT).   
 
For participants getting a lower risk result cognitive defence mechanisms appeared to be 
activated which reduced dissonance between the test result (which threatened the belief in 
genes as a source of external influence) and the prior expectation.  All TT participants 
spontaneously offered alternative explanations for causes of weight gain, diminishing the 
importance of genes, and drawing instead on environmental and psychological explanations: 
‘It’s not all down to genetics because it’s down to the environment, the way you have been 
brought up and all that that has an influence, I think, on you, the choices that you make and 
stuff like that, you know’ (P6, TT). Similarly this participant said: ‘I think until obesity is tackled 
from the mind, I’m not sure that it will ever change’ (P3, TT).  
 
One pointed out that the contribution of FTO is only small and that there may be other genes 
that are the cause of their weight gain: ‘And it doesn’t make a lot of difference having it. 
Because if you have got it you are 3 kilos, 7.3 pound, yeah, no, it’s a very small amount […]. I 
still think that there’s something in the genes, but not in these particular ones, which are 
simply related to body build […]’ (P7, TT).  
 
One participant also considered potential advantages from not having the ‘higher risk’ variant, 
demonstrating evidence for positive active coping: ‘[…] in a way I should be pleased because 
then, you know, there’s less things that stop you from losing weight because if I did have the 
gene, maybe it’s harder to lose weight.’ (P6, TT).   
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Although AA and AT participants also held multifaceted beliefs about the causes of obesity, 
they were only shared once prompted.  Furthermore, TT participants showed tendencies to 
draw distinctions between themselves ‘as a person’ and their genes, as if to distance 
themselves, for example: ‘I felt, you know, this is my issue. It’s not my genes; it’s to do with 
what’s going on in my head’ (P3, TT). These observations suggest that reflexive assertion of 
alternative explanations for obesity helped TT individuals to accept their test result without 
having to adjust their core beliefs, thereby resolving cognitive dissonance and maintaining a 
coherent, integrated sense of self.  
 
 
Theme 5: Anticipated behavioural reactions  
Awareness of FTO status was considered beneficial for behaviour by most participants.  For 
example, one woman thought it would help maintain control over eating:  ‘I know that I am 
likely to want more food, whether or not I really need more. So I suppose it’s helped, it’s 
definitely helped in the way I will decide what to do when I make food choices so it will 
definitely make a difference.’ (P4, AA).  Another explained how it would help motivate 
healthier lifestyle choices: ‘you know what - I think I have already. Because I am thinking about 
it more now, I am consciously making an effort to make better choices’ (P2, AT).  It appeared 
that participants intended to use their result as a reminder to make an effort to make healthy 
choices, either because their biology was different (AA and AT participants), or, because it ‘it is 
really just down to me’ (TT participants); again demonstrating that participants make their 
result ‘fit’ with their beliefs about weight control.  
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6.6 Discussion     
 
This qualitative study allowed for an in-depth exploration of emotional reactions to genetic 
test feedback for obesity risk in a sample of overweight and obese individuals.  In line with 
findings from Studies 1 and 2a, and other hypothetical and clinical studies (Conradt et al., 
2009, Harvey-Berino et al., 2003), the results suggested that genetic test feedback for obesity 
risk may have beneficial psychological effects for overweight and obese individuals beyond 
‘objective’ clinical utility.   
 
6.6.1 Study limitations 
However, the current study has many limitations.  Consistent with the methodology and aims 
of qualitative research, the sample was small and highly selected. Findings cannot therefore be 
generalised to the wider population; yielding findings low in validity and reliability.  All 
participants in this study had high levels of weight dissatisfaction, which may have influenced 
their responses.  However, weight dissatisfaction is very high in the general population, 
particularly among women (Rodin, Silberstein, & Striegel-Moore, 1984) and therefore, may 
merely be a reflection of societal attitudes towards bodies that do not confirm to the ‘thin 
ideal’.  Reactions may thus be less pronounced in men, but because the current sample only 
included women, this could not be investigated further.  Like in Study 2a, social desirability 
bias cannot be excluded and participants may have overstated the benefits of their respective 
results.  However, these effects would have been mild, because participants still expressed 
their disappointment with unexpected FTO results.  Furthermore, using telephone interviews 
was likely to diminish social desirability bias because they commonly make the participant 
more comfortable (interviews are carried out in the participant’s familiar environment) 
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(Oppendakker, 2006). Lastly, qualitative methods always carry the risk of the researchers’ 
personal background shading the research findings (Brocki & Wearden, 2006).  We tried to 
minimise this by meeting frequently to discuss the interviews, having a third researcher code 
the interviews, and by choosing an analysis method that acknowledges the researchers’ role in 
the analysis process. 
 
6.7 Conclusion 
 
In this sample, genetic test feedback for obesity risk had personal value beyond ‘objective’ 
clinical utility by potentially providing an ‘explanation’ for their weight control problems and 
relieving some stigma and self-blame.  However, the consequence was that a lower risk result 
is disappointing, although defensive cognitive processes appeared to be activated that limited 
any lasting adverse psychological effects.  This is the first study to describe that accepting a 
negative rather than a positive genetic test result was a personal challenge, which is a reversal 
of common findings. Adverse effects on weight control intentions or self-control were not 
reported. These findings offer interesting hypotheses for further research and may be 
considered in clinical practice.  
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Chapter 7:  Study 3 – The association of FTO SNP rs9939609 with weight 
gain in the first year of university 
 
7.1 Background 
 
As discussed in Chapter 1, the genetic susceptibility model proposes that genetic differences in 
appetitive traits leave some individuals more prone to weight gain than others in the current 
environment.  FTO is one gene which has unambiguously been shown to be associated with 
obesity susceptibility.  Chapter 2 gave evidence that the start of university can be considered 
as a ‘high-risk’ period for unhealthy weight gain, because of high environmental pressures to 
engage in obesity-promoting behaviours and low motivation to resist these forces.  
 
If the genetic susceptibility model is valid, moving into this environment would be expected to 
have differential effects on individuals depending on their genotype.  The established effects 
of FTO make it a good model for testing this hypothesis further.  However, no study to date 
has investigated the effect of FTO status on weight gain in the first year of university. 
 
7.2 Study aims and contribution to the literature 
 
The aim of the present study was to investigate the association between FTO and weight gain 
over a one-year period in a large sample of young adults starting university.  I hypothesised 
that individuals carrying at least one higher risk allele (AT, AA) would gain more weight during 
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the study period than TT individuals because of their higher genetic vulnerability to weight 
gain when environmental pressures are high.  
 
Because some weight fluctuation within individuals is common, small changes in weight might 
not be meaningful.  The weight loss literature considers a 5% weight loss as sufficient to 
mitigate some of the health problems associated with obesity (Blackburn, 1995;Goldstein, 
1992).  Conversely, a 5% weight gain should raise the risk of many conditions related to 
obesity.  Therefore, I supplemented analyses investigating mean weight change with an 
analysis that explored the association of FTO status with weight gain of 5% or more over the 
course of the year.   
 
The study contributes to the literature by being the first to focus on the effects of FTO young 
adults exposed to a high-risk environment for weight gain.  Identifying individuals at high risk 
for weight gain early might ultimately support the development of targeted strategies for 
obesity prevention and treatment; particularly for those at the highest risk.  
 
7.3 Methods and Procedure 
 
7.3.1 Participants 
In total, 1518 first-year students from UCL participated in the study. They were recruited at 
the beginning of three consecutive academic years (2010-2012); follow-up anthropometric 
data was collected in the last week of May of each respective academic year.  Figure 7.1 
includes a flowchart of participants through the study.  Analyses included participants from all 
three study waves.  
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Inclusion and exclusion criteria 
We included all interested individuals within the university aged between 18 and 30 years who 
were able to give informed consent.  Although it would have been preferable to restrict the 
age range to age 25 because older students are unlikely to only have just started university, in 
practice it was too difficult to distinguish between participants aged 18 to 25 and those older.  
Instead, we opted to dichotomize age into participants aged 18-20 and those older, as the 
younger age group should consist predominantly of first-year students.  
 
7.3.1.1 Recruitment and Consent 
Potential participants were invited by email, poster advertisements and by setting up a stall 
with a ‘collection-station’ on campus, in halls of residence and at the ‘Welcome Fayre’, inviting 
students to take part in a study on genetic influences on weight gain.  Recruitment materials 
are included in Appendix 5.  Interested participants were invited to come to the ‘collection 
station’ during the second week of term.  When they arrived at the station, a researcher 
explained the project in more detail.  An information sheet was given out and participants had 
the opportunity to ask questions.  Written consent was obtained once all questions were 
answered.  Ethical approval for the study was granted by the UCL ethics committee for non- 
NHS research (study no. 2471/002).  A copy of the approval letter is included in Appendix 3.  
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Figure 7.1 Flowchart of study procedures 
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7.3.2 Measures 
7.3.2.1 Demographics  
Demographic information collected included age and gender.  
 
7.3.2.2 Anthropometric data 
Anthropometric data were collected upon study enrolment and at 8-month follow-up.  Follow-
up measures were taken in the same location as at baseline to minimise the risk of 
measurement error.  Participants were asked to remove shoes, socks and heavy items, but 
stay otherwise fully clothed. Height was measured using the Leicester Height Measure 
(Marsden Group, UK). They were then invited to step on the TANITA scale which measured 
weight and body fat using electrical impedance.  Electrical impedance usually compares well to 
other measures of body composition such as whole body magnetic resonance imaging and 
dual X-ray absorptiometry (Beeson et al., 2010).  Antibacterial gel was applied to the footplate 
area to minimise risk of infection and facilitate contact.  BMI was calculated from weight and 
height data obtained.  Participants could opt to receive a printout of the results together with 
an explanation of the body composition results from the research team or not.  All participants 
opted to receive their printout and explanation of the body composition results.   
 
7.3.2.3 DNA Collection  
Participants were asked to give a saliva sample for DNA collection by placing some sugar on 
their tongue to stimulate saliva flow and then spitting into a plastic tube to generate 1.5 -2 ml 
of saliva.  Although it would have been preferable if participants had refrained from eating, 
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drinking (other than water), smoking or brushing their teeth in the hour beforehand, the 
practicalities of data collection (at a busy welcome fayre and in student halls around dinner 
time) made it impossible to adhere to this restriction.  However, staff from the Institute of 
Metabolic Sciences, Cambridge, where the data was analysed, assured that analysis would still 
be possible (if slightly unpleasant), so we decided to drop them.  Samples were coded with a 
unique identifier number immediately after collection so that they were anonymous but could 
be linked to the anthropometric data.  
 
7.4 Analyses 
 
7.4.1 DNA analysis 
DNA was isolated from saliva and analysed at The Institute of Metabolic Science, Cambridge 
UK, under leadership of Professor Sir Steve O’Rahilly (I had no role in it).  DNA was analysed 
using TaqMan and an automatized extraction system.  The Taq Man is an assay for identifying 
single nucleotide polymorphisms (SNPs) after DNA is amplified with a polymerase chain 
reaction (PCR).  TaqMan molecules are usually fluorophore and bind to the site of interest to 
make it visible.  The polymorphism of interest was a base substitution from A to T at SNP 
rs9939609.  For PCR, the DNA double-helix was denatured (split open) with heat, and 
enzymatic complementary DNA fragments (primers) were attached to the target regions to 
replicate DNA.  The newly generated DNA constituted a template for further replication, 
causing a chain reaction, thereby causing the DNA to replicate exponentially.  Protocols for 
saliva isolation and extraction are shown in Appendix 7.  
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7.4.2 Statistical analyses 
Statistical analyses were carried out using the Statistical Package for Social Sciences (SPSS) 
version 20.0. Significance levels for all analyses were set at α = 0.05.  
 
A power calculation was carried out a priori using GPower (version 3.1) which showed that a 
sample size of 1302 participants would be required to detect a small effect (d = 0.10) of FTO 
on weight gain with 95.0% power.   
 
Descriptive information was based on frequency tables and cross-tabulation.  Differences 
between participants in each wave were assessed with one-way ANOVAs for continuous 
variables and chi-square tests for categorical outcomes. All data were tested for assumptions 
of normality (Skewness, Kurtosis, Levene’s Test) and results are only reported if these were 
violated.  For Skewness and Kurtosis, values between -1 and + 1 were acceptable.   
 
FTO risk status was dichotomized into higher (AT/AA) and lower risk (TT) for the current 
analyses.  Inspection of baseline means showed that mean BMI and weight were more similar 
in AT and AA individuals and thus grouping higher risk variants together was appropriate.  
 
Differences between participants who did and did not return for follow-up weighing were 
assessed with chi-square tests for categorical variables and t-tests for continuous variables.   
 
Associations of FTO genotype status with baseline BMI, baseline weight, follow-up BMI and 
follow-up weight, respectively, were determined in identical manner:  For all models, analyses 
were run at first only including FTO status.  Thereafter, the models were run including age and 
gender as covariates.  Analyses with weight as the outcome variable included height as 
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covariate in all analyses.   Thereafter, analyses were repeated, including interactions between 
respective covariate and FTO status.  For the purpose of all analyses, age was dichotomized 
into ‘younger’ (aged 18-20) and ‘older’ (aged 21 and over).  Analyses using follow-up data also 
adjusted for trial participation because some participants were later enrolled in a trial (details 
of which are discussed in Chapter 8). 
 
The association of FTO genotype with body weight change over the year was assessed using 
linear regression models, adjusting for baseline values. As before, the first model included only 
FTO status and baseline weight and height.  Analyses were repeated with age, gender and trial 
participation as covariates, investigating only main effects.  This was followed by an analysis 
including the FTO*age, interaction because the strength of the association of FTO and BMI has 
been shown to vary by age (Hardy et al., 2010) .  As at baseline, age was dichotomized into 
‘younger’ (aged 18-20 years) and ‘older’ (aged 21-30 years).  
 
Weight change (absolute, in kg, and relative, in per cent) was calculated for each participant.  
Participants who gained 5% of their starting weight or more were classified as ‘gainers’; those 
who lost weight, stayed the same or gained below the 5% threshold were classified as ‘non-
gainers’.  Predictors of a 5% weight gain over the course of the year were investigated using 
binary logistic regression analyses.  At first, only FTO status was included in the model.  
Analyses were repeated adjusting for age (dichotomized), gender and trial participation.  
Thereafter, the model was re-run, including the FTO*age interaction.   
 
Although several methods exist to account for missing data, all analyses were conducted using 
completers only; accepting a significant loss of power for analyses using follow-up data.  
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Replacing missing values with mean scores (either overall mean or FTO group mean) or by 
using regression substitution would have resulted in imputing nearly 80% of the outcome 
data, which would almost certainly have yielded inaccurate results.  Similarly, using intention-
to-treat design or last-observation-carried-forward would have been problematic because we 
had only baseline values available; as weight change was the main outcome of interest, this 
would have distorted the data.   
 
I conducted a sensitivity analysis, including only wave 1 participants who did not receive any 
weight-related information to exclude potential effects of trial participation on BMI change, 
weight change and 5% weight gain.  Analyses were identical to those described above.  
 
7.5 Results 
7.5.1 Participant characteristics  
Table 7.1 displays participant characteristics of the final sample by wave.  In total, 1518 
participants took part in the study.  107 participants (7.0%) had to be excluded for the 
following reasons: Genotype could not be determined (5.8%, n = 89), missing anthropometric 
data (1.4%, n = 16) and no assigned ID so genotype data could not be matched to 
anthropometric data (0.03%, n = 5).  The final sample consisted of 1411 participants at 
baseline.  However, only 21.9% of participants (n = 310) provided follow-up anthropometric 
data. 
 
There were significantly fewer males in wave 1 and wave 3 than in wave 2 (χ2 (2) = 24.99, p < 
0.001).  Consequently, height differed modestly, but significantly between all three waves at 
baseline, with participants in wave 3 being shortest, followed by participants in wave 1 and 
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those in wave 2 being tallest (F (2, 1408) = 19.15, p <0.001).  Although baseline weight differed 
between waves 2 and 3, with participants in wave 3 being lighter (F (2, 1408) = 8.61, p <0.001) 
than those in waves 1 and 2, there were no significant differences in BMI at baseline (BL) or 
follow-up (FU) between waves (FBMIBL (2, 1408) = 0.47, 0.621; FBMIFU (2, 305) = 2.87, p = 0.058).  
There was also no significant difference between waves in the proportion of individuals who 
gained 5% of body weight or more (χ2 (2) = 1.70, p = 0.427).  There were no significant 
differences in either mean age (F (2, 1408) = 0.96, p = 0.496) or proportion of participants aged 
18-20 and those older (χ2 (2) = 2.53, p = 0.282).  Differences in FTO genotype distribution 
between waves was also not significant (χ2 (2) = 8.11, p = 0.088) and FTO was in Hardy-
Weinberg equilibrium, (χ2 (2) = 0.54, p = 0.462.  
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Table 7.1 Participant characteristics 
 Wave 1  Wave 2  Wave 3 χ2/F Sig 
N  baseline = 1411  % (n) 
N follow-up =  310  % (n) 
33.9 
21.1 
 (479) 
 (101) 
 56.5 
22.5 
(797) 
(179) 
 9.6 
22.2   
(135) 
  (30) 
 
   0.33 
 
0.846 
           
Height at baseline (m), mean 
(SD) 
1.69a (0.09)   1.71b   (0.09)  1.66c (0.09) 19.15 <0.001 
Height at follow-up (m), mean 
(SD) 
1.70 (0.09)   1.71 (0.09)  1.68  (0.09)   1.10   0.334 
Weight at baseline (kg), mean 
(SD) 
63.9a (11.9)  65.0a, b (12.0)  60.4c  (10.9)    8.61 <0.001 
Weight at follow-up (kg), 
mean (SD) 
64.6 (12.9)  63.3 (11.0)  63.4 (10.1)    0.44   0.644 
BMI at baseline, mean (SD) 22.0  (3.0)   21.9   (2.8)  21.7  (3.1)    0.47   0.621 
    Normal  % (n) 
    Overweight/obese % (n)  
84.6 
15.4 
(405) 
  (74) 
 
 
 87.1 
 12.9 
 (694) 
 (103) 
 87.4 
12.6 
(118) 
  (17) 
   1.77   0.411 
BMI at follow-up mean (SD) 
    Normal % (n) 
    Overweight/obese % (n) 
22.2 
85.1  
14.9 
 (3.4) 
  (86) 
  (15) 
 21.4 
93.8 
  7.3 
  (2.5) 
 (166) 
   (13) 
 
 
 
22.2 
80.0 
20.0 
(2.7) 
 (24) 
   (6) 
   2.87 
   8.45 
  0.058 
  0.015 
 
Gender male, % (n) 
 
44.7  
 
(214) 
  
54.3 
 
 (433) 
   
34.1 
 
  (46) 
 
24.99 
 
<0.001 
Age in years, mean (SD) 
    Age 18-20 % (n) 
    Age 21-30 % (n) 
20.3 
63.5  
36.5 
 (2.3) 
(304) 
(175) 
 20.4 
63.1 
36.9  
  (2.5) 
 (503) 
 (294) 
 20.6 
56.3 
43.7 
 (2.6) 
  (76) 
  (59) 
   0.70 
   2.53 
  0.496 
  0.282 
 
FTO status % (n) 
          
    TT   38.4 (184)  43.4 (346)  51.1    (69)    8.11   0.088 
    AT   47.2 (226)  44.2 (352)  39.3    (53)   
    AA   14.4    (69)  12.4    (99)   9.6    (13)   
5 % Weight gain  % (n)   21.8   (22)   16.4   (29)  13.3      (4)    1.70   0.427 
Note: Means that do not share superscripts differ by p <0.05.  
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7.5.2 Baseline associations of FTO status with BMI and body weight 
The majority of participants (87.3%) had a BMI in the ‘normal’ range, with a mean of 21.96 
kg/m2 (SD = 2.95); only 13.7% (n = 194) of participants were classified as overweight/obese.  
Table 7.2 shows mean BMIs by FTO genotype and results from the ANCOVAs, including age 
and gender as covariates.  Although the effect was modest, as shown in Figure 7.2, the 
association of FTO genotype status with baseline BMI was significant, with AT/AA participants 
having a higher BMI than TT participants (F (1, 1409) = 4.89, p = 0.027).  This association 
remained significant when age and gender were added as covariates, p = 0.017. Main effects 
of age and gender were also significant, with BMIs of older participants and those of men 
being higher than those of younger ones (F (1, 1406) = 30.37, p < 0.001) and those of women 
(F (1, 1406) = 100.12, p < 0.001). However, the interaction between FTO and age revealed no 
significant effect; suggesting that the effect of FTO was similar for both age groups (F (1, 1405) 
= 0.071, p = 0.789).   
 
 
Table 7.2 ANCOVA results for associations of FTO status with baseline BMI and body 
weight 
Outcome FTO status    
 mean ±sd mean ±sd F (df, error) Sig Cohen’s d 
 TT AT/AA    
Baseline BMI 21.7   (2.8) 22.1   (2.9) 5.72 (1, 1405) 0.017 -0.14 
Baseline weight 63.2 (11.6) 65.0 (12.1) 6.55 (1, 1405) 0.011 -0.15 
Note: Results are adjusted for age and gender  
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Figure 7.2 Mean differences in baseline BMI by FTO genotype 
 
 
Mean weight of participants was 64.22 kg (SD = 11.98) and height was 1.70 m (SD = 0.09).  
Table 7.2 shows mean weights by genotype and results from the ANCOVAs, adjusted for age, 
gender and height.  Consistent with FTO and BMI association, the association of FTO status 
and body weight was also significant, with AT/AA participants being heavier than TT 
participants (F (1, 1408) = 4.26, p = 0.039) in the model adjusting only for height (Figure 7.3). 
This difference remained significant once age and gender were added (p = 0.011). However, as 
before, the FTO*age interaction were not significant (F (1, 1404) = 0.115, p = 0.734). 
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Figure 7.3 Mean differences in baseline body weight by FTO genotype 
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7.5.3 Follow-up differences in body weight and BMI by genotype 
Attrition was very high, with nearly 80% of the sample not returning for follow-up weighing.  In 
total, only 310 participants provided follow-up anthropometric data.  The poor follow-up may 
have been in part due to delays in DNA analysis which caused subsequent delays in return of 
genetic test results, and in part due to the overall timing of follow-up being scheduled at the 
end of the academic year where students also have exams, or have already returned home. 
 
Table 7.3 shows differences between participants who did and did not return for follow-up 
weighing.  Notably, participants who returned had a significantly lower BMI at baseline (t 
(1409) = 2.33, p = 0.020) and were less likely to be overweight or obese (χ2 (1) = 5.55, p = 
0.018) than those who did not return, but there were no significant differences in other 
variables. Although the range of weight change varied widely, mean body weight changes over 
the year were modest, Δ weight = 0.54 kg, SD = 3.36, range: -12.60 kg to 14.40 kg).  Body 
weight remained stable in only a small number of participants (2.9%, n = 9); over half of the 
participants returning for follow-up gained weight (51.3%, n = 159) and slightly fewer lost 
weight (45.8%, n = 142).   
 
FTO was not associated with follow-up BMI in cross-sectional analyses (F (1, 308) = 0.33, p = 
0.566), and this remained unchanged in multivariate analyses (F (1, 306) = 0.61, p = 0.435).  
Similarly, FTO was not associated with body weight at follow-up (F (1, 307) = 0.24, p = 0.618), 
and adding covariates had no effect (F (1, 305) = 0. 91, p = 0.339). Younger age and male 
gender were significantly associated with follow-up BMI (F age (1, 306) = 6.64, p = 0.010; F gender 
(1, 306) = 21.66, p <0.001) and body weight (F age (1, 305) = 7.24, p = 0.008; F gender (1, 305) = 
20.75, p <0.001).  The interaction between FTO and age was not significant.  
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Table 7.3 Baseline differences between participants who returned and did not return 
for follow-up weighing 
 Follow-up 
Weighing 
n = 310 
 No follow-up 
Weighing 
n = 1101 
χ2/t  Sig 
Height at baseline (m), mean (SD)   1.70 (0.09)  1.70 (0.09)  - 0.21 0.813 
Height at follow-up (m,) mean (SD)   1.70 (0.09)  ---    ---    
Weight at baseline (kg), mean (SD)  63.2 (11.3)  64.4 (12.1)    1.62  0.105 
Weight at follow-up (kg), mean (SD) 
 
 63.7 (11.6) 
 
 -- 
 
   -- 
 
   
 
BMI at baseline, mean (SD)  21.6   (2.8)  22.0    (3.0)    2.33 0.020 
   Normal  % (n) 
   Overweight/obese % (n)  
 90.3  (280) 
   9.7    (30) 
 85.1 
14.9 
  (937) 
  (164) 
 
 
  5.55 0.019 
        
BMI at follow-up, mean (SD) 
    Normal % (n) 
    Overweight/obese % (n) 
21.9     (2.9) 
89.0    (276) 
11.0      (34) 
 -- 
-- 
-- 
-- 
-- 
-- 
   
 
        
Gender male % (n) 47.7    (148)  49.5   (545)     0.29 0.584 
        
Age in years, mean (SD) 
    Age 18-20 % (n) 
    Age 21-30 % (n) 
20.3     (2.6) 
63.9    (198) 
36.1    (112) 
 20.4 
62.2 
37.8 
   (2.5) 
  (685) 
  (416) 
    0.71 
   0.28 
0.475 
0.595 
 
FTO status % (n) 
       
    TT 42.9    (133)  42.3   (466)     0.04 0.978 
    AT 44.2    (137)  44.9   (494)    
    AA 12.9      (40)  12.8    (141)    
 
 
 
Table 7.4 shows the complete results for predictors of weight change over the year.  Baseline 
weight was highly predictive of follow-up weight (OR = 2.50, 95%CI = 2.39-2.62, p < 0.001), and 
this first linear regression model, including baseline weight, height and FTO status, accounted 
for 95.8% of the variance in weight change (R2 = 0.919, F (3, 306) = 1151.72, p < 0.001).  
However, FTO status was not a significant predictor of weight change; neither in the model 
including only FTO, baseline weight and height (OR = 1.01, 95%CI = 0.48-2.14, p = 0.557), nor 
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once age, gender and trial status were added (OR = 1.01, 95% CI = 0.47-2.16, p = 0.577)  
Adding these variables improved the predictive value of the model marginally; now explaining 
95.9% of the variance in weight ( R2 = 0.919, F (6, 303) = 547.00, p < 0.001).  Main effects of 
age, gender and trial status were also not significant (OR age = 0.96, 95%CI = 0.20-4.70, p = 
0.183; OR gender = 1.02, 95% CI = 0.11-9.13, p = 0.722; OR Trial = -0.99, 95% CI = 0.44-2.21, p = 
0.599), and neither was the FTO*age interaction (p =0.595).   
 
Table 7.4 Linear regression predictors of weight and BMI change 
Model 
 
Predictors only Interaction FTO*age 
 OR 95% CI p-value OR 95% CI p-value 
Baseline weight 2.51 2.42-2.61 < 0.001 2.51 2.42-2.61 < 0.001 
Baseline height 1.05 0.00-579.52    0.050 1.05 0.00-580.10    0.048 
FTO status 1.01 0.48-2.13    0.577 0.98 0.10-9.53    0.707 
Age 0.97 0.44-2.17    0.119 0.94 0.07-12.54    0.294 
Gender 1.00 0.35-2.88    0.990 1.00 0.34-2.94    0.976 
Trial status 0.99 0.44-2.21    0.599 0.99 0.44-2.21    0.556 
FTO*age --- ----     ---- 1.04 0.22-5.01    0.595 
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7.5.4 FTO status and 5% weight gain 
Results from the logistic regression analysis are shown in Table 7.5.  Of the 310 participants 
that provided follow-up weight data, 17.8% (n = 55) gained at least 5% of their initial body 
weight (Mean gain: 8.86%, SD = 4.08, range: 5.8% - 26.8% of initial body weight). The first 
model including only FTO status revealed that participants with AT/AA genotypes were about 
twice as likely to have gained at least 5% of their body weight over the year than those with 
the TT genotype (OR = 2.06, 95% CI = 1.10-3.89, p = 0.024).  As shown in Figure 7.4, when age, 
gender and trial status were added to the model, FTO status remained a significant predictor 
of 5% weight gain (OR = 2.05, 95% CI = 1.08-3.90, p = 0.029).  Furthermore, age was a 
significant predictor of weight gain, with those who were aged between 18 and 20 being three 
times more likely to have gained at least 5% of their starting weight than older participants 
(OR = 3.11, 95% CI = 1.47-6.56, p =0.003); gender was not a significant predictor of weight gain 
(OR = 0.79, 95% CI = 0.43-1.45). The FTO*age interaction was also not significant (OR = 1.81, 
95% CI = 0.40-8.31, p = 0.447). 
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Table 7.5 Predictors of 5% weight gain 
Model Predictors only Interaction FTO*age 
 OR 95% CI p-value OR 95% CI p-value 
       
FTO status 
  TT 
  AT/AA 
 
1 
2.05 
 
 
1.08-3.90 
 
 
0.029 
 
1 
1.30 
 
 
0.41-4.14 
 
 
0.704 
Age 
   21-30  
   18-20 
 
1 
3.11 
 
 
1.47-6.56 
 
 
0.003 
 
1 
2.11 
 
 
0.66-6.75 
 
 
0.225 
Gender 
  Male 
  Female 
 
1 
0.79 
 
 
0.43-1.45 
 
 
0.113 
 
1 
0.80 
 
 
0.25-2.57 
 
 
0.477 
Trial status 
  No 
  Yes 
 
1 
0.60 
 
 
0.32-1.13 
 
 
0.113 
 
1 
0.66 
 
 
0.19-1.96 
 
 
0.129 
FTO TT*age 18-20 
FTO AT/AA*age 18-20 
 
---- 
 
------ 
 
----- 
1 
1.81 
 
0.40-8.31 
 
0.447 
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Figure 7.4 Weight gain by genotype status over the year 
 
 
 
7.5.5 Sensitivity analysis: Weight change and 5% weight gain 
The sensitivity analysis included 101 participants from wave 1 who provided follow-up weight 
data.  Characteristics of wave 1 participants are shown in Table 7.1. 
 Baseline BMI in wave 1 participants was comparable to BMI in waves 2 and 3 combined (mean 
BMI wave 1= 22.03 kg/m2 vs. mean BMI waves 2/3 = 21.93 kg/m2, t (1409) = 0.65, p = 0.513).   
 
FTO status, BMI and body weight at baseline FTO status was not associated with baseline BMI 
in the subsample; neither when FTO status was the only predictor, F (1, 477) = 2.53, p = 0.112, 
nor when age and gender were added to the model, F (1, 475) = 2.43, p = 0.120. However, age 
and gender were significantly associated with baseline BMI in the subsample, with women and 
younger participants having lower BMIs than men or older participants (F age (1, 475) = 4.12, p 
= 0.043; F gender (1, 475) = 28.82, p <0.001). FTO*age or FTO*gender interactions were not 
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significant (p = 0.736; p = 0.661). Likewise, FTO status was not significantly associated with 
body weight; neither in analysis including only FTO status and height (F (1, 431) = 2.08. p = 
0.149; nor once age and gender were added as covariates (F (1, 429) = 2.36, p = 0.125). As 
before, age and gender were significantly associated with body weight, with women and 
younger participants being lighter than men or older participants (F age (1,429) = 4.94, p = 
0.027; F gender (1, 429) = 13.57, p 0.001).  However, interactions between FTO status with either 
age or gender were not significant (p= 0.511; p = 0.439).  
 
FTO status, BMI and body weight at follow-up Differences between wave 1 and wave 2/3 
participants in BMI at follow-up were not significant (mean BMI follow-up wave 1 = 22.20 
kg/m2 vs. mean BMI = 21.59 kg/m2 follow-up waves 2/3, t (308) = 1.72, p = 0.086).  FTO status 
was not significantly associated with BMI at follow-up in cross-sectional analyses when it was 
the only predictor (F (1, 99) = 0.17, p = 0.673; nor when age and gender were added to the 
model (F (1, 97) = 0.81, p = 0.368). Gender was now the only variable significantly associated 
with BMI (F (1, 97) = 4.86, p = 0.030; F age (1, 97) = 1.91, p = 0.170). Interactions between FTO 
status and age were not significant (p = 0.189 and p = 0.867).  FTO status was also not 
significantly associated with body weight at follow-up; neither in analyses including only 
height as the other covariate (F (1, 65) = 0.23, p = 0.631); nor once age and gender were added 
(F (1, 65) = 0.71, p = 0.412).  Gender was associated with body weight at follow-up (F (1, 63) = 
5.21, p = 0.26); whereas age was not (F (1, 63) = 0.82, p = 0.367).  The FTO*age interaction was 
also not significant (p = 0.742).  
 
FTO status and body weight changes Weight change was of similar magnitude as in wave 2 and 
3 participants, Δ weight= 0.56 kg, SD = 3.90, range: -12.50 kg -14.40 kg, t (308) = 0.097, p = 
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0.923). Only 3% of participants (n = 3) stayed the same weight; 45% lost weight (n = 45) and 
52% (n = 53) gained weight.  Results of the linear regression analysis are shown in Table 7.6.  
The first linear regression model including only baseline weight, height and FTO status 
explained 95.6% of the variance in weight change, R2= 0.914, F (3, 97) = 341.62, p < 0.001. As 
before, FTO status was a significant predictor of weight change, OR = 1.07, 95%CI = 0.33-3.41, 
p = 0.032, as was baseline weight, OR = 2.58, 95%CI = 0.81-8.26, p < 0.001.  However, when 
covariates were added to the model, FTO status was no longer  a significant predictor of 
weight change; although a trend still existed which indicated that that higher risk status was 
predictive of greater weight change (OR = 1.06, 95% CI = 0.33-3.38, p =0.067). The FTO*age 
interaction was not significant (OR FTO*age = 0.94, 95% CI = 0.30-3.02, p = 0.644).   
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Table 7.6. Linear regression analysis for weight change in the sensitivity analysis 
Model 
 
Predictors only Interaction FTO*age 
 OR 95% CI p-value OR 95% CI p-value 
Baseline weight 2.62 2.43-2.84 <0.001 2.63 2.43-2.85 <0.001 
Baseline height 1.01 0.00-580.10   0.853 1.01 0.00-580.1   0.911 
FTO status 1.06 0.22-5.08   0.067 1.10 0.01-173.43   0.351 
Age 0.96 0.20-4.70   0.183 1.10 0.001-177.22   0.178 
Gender 1.02 0.12-8.78   0.722 1.02 0.11-9.13   0.714 
FTO*age --- ---- ---    
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FTO and 5% weight gain About five per cent of participants (n = 22) in the subsample gained 
5% or more of their initial body weight (mean: 9.29%, SD = 5.34, range: 5.08% -26.86%).  
Results from the logistic regression analyses are shown in Table 7.7.  The first model including 
only FTO status as predictor variable showed that FTO status was a significant predictor of a 
5% weight change.  Participants with higher risk status were about four times more likely to 
gain 5% or more of their initial body weight than lower risk participants (95% CI = 1.29-13.43, p 
= 0.017).  When covariates were added to the model, FTO status remained a significant 
predictor of 5% weight gain (OR = 3.80, 95% CI = 1.15-12.53, p = 0.028).  Age and gender were 
not significant predictors of 5% weight gain (OR age = 2.12, 95% CI = 0.76-2.6.42, p =0.145; OR 
gender = 0.90, 95%CI = 033-2.44, p = 0.844). The interactions of FTO*age was also not significant 
(OR = 6.51 95% CI = 0.61.14, p = 0.101).    
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Table 7.7 Logistic regression for 5% weight gain sensitivity analysis 
Model Predictors only Interaction FTO*age 
 OR 95% CI p-value OR 95% CI p-value 
       
FTO status 
  TT 
  AT/AA 
 
1 
3.08 
 
 
1.15-
12.53 
 
 
0.028 
 
1 
6.61 
 
 
0.69-62.90 
 
 
0.100 
Age 
   21-30  
   18-20 
 
1 
2.12 
 
 
0.76-6.42 
 
 
0.145 
 
1 
4.26 
 
 
0.40-45.45 
 
 
0.229 
Gender 
  Male 
  Female 
 
1 
0.90 
 
 
0.33-2.44 
 
 
0.844 
 
1 
0.94 
 
 
0.34-2.59 
 
 
0.915 
FTO TT*age 18-20 
FTO AT/AA*age 18-20 
 
---- 
 
------ 
 
----- 
 
1 
0.45 
 
 
0.03-6.37 
 
 
0.553 
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7.6 Discussion 
 
This study investigated associations of the FTO gene with weight gain at the start of university 
to explore the validity of the genetic susceptibility model.  As hypothesised, participants who 
had at least one higher risk FTO A allele were twice more likely to gain a clinically significant 
amount of weight over one year than FTO lower risk homozygotes; although weight change 
was modest overall (about 2 Pounds), and far less than the anecdotally described ‘freshmen 
15’ or the 5kg commonly observed in American samples.  
 
7.6.1 Study limitations 
The study had many limitations.  First, participant retention proved a true challenge.  Despite 
several personalized email reminders and small incentives to return for follow-up weighing, 
nearly 80% of the sample was lost to follow-up.  One reason for poor follow-up may have been 
major unanticipated problems in the time frame of DNA analysis in wave 1 which delayed 
return of the test results and therefore follow-up.  Problems with the automation of DNA 
extraction caused a delay of three months, meaning that results could not be returned until 
late June.  However, because of exams and summer holidays, timing was crucial for participant 
retention, especially because the incentive for returning for follow-up was to receive test 
results at the same time.  The delay meant that the majority of students were not reachable 
any more, as the email address provided was commonly the UCL email, which students might 
not access outside term times.  A further problem associated with the delay was that I had to 
spend considerable time managing participants who were understandably displeased with not 
receiving their result on time.  It is also possible that students might have been less 
cooperative than at the beginning, which was further augmented by the delays in DNA 
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processing.  One way to improve retention rates (apart from collecting follow-up data earlier) 
would perhaps been incentivizing participants more if they completed all measures.  However, 
this practice is not without ethical concerns and therefore, we refrained from offering 
incentives beyond a small compensation for participants’ time and effort. 
 
The small sample size at follow-up meant that it was necessary to dichotomize FTO genotype 
into higher risk (AT/AA) and lower risk (TT) participants to increase power, instead of 
investigating the effects of each individual genotype on weight gain; and even then; the 
follow-up sample was significantly underpowered to detect FTO’s small effects on weight gain.  
Therefore, it was even more surprising to observe the described effects of FTO on clinically 
meaningful weight gain, which makes it likely that the ‘true’ effect of FTO on weight gain is 
larger than observed here.  
 
A further limitation is that participants in the current study may differ from the general 
student population in their interest in genetic testing and/or weight control which may have 
caused them to participate.  However, as students often participated as a group together with 
their friends, it is unlikely that these effects were very pronounced.  However, only few 
overweight and obese individuals took part in the study, and even fewer returned for follow-
up weighing, which may be the reason why we failed to observe an effect of FTO genotype on 
mean weight change.  This suggests that the ‘true’ mean weight gain in students at the start of 
university is likely to be significantly higher than we observed.  However, unless a programme 
is introduced that would make weighing of every student at the beginning and the end of their 
first academic year compulsory, accurately estimating the rate of weight change in this 
population will remain difficult.  It would have also been useful to assess body fat alongside 
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weight and BMI, and we attempted to include this measure, but because of measurement 
errors the data had to be disregarded. 
 
Lastly, it is important to note that two thirds of the baseline sample were later enrolled in a 
trial designed to motivate individuals to engage with weight gain prevention (discussed in 
Chapter 8) which may have diminished the effects of FTO on weight gain. It would have been 
preferable to use only participants in this study who did not participate in the trial, but the 
time and staffing constraints of the PhD did not allow for mustering another sample size large 
enough to be sufficiently powered. However, we controlled for trial participation in the 
current analyses, and I conducted a sensitivity analysis with the subsample that was not 
involved in the intervention to assess whether trial participation would unduly influence 
results.  Results were unchanged which suggests that trial enrolment was not a confounding 
variable for the observed effects of FTO on weight change.  
 
7.7 Conclusion 
Despite high attrition rates and low rates of enrolment of participants with higher BMI, this 
study demonstrated that carriers of at least one FTO higher-risk allele were more likely to gain 
weight when starting university than participants with the lower risk TT genotype. Developing 
an intervention that informs individuals about their FTO status alongside tangible weight 
control advice may provide a novel avenue of forestalling these effects.
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Chapter 8:  Study 4 – Adding genetic test feedback for weight gain 
susceptibility to weight control advice: A randomised controlled trial
7
 
 
8.1 Background 
 
The previous chapter demonstrated that genetically susceptible individuals are at risk of 
gaining significant amounts of weight, when exposed to the obesity-promoting university 
environment.  Although weight gain prevention interventions targeting this time period have 
shown some positive effects, these are limited to the most time- and resource intensive 
interventions (courses/small groups); running over an extended time period and incorporating 
different aspects of weight control.  
 
Considering the low motivation to prevent unhealthy weight gain of young adults discussed in 
Chapter 1, these interventions are unlikely to reach the majority of students, especially if they 
are of normal weight upon entering university and perceive themselves to be at low risk of 
weight gain.  Returning FTO genetic test feedback may be a novel, cost-effective way (FTO 
genetic testing currently costs about £5) to increase awareness of weight gain susceptibility, 
especially in individuals previously unaware of their risk, which in turn may motivate 
engagement in weight control behaviours, as predicted by the Health Belief Model 
                                                          
7
 The trial protocol has been published as part of this work in Trials Meisel, S. F., Beeken, R. J., van 
Jaarsveld, C. H., & Wardle, J. (2012). Genetic test feedback with weight control advice: study protocol for 
a randomized controlled trial. Trials, 13(1), 235. 
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(Rosenstock, 1974).  With further research into effective interventions, linking genetic test 
feedback to simple weight control advice that can be delivered in a cost-effective manner may 
provide a feasible option for increasing weight gain prevention in higher risk contexts. 
 
 
8.2 Study Aims and contribution to the literature 
 
Although several RCTs were concerned with effects of genetic test feedback on other health 
behaviours such as smoking cessation (Audrain et al., 1997; Hollands et al., 2012), only two 
studies have explored the effect of genetic test feedback for weight loss in clinical samples and 
no study to date has explored the effects on motivation to prevent weight gain in young, 
healthy individuals.  Results from these earlier studies cannot be assumed to equally apply to 
weight gain prevention because their purpose is somewhat different: Whereas weight loss and 
smoking cessation studies aim to initiate treatment and improve maintenance (weight loss 
and abstinence), the current study was designed to motivate engagement with disease 
prevention (avoidance of unhealthy weight gain) in a young, healthy population.  
 
The aim of the current study was therefore to discover whether genetic feedback provides an 
impetus for individuals to prevent unhealthy weight gain in young adults entering a life stage 
where weight gain is relatively common; contributing to the on-going debate about clinical 
utility of genetic test feedback for common, complex conditions.   
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8.3 Methods and procedure 
 
8.3.1 Study design 
The design was a single-centre, open, two-arm, parallel group, individually-randomised 
controlled trial comparing the effects of genetic test feedback for risk of weight gain combined 
with weight control advice (FA) with a control condition of giving weight control advice only 
(AO) on motivation to prevent weight gain.  The control group received their genetic test 
result at the end of the study.  A summary of the study procedures is shown in Figure8.1.  
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Figure8.1 Flowchart study procedures  
 
Chapter 8: Trial  
 
178 
 
The study was designed according to the Consolidated Standards of Reporting Trials CONSORT 
2010 (Kenneth, Douglas, & David, 2010). CONSORT guidelines were developed to counteract 
the widespread, inadequate reporting of clinical trials and the associated risk of biased results.  
The original guidelines were revised in 2001 and 2010 to encapsulate new evidence and 
provide minimum criteria for reporting clinical trials.  The completed checklist of information 
to be included when reporting a randomised trial is shown in Appendix 12.  The Trial was 
registered (Registration no. ISRCTN91178663), an analysis plan was designed and the study 
protocol was published before data collection was complete.  A copy of the published protocol 
is included in Appendix 13.  
 
8.3.2 Participants 
A volunteer sample of 1016 students took part in the study.   
 
Inclusion and exclusion criteria 
All interested students between 18 and 30 years who were able to give informed consent 
were included.  We chose this age range because the association between FTO and BMI peaks 
in early adulthood, with less effect thereafter (Hardy et al., 2010).   
 
Although it is specified in the original protocol that we would exclude students over 25, in 
practice, it was very difficult to distinguish between those aged 18-25 and those aged over 
because of the method of data collection and the large number of people required to achieve 
the target sample of 1000 participants.  Although the group aged over 25 were unlikely to be 
first-year students, this group was small (5.6%, n = 76) and there is no reason why the 
intervention would not be applicable to older students.  Therefore, we decided after 
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discussion not to exclude them but to dichotomize age into ‘younger’ (aged 18-20) and ‘older’ 
(aged 21 and over) and to include the dichotomized variable in all analyses. As FTO has effects 
in all major ethnic groups, participants were not excluded based on ethnicity. 
 
We anticipated that a small number of individuals suffering from eating disorders would 
express interest in taking part, because eating disorders are relatively common in this age 
group.  However, because eating disorders are difficult to screen for, and findings from Study 2 
indicated that genetic test feedback might be helpful for affected individuals, we decided not 
to exclude participants based on suspected eating disorders.   
 
Recruitment and Consent 
Ethical approval was granted by the University College London Research Ethics Committee for 
non-NHS research in September 2010 (Application no: 2471/003).  A copy of the approval 
letter is included in Appendix 3. A copy of the information sheet and consent form is included 
in Appendix 4.  To ensure that participants were aware of the details of the study, especially 
about DNA handling and privacy, information contained in the information sheet was verbally 
reiterated by me or one of my colleagues before saliva was collected.  Participants were told 
that the DNA analysis would be only for one gene (FTO) which is related to a small increase in 
weight gain susceptibility and that they would be randomly allocated to receive their results 
either during term 2 (FA, intervention group) or at the end of the academic year (AO, control 
group).  Participants were informed that their samples would be destroyed on completion of 
the study and not stored for further analyses.  Written consent was obtained before 
participants gave saliva for DNA analysis.  The right to withdraw from the study without giving 
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reason was be respected at all times, and saliva samples would have been destroyed 
immediately after participant withdrawal.  However, no participant withdrew from the study. 
 
8.3.3 Study setting  
The study was conducted at University College London (UCL). Data was collected in the first 
two weeks of the first term (last two weeks of September) of three consecutive academic 
years (2010-2013) and ran over the course of the academic year, with follow-up data collected 
in the last week of May at the end of the third term of the respective academic year.  UCL is a 
large university with over 22.000 new undergraduate students enrolled each year.  Most 
students are expected to attend the main campus at some point during the first few weeks of 
term (e.g. the welcome fayre, which attracts nearly 10.000 attendees over two days).  
However, data was also collected in student halls because most first-year students live in halls, 
and to give participants who would not attend the main campus the option to participate. 
 
8.3.4 Interventions 
Development of a low-intensity intervention to promote weight gain prevention 
Habit theory proposes that behaviours frequently repeated in a consistent context will be 
initiated in that context without little conscious effort and ‘willpower’ (Neal, Wood, & Quinn, 
2006).  Therefore, establishing beneficial habits by context dependent repetition is desirable 
as they are, once acquired, resistant to change. Although long-term habit change is an integral 
component of most programmes aimed at weight control, they are usually not explicitly 
designed with habit theory in mind (Beeken et al., 2012).  
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In the first study assessing the efficacy of habit-formation for weight control, Lally and 
colleagues (2008) developed a leaflet with ten easy to follow tips for weight reduction 
alongside brief advice encouraging habit-formation. Tips in the leaflet were designed to create 
a daily caloric deficit of about 800-900 calories if all tips were followed (vs. none, although 
most people would probably already be doing some), but not to involve too much effort (e.g. 
choose low-calorie drinks, choose low-fat options, have small portions and no second 
helpings).  The efficacy of the leaflet was piloted in a RCT involving 104 volunteers aged 18 and 
over. Participants in the intervention group received the leaflet; control participants no 
intervention (wait-list control).  There was no contact with the research team from baseline 
assessment to the eight-week follow-up appointment.  After 8 weeks, participants in the 
intervention group had lost on average 2 kg, which was significantly different from control 
participants who lost only 0.4 kg.  Moreover, weight loss continued after the initial follow-up 
visit.  At 32 weeks, weight loss in completers was 3.6 kg, with about half of the participants in 
the intervention group achieving weight reduction of 5% or more. Although the trial was only 
small, the results were encouraging and the efficacy of the Ten Top Tips programme is 
currently being investigated in a large population-based trial in primary care(Beeken et al., 
2012).   
 
I decided to base the weight control advice for the current study on the ‘Ten Top Tips’ system 
because of its strong theoretical background, promising results, and ease of application (no 
specific training required, non-labour intensive) which made it suitable for use in a large 
sample. Furthermore, the ‘Ten Top Tips’ intervention requires only minimal engagement from 
participants and was therefore well-suited for the current study population.  However, we did 
not expect the pathway whereby genetic test feedback was assumed to influence motivation 
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for behaviour change (by increasing risk perceptions and perceived susceptibility as proposed 
by the Health Belief Model, Rosenstock, 1974) to be altered by basing the leaflet on Habit 
theory.  
 
 
The weight control leaflet was developed together with Jane Wardle (Professor of Psychology), 
Helen Croker (a Dietician) and Rebecca Beeken (Project Manager of the ‘Ten Top Tips’ trial) 
and is shown in Appendix 9. The leaflet is divided in three short sections: The first section 
outlines why it is easy to gain weight at university, the second explains the contribution of 
genes to weight gain, and the third section consists of seven tips that may be helpful to 
counteract weight gain.  My role was to identify a range of behaviours in students which were 
likely to lead to unhealthy weight gain and to draft the content of the leaflet.  I was also 
responsible for overseeing its design. The final choice of tips to be included was made after 
joint discussions.  
 
Identification of common health behaviours in students was based on the review of the 
literature discussed in Chapter 1.  It was found that constraints of time and money lead to a 
lack of physical activity and the purchase of food focused on value and not on nutritional 
content (e.g.Serlachius, Hamer, & Wardle, 2007; Cluskey & Grobe, 2009; Provencher et al., 
2009).  Furthermore, it emerged that university provides a multitude of ‘eating opportunities’ 
which foster passive overconsumption; alongside frequent alcohol intake.  
 
The set of tips chosen aimed at raising awareness of these ‘weight gain promoting’ aspects of 
university life and provided students with specific strategies for intervention at those 
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occasions.  Furthermore, we ensured that the tips chosen would require minimal effort to 
implement to also reach students with little interest in weight control.  
 
Following the concern that genetic test feedback may facilitate overly restrictive eating 
behaviour that emerged in study 3a, a paragraph was included about the importance of 
weight not dropping too low and where to find help and advice.  My contact details were 
provided and students were encouraged to contact me if there were any concerns regarding 
their weight.  However, none of the participants contacted me.  
 
As in the original Ten Top Tips study, the tips are written to be short and easy to remember, 
each with a memorable heading followed by a short explanation, e.g. ‘Stand back from that 
snack – University offers plenty of ‘eating opportunities’; many events and meetings offer free 
food and spending all day at university can lead to eating in between meals. Snack calories are 
not always compensated for at the next meal, so it is best to politely pass those ‘extra’ snacks’.  
Preliminary versions of the leaflet were piloted in 45 UCL students to ensure design and ‘tone’ 
was appropriate; amendments were made according to feedback to arrive at the final version.  
Readability was assessed with the Flesch Reading Ease formula and the Flesch-Kincaid Grade 
Level formula, and received a score of 70.6, which translates to the reading level expected in 
grade 6 (age 12).   
 
Intervention group (‘FA’ group) 
The FA group received the weight control leaflet described earlier (Appendix 9) and their FTO 
gene test result in an email with the following text sent by me approximately four months 
after baseline data collection in the respective wave was complete.  ‘Thank you very much for 
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your patience.  I am very happy to tell you that you will find your result in the attached letter. I 
have also attached two short information leaflets that you may find helpful. Should you have 
further questions or concerns about your test result, please find my contact details in your 
result letter and below, I am happy to answer questions you may have.’ A similar format is 
used by internet-based genetic testing services and was also used in studies 2 and 2b and 
found acceptable to participants.  The result letter was sent as an email attachment so that 
participants could open and read it at a convenient time.  The letter contained the personal 
result in addition to information about prevalence in the population.  The email also included 
the short FTO information leaflet used in Studies 2 and 2b, giving a brief overview about the 
FTO gene, its mode of inheritance, and magnitude of influence on body weight (Appendix 2).  
My contact details were included for questions about the test results. As described in the 
relevant section of Chapter 5,( p. 119), result letter and FTO leaflet were piloted and were 
deemed clear, easy to read and informative.  
 
Control group (‘AO’ group) 
Participants randomised to the AO control group received the weight control advice leaflet 
attached to an email from me in identical format to and at the same time as the intervention 
group.  The email also informed them that they would receive their FTO genetic test result by 
the end of the academic year; resembling a ‘wait-list control’ group for the genetic test 
feedback condition. The email read the following: ‘Dear Participant, thank you very much once 
again for your patience. We did not determine your test result at this stage because you were 
assigned by chance to the group that will receive their genetic test result by the end of May. I 
attached a short leaflet for your information that you might find helpful. You will still qualify 
for your reimbursement if you fill in any questionnaires we may send.  I hope that the delay will 
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not cause any inconvenience. Please feel free to contact me should you have further questions 
or concerns (details below).Thank you very much for your continued participation.’ 
 
8.3.5 Study objectives 
Primary research Objective  
The primary aim of the study was to test the hypothesis that adding FTO genetic test feedback 
to weight gain prevention advice would result in higher motivation to prevent weight gain one 
month after receiving genetic test feedback compared with receiving weight gain prevention 
advice alone. 
 
Secondary Research Objectives  
There were four secondary objectives. First, it was of interest to investigate differences in 
motivation to control weight in participants receiving genetic test feedback by risk status to 
explore whether receiving higher risk genetic test feedback would be more motivating than 
receiving a lower risk genetic test result.  Based on findings from Study 1, I hypothesised that 
receiving higher risk genetic test feedback (AA/AT) would result in significantly higher 
motivation to control weight than receiving a lower risk (TT) genetic test result. Interactions 
with age and gender were also explored.  It would have been of interest to explore 
interactions between gene status and BMI, and this point was specified in the protocol, but 
because of small sample sizes this was unfortunately not possible. 
Secondly, one aim was to explore whether receiving genetic test feedback alongside weight 
control advice would be especially effective in subgroups.  I explored effects of receiving 
genetic test feedback and advice by age, gender and BMI.  I hypothesised that participants 
who were female or overweight/obese would be more motivated to control weight than older 
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participants, men or those of normal weight, based on the literature showing that pressures to 
be slim are higher for women and findings from Studies 2 and 2b showing that FTO feedback 
may have benefits especially for individuals having difficulties at weight control.  Furthermore, 
I hypothesised that females or those with higher BMI receiving genetic test feedback and 
advice (FA) would be more motivated to control their weight than females or those with 
higher BMI receiving only weight control advice (AO).  
 
Thirdly, I assessed whether recieivng genetic test feedback for weight gain susceptibility would 
translate into behaviour change.  I investigated differences in adherence to the weight control 
advice (tips) and weight change from baseline to 8-month follow-up in those receiving genetic 
test feedback and weight gain prevention advice compared with those receiving advice alone.  
I hypothesised that participants receiving genetic test feedback would be more likely to 
adhere to the weight control advice, evident in the frequency and number of weight control 
tips followed.  Furthermore, I hypothesised that participants receiving genetic test feedback 
and weight control advice would gain less weight over the study period than those receiving 
only weight control advice. 
 
All secondary objectives were exploratory, because the sample size limited power.    
 
8.3.6 Study materials and Measures 
DNA Collection and genotyping 
DNA was collected as described in Chapter 5 (Study 2).  Briefly, participants were asked to give 
a saliva sample for DNA collection by placing some sugar onto their tongue to stimulate saliva 
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flow and then spitting into a plastic tube to generate 1.5 -2 ml of saliva.  DNA was extracted 
and analysed at the Institute of Metabolic Sciences, Cambridge, UK.  
 
Demographic characteristics 
Demographic information was assessed in an online questionnaire.  The link to the 
questionnaire was sent to participants the day after saliva collection and included age and 
gender.  BMI was calculated using measured height and weight (described below).  The email 
with the invitation to fill in the questionnaire is shown in Appendix 5 and the questionnaire is 
shown in Appendix 11. 
 
Body composition was assessed upon enrolment in the study and at 8-month follow-up (end 
of the academic year). Participants were asked to remove shoes, socks and heavy items, but 
stay otherwise fully clothed.  Height was measured, rounded up to the nearest centimetre, 
using the Leicester Height Measure (Marsden Group, UK) a standardized instrument for 
determining height.  Weight and body fat was assessed using the TANITA TBF-300 MA Body 
Composition Analyzer (Sindlfingen, Germany) which uses electrical impedance to assess body 
fat and BMI.  Electrical impedance usually compares well to other measures of body 
composition such as whole body magnetic resonance imaging and dual X-ray absorptiometry 
(Beeson et al., 2010).  Antibacterial gel was applied to the footplate area to minimise risk of 
infection and facilitate contact.  Participants could opt to receive a printout of the results 
together with an explanation by the research team or not.  All participants opted to receive 
their printout and an explanation by the research team.  
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Although it was specified in the original protocol that we would also assess changes in body fat 
we decided to drop this outcome measure from the analyses because we found that the 
measure was not accurate (the correlation between BMI and body fat was only r = 0.047).  
 
Motivation to control weight 
Motivation to control weight was assessed using a validated measure of readiness for 
behaviour change (Sarkin, Johnson, Prochaska, & Prochaska, 2001) adapted to relate to 
prevention of weight gain.  Participants were asked ‘Please mark with an ‘X’ the statement out 
of the next four that best describes you’: ‘I am not trying to control my weight, and I have no 
intention of doing so in the next month’, ‘I am not trying to control my weight, but I am 
thinking of doing something in the next month’, ‘I started to try to control my weight within the 
last month, ‘I have been trying to control my weight for more than a month’.  Responses were 
used to classify individuals into one of the five stages of behaviour change outlined by 
Prochaska and DiClemente (1984): Precontemplation, Contemplation, Preparation, Action and 
Maintenance.  Table 8.1 displays the statements and corresponding stages of change. Because 
of difficulties in distinguishing meaningfully between Contemplation and Preparation stages 
with respect to weight control intentions, these two stages were grouped together.  
Furthermore, the time frame was adjusted to one month as opposed to six months in the 
original model to reflect the time frame of the current study.  
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Table 8.1 Stages of change and corresponding statements 
Stage of  Change Questionnaire item  
Precontemplation I am not trying to control my weight, 
and I have no intention of doing so in 
the next month  
 
Contemplation/preparation I am not trying to control my weight, 
but I am thinking of doing something 
in the next month  
 
Action I started to try to control my weight 
within the last month 
 
Maintenance I have been trying to control my 
weight for more than a month   
 
Behaviour change 
Behaviour change was measured by adherence to the weight loss tips, which was assessed by 
asking: ‘How often in the last month did you... watch portion sizes, avoid second helpings, slow 
down your eating, avoid eating mindlessly/focus on your food, pass up extra snacks between 
meals, avoid sweet drinks or chose a ‘lite’ drink, integrated some physical activity into your 
day’.  Response options were given on a 5-point Likert scale, with response options being 
‘never’, ‘occasionally’, ‘sometimes’, ‘most of the time’ and ‘always’.  
 
Participants were not specifically instructed to read the weight control leaflet or adhere to the 
tips (other than mentioning in the email that they may find it helpful) because we were 
interested to explore whether genetic test feedback would raise self-motivation to seek out 
the information provided and initiate weight control more than receiving only weight control 
advice. Although one section of the weight control leaflet explained that tips were chosen with 
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the mechanisms of action of FTO in mind, it was pointed out that the tips would be helpful for 
anyone wanting to avoid weight gain regardless of genotype to ensure that students within 
the control group or TT genotype would not disregard the leaflet as not applicable to them.  
 
Motivation to control weight and adherence to the weight loss tips were assessed one month 
after the intervention group received their genetic test result.  We chose the respective time 
frame, because we saw it as crucial that participants would have had sufficient time to think 
about their result, to ask any questions, and to implement eventual behaviour change.  
Participants who reported having controlled their weight for more than one month were 
excluded from the analyses because the intervention was not applicable to them (they were 
already in the maintenance stage).  
 
8.3.7 Randomization 
I conducted all elements of the trial (study enrolment, data collection, group allocation, data 
analysis) myself.  Although this is not desirable because it increases the risk of bias and data 
manipulation, it was difficult to circumvent because the study was part of the PhD. Ideally, 
group allocation and data analysis would have been conducted by independent parties to 
ensure that data was not manipulated. To minimise the risk of inadvertent data manipulation, 
all questionnaire data was collected online and anthropometric data were objectively assessed 
and print-outs of weight records were kept in locked filing cabinets according to university 
regulations.  
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Sequence generation 
Data was anonymised using serial numbers immediately after saliva collection. The 
randomisation sequence was generated using the ‘randomise’ function of SPSS v. 19 which 
randomly assigns a set number of cases (here: 100%) to a specified number of groups (here: 
2), corresponding to a 1:1 allocation ratio of treatment and control group. Group allocation 
occurred immediately after saliva collection of the respective wave was complete and before 
genetic test results became available. Genotypes within the intervention group are intrinsically 
randomised because they are assigned at birth (Mendelian randomization).  
 
Allocation concealment 
Group allocation was not concealed because I conducted all aspects of the trial myself. 
However, ideally, group allocation would have been concealed to avoid the possibility of 
selection bias and to protect the assignment sequence.  One way could have been to use a 
third party to assign participants according to the random sequence.  In hindsight, a third 
person (e.g. another PhD student) from a different department could have allocated 
participants but this was not considered at the time.  
 
Blinding 
Neither I nor the participants were blind to group allocation because they knew whether they 
received their FTO result after four months or at the end of the respective academic year. 
However, because participants were not specifically signing up for a weight gain prevention 
intervention (the main interest for most participants was to receive genetic test feedback) this 
should have not unduly influenced the results. 
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Minimising other sources of bias 
Participants who selected themselves into the study were likely to be more positive towards 
genetic testing than the average student population.  However, if genetic testing was offered 
through a healthcare provider or over the internet, the same situation would hold, i.e. only 
interested individuals would have chosen to take part.  
 
8.4 Statistical Analyses 
 
Sample size and assumptions 
A power calculation conducted a priori using GPower (version 3.1) showed that a total sample 
size of n=340 should suffice to detect a small effect (d=0.25) for motivation to prevent weight 
gain between ‘FA’ and ‘AO’ group with 95% power or greater at the 5% significance level, 
accounting for an attrition rate of 60% (based on research with other student samples).  The 
small effect size was chosen based on data from the vignette study and on FTO’s modest 
effects on weight.  
 
However, because the final sample size was smaller than expected (n = 279 instead of 
expected n = 406), we decided to lower power to detect a small effect to 90% which is still 
acceptable for trials according to CONSORT.  The new sample size required was n = 252.  
Therefore, the current study was adequately powered to detect a small effect (d=0.25) for 
motivation to prevent weight gain between ‘FA’ and ‘AO’ group with 90% power or greater at 
the 5% significance level, accounting for an attrition rate of 60% .  
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Analyses 
Analyses were conducted per protocol (completers only) because of the anticipated large 
amount of missing data (attrition from baseline to one-month follow-up was 59.5%).  Analyses 
on intention-to-treat basis would have resulted in imputation of more than half of the data 
points and because data was only available from one time point, this was likely to be 
inaccurate.  Analyses were carried out using the Statistical Package for Social Sciences (SPSS) 
version 20.  
 
Differences between completers and non-completers of follow-up 1 and follow-up 2 were 
assessed with chi-square tests for categorical variables and independent-samples t-tests for 
continuous variables.  Participants who had been controlling their weight for more than one 
month were excluded from analyses (n = 104); because the intervention was not applicable to 
them (they already controlled their weight).  
 
Descriptive information was based on frequency tables and cross-tabulation. All data were 
tested for assumptions of normality (Skewness, Kurtosis, Levene’s Test) and results are only 
reported if these were violated.  For Skewness and Kurtosis, values between -1 and + 1 were 
deemed acceptable.  
 
Primary outcome 
Ordinal logistic regression (Polytomous Universal Model, PLUM) was used to assess the 
difference in ‘FA’ vs. ‘AO’ group for motivation to prevent weight gain.  In contrast to other 
multinomial methods of analysis, PLUM extends the general linear model to ordinal 
categorical data by taking the order of categories within a variable into account; predicting 
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membership to a certain category or less (Armstrong & Sloan, 1989). Therefore, it was an 
appropriate model to use for the current analyses because higher categories reflect a more 
advanced stage of change.  It would not have been very meaningful to treat the main outcome 
variable as continuous; dichotomizing it for use in logistic regression (e.g. ‘no intention to 
control weight’ vs. all other categories) would have been possible but less desirable because 
information about the stage of change would have been lost using this method.  
 
Secondary outcomes 
Results from all secondary analyses were considered exploratory.  For all models, analyses 
were run at first only including the predictor variable of interest.  Thereafter, the models were 
run including age, gender and BMI as covariates.  Where significant main effects of covariates 
were found, analyses were run a third time, including interactions between the respective 
covariate and main predictor variable. For the purpose of all analyses, age was dichotomized 
into ‘younger’ (aged 18-20) and ‘older’(aged 21 and over); weight status was dichotomized 
into ‘normal weight’ (BMI < 25 kg/m2) and ‘overweight/obese’ (BMI>25 kg/m2). 
 
To assess the effect of risk status on motivation to control weight, FTO status was 
dichotomized into higher/lower risk, with those having at least one risk allele being classified 
as higher risk in the FA group.  Ordinal regression analyses were used to examine effects of risk 
status on motivation to control weight by first comparing higher/lower risk with the control 
group and then comparing higher vs. lower risk FTO status.  For the latter analysis, data was 
recoded so that TT participants constituted the reference group (AA/AT = 0, control = 1, TT = 
2). Age, gender and BMI were included as predictor variables in all models but it was only 
possible to test interactions between risk status and age and gender, respectively, but not BMI 
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because of the small sample size.  To determine the effects of genetic test feedback on 
motivation to control weight in subgroups, the model included age, gender and weight status.  
Analyses were repeated as described above. 
 
Group differences in actual behaviour change (as measured by adherence to the individual 
tips) were assessed with a one-way ANOVA followed by one-way ANCOVA including age, 
gender and BMI. In addition, I built a mean score of the frequency with which participants 
adhered to all tips by summing the frequency with which they adhered to each tip and dividing 
it by the number of tips.  Furthermore, I built an additive score of the total number of tips 
adhered to at least ‘occasionally’.  Differences between groups were explored as described 
above.  Bonferroni corrections for multiple comparisons were used in all analyses.   
 
Repeated-measures ANOVAs were used to determine change in anthropometric measures 
(BMI, weight) within and between groups over time.  Again, the models were re- run with 
covariates (including height for analyses where weight was the outcome) as described.  
 
8.5 Results 
 
8.5.1 Data checks  
One assumption of PLUM is that ‘the relationship between the independent variable and the 
logits is the same for all logits’ (Norusis, 2011).  The test of parallel lines examines the accuracy 
of this assumption and was not significant for any of the analyses, indicating equal 
relationships between the independent variable (Treatment Group) and each category within 
the outcome variable (motivation to control weight).  Because PLUM does not require data to 
be normally distributed (Anderson, 1984), skewness and kurtosis were not investigated.   
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8.5.2 Participant flow and Demographic characteristics  
Participant flow through the study is shown in Figure8.1. Of 1016 participants taking part in 
the study, 7.5% (n = 77, intervention n = 26, control n = 51) had to be excluded because their 
genotype could not be determined.  939 participants were invited to complete the one-month 
follow-up questionnaire and 383 (40.7%) completed it; just attaining the expected 40% 
completion rate.  Participants who completed the one-month follow-up (vs. those who did 
not) were more likely to be older, t (937) = - 1.99, p = 0.046) women (χ2 (1) = 13.25, p < 0.001), 
with lower BMI at baseline, but not 8-month follow-up (tBMIBL (937) = 2.77, p = 0.006; tBMIFU 
(109) = 1.93, p = 0.054).  Drop-out was not related to group allocation (χ2 (1) = 1.00, p = 0.317).  
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Participants who reported having controlled their weight for more than one month were 
excluded from further analyses because the intervention would not be applicable to them 
(27.2%, n = 104).  These participants were more likely to be female (χ2 (1) = 9.14, p = 0.002), 
with slightly higher BMI at both baseline and 8-month follow-up (t BMIBL (381) = -3.29, p = 
0.001; t BMIFU (146) = -2.03, p = 0.045) with no differences in age.  The final sample consisted of 
n= 279 participants.   
 
Participant characteristics for each group are shown in Table 8.2.  There were 139 participants 
in the FA group (49.7%), and 140 (50.3%) in the AO group. About half of the participants in 
each group were male (FA = 51.1%, n = 79; AO = 47.9%, n = 67).  Mean age in intervention and 
control group was 20 (SD = 2.9) and 21 years (SD = 3.0), respectively. Mean BMI was about 21 
in both groups (Mean BMI FA = 21.0 kg/m
2, SDFA = 2.5, Mean BMIAO = 21.4 kg/m
2, SDAO = 2.6) 
and most participants in either group were ‘normal weight’ (FA = 92.1%, n = 128; AO = 89.3%, 
n = 125).  
 
Following CONSORT guidelines, differences between intervention and control groups were not 
assessed; therefore, no p-values are reported.  The reason for this is that it is assumed that 
groups were assigned at random; therefore, there should be no differences between the 
groups. 
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Table 8.2 Participant characteristics 
 Intervention 
(Feedback and 
Advice, n = 139) 
Control  
(Advice only, 
 n = 140) 
Gender male % (n) 51.1    (71)  47.9       (67)   
Age (years) mean (SD) 20.2   (2.5)  20.9   (3.0) 
      
Height (m) mean (SD) 1.70 (0.97)     1.7   (0.97) 
Weight (kg) mean (SD) 62.3 (10.8)   63.0 (11.7) 
BMI kg/m kg/m
2 
mean (SD) 21.2   (2.5)   21.4    (2.6) 
   Normal weight % (n) <25 
   Overweight/obese % (n) >25 
 
92.1 
  7.9 
 (128) 
   (11) 
 
 
 89.3 
 10.7 
   
  (125) 
    (15) 
Motivation weight control 
mean (SD) 
    1.6    (0.8)      1.5    (0.7) 
   No intention % (n) 
   Thinking about it % (n) 
   Started % (n) 
  55.4 
  23.0 
  21.6 
    (77) 
    (32) 
    (30) 
   66.4 
  15.7 
  17.9 
    (93) 
    (22) 
    (25) 
      
FTO status % (n)      
    AA   13.7       (19)     ---         --- 
    AT   39.6       (55)     ---         --- 
    TT   46.8       (65)     ---         --- 
      
 
 
 
 
8.5.3 Primary outcome: Motivation to control weight 
Mean scores and number of participants for each stage of are shown in Table 8.2. Participants 
in the intervention (FA) group were slightly more motivated to engage with weight control 
(Mean = 1.6, SD = 0.8) than participants in the control group (Mean =1.5, SD = 0.8); although 
low means in both groups indicated low motivation overall. However, eyeballing percentages 
for each stage of change, it appeared that fewer participants in the intervention group had ‘no 
intention’ to control their weight (55.4% vs. 66.4%) than participants in the control group. 
Furthermore, more participants in the intervention group thought about controlling their 
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weight (23.0% vs. 15.7%) or had already started to do so (21.6% vs. 17.9%) than in the control 
group
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Table 8.3 Ordinal regression (PLUM) for the effect of the intervention on weight control intentions 
Model Dic only Interaction 
Treat*age_DIC 
Interaction 
Treat*gender 
Interaction 
Treat*BMI_DIC 
 OR 95%CI Sig OR 95%CI Sig OR 95%CI Sig OR 95%CI Sig 
Gender             
Male 
Female 
1 
2.91 
 
1.76-4.81 
 
< 0.001 
1 
2.92 
 
1.76-4.83 
 
< 0.001 
1 
3.46 
 
1.62-7.39 
 
   0.001 
1 
2.98 
 
1.79-4.95 
 
< 0.001 
Age             
   18-20 
   21-30 
1 
0.87 
 
0.53-1.44 
 
   0.594 
1 
0.40 
 
0.19-0.82 
 
  0.803 
1 
0.88 
 
0.53-1.47 
 
   0.626 
1 
0.89 
 
0.53-1.48 
 
   0.646 
BMI             
   Nw 
   Ow/ob 
1 
4.80 
 
2.14-10.77 
 
< 0.001 
1 
4.78 
 
2.13-10.72 
 
 <0.001 
1 
4.83 
 
2.14-10.89 
 
< 0.001 
1 
2.32 
 
0.79-6.83 
 
   0.127 
Treatment Group             
   AO 
   F+A 
1 
1.77 
 
1.08-2.89 
 
   0.023 
1 
2.00 
 
1.06-3.76 
 
   0.061 
1 
2.12 
 
0.97-4.64 
 
   0.059 
1 
1.46 
 
0.87-2.45 
 
   0.127 
TreatFA* 
age_18-20  
TreatFA*  
age_21-30 
 
 
 
- 
 
 
 
- 
 
 
 
- 
 
1 
 
0.42 
 
 
 
0.15-1.15 
 
 
 
   0.865 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
TreatFA* 
gender_male 
TreatFA* 
gender_female 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
1 
 
0.73 
 
 
 
0.27-2.01 
 
 
 
   0.547 
 
 
- 
 
 
- 
 
 
- 
TreatFA*BMI_Nw 
TreatFA* 
BMI_Ow/ob 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
1 
 
6.67 
 
 
1.13-39.25 
 
 
   0.036 
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Running PLUM without covariates yielded non-significant results (OR = 1.51, 95% CI = 0.94-
2.41, p = 0.087). However, as shown in Figure 8.2, once age, gender and BMI were included, 
the effect of the intervention became significant.  Participants receiving  genetic test feedback 
in addition to weight control advice were significantly more likely to think about controlling 
their weight, or to had started to do so within the last month than participants receiving only 
weight control advice, OR = 1.77, 95% CI = 1.08-2.89, p = 0.023.   
Table 8.4 shows the results of the PLUM including age, gender and BMI as covariates  
 
Figure 8.2 Group differences in weight control intentions 
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8.5.4 Secondary outcomes  
Effects of the intervention in subgroups 
The model also revealed significant main effects for gender and BMI, suggesting that females 
and overweight participants were more likely to think about controlling their weight or had 
started to do so in the last month than males or those of normal weight (OR gender = 2.91, 95% 
CI = 1.76-4.81, p<0.001; OR BMI = 4.80, 95% CI = 2.13-10.77, p<0.001). 
 
Models were run that included interactions with age, gender and BMI respectively. There was 
no significant interaction between Treatment Group* age (p = 0.865) and Treatment Group* 
gender (p = 0.547), indicating no difference in motivation to control weight by age or between 
genders in the intervention group.   However, the Treatment Group*BMI interaction was 
significant.  As shown in Figure 8.4, overweight/obese individuals in the intervention group 
were more motivated to think about controlling their weight or to had started to do so in the 
last month than normal weight individuals receiving the intervention (OR = 6.67, 95% CI = 
1.13-39.25, p = 0.036).
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Table 8.4 Ordinal logistic regression (PLUM) for the effect of the intervention on weight control intention 
Model Dic only Interaction 
Treat*age_DIC 
Interaction 
Treat*gender 
Interaction 
Treat*BMI_DIC 
 OR 95%CI Sig OR 95%CI Sig OR 95%CI Sig OR 95%CI Sig 
Gender             
Male 
Female 
1 
2.91 
 
1.76-4.81 
 
<0.001 
1 
2.92 
 
1.76-4.83 
 
<0.001 
1 
3.46 
 
1.62-7.39 
 
0.001 
1 
2.98 
 
1.79-4.95 
 
<0.001 
Age             
18-20 
21-30 
1 
0.87 
 
0.53-1.44 
 
0.594 
1 
0.40 
 
0.19-0.82 
 
0.803 
1 
0.88 
 
0.53-1.47 
 
0.626 
1 
0.89 
 
0.53-1.48 
 
0.646 
BMI             
Nw 
Ow/ob 
1 
4.80 
 
2.14-10.77 
 
<0.001 
1 
4.78 
 
2.13-10.72 
 
<0.001 
1 
4.83 
 
2.14-10.89 
 
<0.001 
1 
2.32 
 
0.79-6.83 
 
0.127 
Treatment 
Group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AO 
F+A 
1 
1.77 
 
1.08-2.89 
 
0.023 
1 
2.00 
 
1.06-3.76 
 
0.061 
1 
2.12 
 
0.97-4.64 
 
0.059 
1 
1.46 
 
0.87-2.45 
 
0.127 
TreatFA* 
age_18-20  
TreatFA*  
age_21-30 
 
 
 
- 
 
 
 
- 
 
 
 
- 
 
1 
 
0.42 
 
 
 
0.15-1.15 
 
 
 
0.865 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
TreatFA* 
gender_male 
TreatFA* 
gender_female 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
1 
 
0.73 
 
 
 
0.27-2.01 
 
 
 
0.547 
 
 
- 
 
 
- 
 
 
- 
TreatFA*BMI_Nw 
TreatFA* 
BMI_Ow/ob 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
1 
 
6.67 
 
 
1.13-39.25 
 
 
0.036 
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Figure 8.3 Group differences in weight control intentions by weight status 
 
 
 
8.5.4.2. Effect of FTO risk status on motivation to control weight 
The FTO genotype was in Hardy-Weinberg equilibrium in the current sample (χ2 (2) = 5.68p = 
0.058). Nineteen (13.7%) participants had the higher risk AA genotype, 55 (39.6%) had the 
intermediate risk AT genotype and 65 (46.8%) had the lower risk TT genotype. 
 
Two ordinal regression models were built to investigate the effect of FTO status on motivation 
to engage with weight control.  The first model compared the effect on motivation by FTO 
status vs. no genetic test feedback; the second model explored the effect between higher risk 
and lower risk FTO status.  Age, gender and BMI were included as covariates.  Results are 
shown in Table 8.5. 
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Table 8.5 Ordinal regression analysis (PLUM) for the effect of FTO status on weight 
control intentions 
Model Dic only Interaction  
Feedback*gender 
 OR  95%CI Sig OR 95%CI  Sig 
Gender       
Male 
Female 
1 
3.15 
 
1.88-5.28 
 
<0.001 
1 
3.59 
 
1.68-7.69 
  
  0.001 
Age       
 
18-20 
21-30 
 
 
1 
0.96 
 
 
0.39-2.36 
 
 
  0.360 
 
1 
0.66 
 
 
 0.61-0.73 
 
 
  0.377 
BMI 
 
Nw 
Ow/ob 
 
 
 
1 
4.90 
 
 
 
 
2.17-
11.07 
 
 
 
<0.001 
 
 
1 
4.96 
 
 
 
 
2.18-11.28 
 
 
 
<0.001 
FTO Feedback 
Control 
TT 
AT,AA 
 
 
1 
1.21 
2.38 
 
 
0.65-2.27 
1.33-4.26 
 
 
   0.546 
   0.003 
 
1 
1.27 
2.90 
 
 
  0.45-3.56 
  1.21-6.92 
 
 
  0.655 
  0.017 
FTO Feedback 
TT 
Control 
AT,AA 
 
 
1 
0.82 
1.97 
 
 
0.44-1.54 
1.00-3.88- 
    - 
 
   0.546 
   0.051 
 
1 
0.79 
2.29 
 
 
  0.28-2.22 
  0.81-6.47 
 
 
   0.119 
   0.655 
FTO Feedback*gender 
Control *female 
AT,AA*female 
 
 
 
   - 
 
 
  - 
 
 
- 
 
1 
2.90 
 
 
  1.21-6.92 
 
 
   0.017 
FTO Feedback*gender 
TT*female 
AT/AA*female 
  
  
  - 
   
  
   - 
    
 
    - 
 
1 
0.53 
 
 
  0.15-1.94 
    
 
   0.924 
       
 
 
As shown in Figure 8.4, there was a significant effect of risk status on motivation to engage 
with weight control, with higher risk participants being more likely to think about controlling 
their weight or having started to do so in the last month than either control or TT participants; 
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although the latter was only borderline significant (OR no feedback = 2.38, 95%CI = 1.33-4.26, p = 
0.003; ORTT = 1.97, 95%CI = 1.00-3.88, p = 0.051).  The significant main effects for gender and 
BMI were replicated, with female and overweight participants being more likely to think about 
controlling their weight or having started to do so in the last month than males or those of 
normal weight (OR gender = 3.15, 95%CI = 1.88-5.28, p< 0.001; ORBMI = 4.90, 95%CI = 2.17-11.07, 
p < 0.001).The main effect of age was not significant (OR = 0.96, 95% CI = 0.39-2.36, p = 0.360), 
and therefore, interactions were not further investigated.  
 
Figure 8.4 Intention to engage with weight control by FTO status 
 
 
The main effect of gender was further investigated by including the FTO Feedback*Gender 
interaction in the model. Results were significant when comparing higher risk participants with 
the control group, indicating that females at higher risk were significantly more motivated to 
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control their weight than females not receiving genetic test feedback (OR = 2.90, 95%CI = 1.21-
6.92, p = 0.017), but no more motivated than females receiving lower risk FTO feedback (OR = 
1.88, 95% CI = 0.51-6.85, p = 0.924).  Because of the small number of overweight and obese 
people in the sample (n = 11), it was not possible to investigate interactions of FTO risk status 
and BMI on motivation to engage with weight control.  
 
Tips followed 
Table 8.6 displays means and SDs for the adherence to the individual tips. Overall, adherence 
was very low with most participants only adhering ‘occasionally’ to each tip.  Engagement with 
physical activity was slightly better, with most participants reporting to engage at least 
‘sometimes’.  The overall mean score of all tips was equally low and identical in both groups, 
reflecting ‘occasional’ engagement.   
 
Participants in either group followed on average 5 tips at least ‘occasionally’; suggesting no 
significant group differences.  Eyeballing means suggested no significant differences between 
groups for any of the variables, and this was confirmed using t-tests. However, ANOVAs, 
followed by ANCOVAs were run as described to conform to the protocol, and results from the 
ANCOVAs are shown in Table 8.6.  Levene’s test for homogeneity of variance was not 
significant for any of the variables.  
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Table 8.6 ANCOVA results for Tips followed 
Outcome Treatment group    
 FA ( n= 139) AO (n = 140)    
 mean ± sd mean ± sd F (df, error) p-value Cohen’s d 
Watch portion sizes 1.06 ± 1.11 1.00 ± 1.09 0.25 (1, 274) 0.471  0.054 
Avoid second helpings 1.23 ± 1.33 1.02 ± 1.23 2.00 (1, 274) 0.158  0.163 
Slow down eating 0.61 ± 0.83 0.64 ± 0.87 0.17 (1, 274) 0.679 -0.035 
Avoid eating mindlessly 1.09 ± 1.14 1.34 ± 1.19 2.53 (1, 274) 0.112 -0.214 
Avoid snacks 1.42 ± 1.24 1.50 ± 1.22 0.14 (1, 274) 0.708 -0.065 
Avoid sweet drinks 1.99 ± 1.55 1.92 ± 1.52 0.27 (1, 274) 0.600   0.045 
Engage in physical 
activity 
2.56 ± 1.26 2.52 ± 1.21 0.05 (1, 274) 0.821   0.029 
Mean frequency tips 
followed 
1.42 ± 0.77 1.42 ± 0.72 0.03 (1, 274) 0.847   0.000 
Total no of tips 
followed at least 
occasionally 
4.51 ± 2.05 4.57 ± 1.97 0.01 (1, 274) 0.925 -0.029 
Note: Results are adjusted for age (dichotomized), gender and BMI (dichotomized) 
 
 
Tip 1: Watch portion sizes There was no significant difference between groups on this variable, 
p = 0.624, and this remained as such when covariates were added, p = 0.471. However, main 
effects of gender and BMI were significant, with females and overweight/obese participants 
being significantly more likely to watch portion sizes than males and normal weight 
participants (F gender (1, 274) = 25.02, p <0.001; F BMI (1, 274) = 5.10, p = 0.025). Age was not 
significantly associated with portion control (p = 0.595). Investigating Treatment 
Group*gender and Treatment Group*BMI interactions revealed a non-significant interaction 
of Treatment Group with gender (F (1, 273) = 1.88, p = 0.171). However, the Treatment 
Group*BMI interaction was significant, with overweight/obese participants receiving genetic 
test feedback in addition to weight control advice engaging significantly more often with 
portion control than overweight/obese individuals receiving only weight control advice(F (1, 
274) = 5.05, p = 0.025).  
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Tip 2: Avoid second helpings Participants in both group avoided second helpings equally rarely, 
p = 0.176 and this did not change once covariates were added, p = 0.158. There was a 
significant main effect of gender, with females avoiding second helpings more often than 
males (F (1, 274 = 14.52, p = <0.001). Main effects of age and BMI were not significant (p age = 
0.136; p BMI= 0.134); neither was the interaction of Treatment Group with gender (p = 0.757).  
 
Tip 3: Slow down eating The intervention had no significant effects on eating speed, p = 0.759 
and addition of covariates had no effect,p = 0.679. Main effects of gender and age were 
significant, with females and younger participants reporting to slow down their eating 
significantly more often than males or older participants  (F gender (1, 274) = 17.37, p <0.001; F 
age (1, 274) = 5.78, p = 0.017); although low means indicate very modest effects. Main effect of 
BMI was not significant (F (1, 274) = 0.32, p = 0.571); neither were interactions of Treatment 
Group with either age or gender (p Treatment Group*age = 0.831; p Treatment Group*Gender = 0.079).  
 
Tip 4: Avoid eating mindlessly Participants in both groups reported to refrain from eating 
mindlessly equally often, p = 0.077, even after adjusting for covariates, p = 0.112. The main 
effect of gender was significant and that of BMI approached significance (F gender (1, 274) = 
7.29, p = 0.007; F BMI (1, 274) = 3.83, p = 0.051). Main effect of age was not significant (p = 
0.895); neither were interactions with Treatment Group and gender or BMI (p Treatment 
Group*Gender = 0.157; p  Treatment Group*BMI = 0.225).  
 
Tip 5: Avoid Snacks The intervention had no effect on snacking frequency, p = 0.610 and 
results were unchanged once covariates were added, p = 0.583. Main effects of gender and 
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BMI were significant, with females and overweight/obese participants reporting to avoid 
snacks more frequently than males or those of normal weight (F gender (1, 274) = 8.61, p = 
0.004; F BMI (1, 274) = 7.06, p = 0.008). Age was not significantly associated with snack 
avoidance (p = 0.451.  Interactions between Treatment Group and gender or BMI, 
respectively, were also not significant (p Treatment Group*Gender = 0.545; p Treatment Group*BMI = 0.507). 
 
Tip 6: Avoid sweet drinks There were no significant group differences for this variable, p = 
0.699, and addition of covariates had no effect, p = 0.640. Female gender was significantly 
associated with avoidance of sweet drinks (F (1, 274) = 8.14, p = 0.744). Main effects of age 
and BMI were not significant p age = 0.744; p BMI = 0.832; neither was the 
TreatmentGroup*Gender interaction (p = 0.649), indicating equal effects of the intervention 
for both genders.  
 
Tip 7: Engage in physical activity Participants in both groups engaged equally often in physical 
activity, p = 0.789 and this was not changed by addition of covariates, p = 0.793. Males 
reported to engage significantly more often in physical activity than females (F (1, 274) = 5.08, 
p = 0.025). Age and BMI were not significantly associated with the frequency with which 
participants engaged in physical activity ( p age = 0.750; p BMI = 0.957).  The Treatment 
Group*Gender interaction was also not significant (p = 0.885).  
 
Mean frequency with which tips were followed  Participants in both groups followed the tips 
equally rarely, p = 0.964 and adding covariates had no influence on the result, p =0.940. 
Females and overweight/obese participants followed the tips more frequently than males or 
normal weight participants (F gender (1, 274) = 18.31, p <0.001; F BMI (1, 274) = 4.25, p = 0.040). 
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Age was not significantly associated with the overall frequency with which participants 
followed the tips, p = 0.401.  Interactions between Treatment Group and Gender and 
Treatment Group and BMI were also not significant (p TreatmentGroup*Gender = 0.199;, p 
TreatmentGroup*BMI = 0.067), indicating that the intervention was no more effective for some 
subgroups than for others.  
 
Total number of Tips followed at least ‘occasionally’ Group differences in the number of tips 
followed were no significant, p = 0.802 and this remained unchanged after adjusting for 
covariates, p = 0.834. The only significant main effect was gender, with females following a 
greater number of tips at least occasionally, F (1, 274) = 32.65, p <0.001).  However, there was 
no significant interaction of TreatmentGroup and Gender (p = 0.236).  
 
Taken together, these results suggest that genetic test feedback has transient effects on 
weight control intentions which do not translate into behaviour change.   
 
 
 
Anthropometric changes over time 
Of the 279 participants included in the analyses, only 111 (39.7%) provided follow-up weight 
data (follow-up 2 completers).  Differences between those who did and did not return for 
follow-up 2 are shown in  
 
Table 8.7. Participants who returned for weighing (vs. those who did not) had significantly 
lower BMIs at baseline, t (1, 277) = 2.15, p = 0.032 and weighed less, t (1, 277) = 2.16, p = 
0.031; although proportions of participants classified as normal or overweight at baseline did 
not differ, χ2 (1) = 1.98, p = 0.159. Differences in mean age and gender were not significant 
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between participants who completed follow-up 2 and those who did not, t (1, 277) = 1.12, p = 
0.340; χ2 (1) = 0.91, p = 0.340; although a greater proportion of younger participants (aged 18-
20) returned, χ2 (1) = 5.22, p = 0.022. Treatment group allocation was unrelated to return for 
follow-up 2, χ2 = 2.68, p = 0. 101.  
 
Table 8.7 baseline differences between completers and non-completers of follow-up 
weighing 
 Follow-up 
(n = 111) 
 No Follow-up 
(n = 168) 
χ2 /t  Sig 
Weight BL (kg) mean (SD)  60.8 (10.8)  63.8 (11.4)  2.16 0.031 
Weight FU (kg) mean (SD)   61.7 (10.9)  --- ---  --- --- 
5%weight gain  % (n)   22.5    (25)  --- ---    
 
BMI baseline mean (SD) 
   Normal weight % (n) 
   Overweight/obese % (n)  
  
20.9   (2.5) 
93.7  (104) 
  6.3       (7) 
  
21.6 
88.7  
11.3     
 
 (2.6) 
(149) 
  (19) 
 
 
 
2.15 
1.98 
 
0.032 
0.159 
 
        
BMI Follow-up mean (SD) 
   Normal  weight% (n) 
   Overweight/obese % (n) 
21.2   (2.6) 
 92.8 (103) 
   7.2      (8) 
 -- 
-- 
-- 
-- 
-- 
-- 
   
 
        
Gender male % (n) 45.9    (51)  51.8    (87)  0.91 0.340 
        
Age years mean (SD) 
   Age 18-20 % (n) 
   Age 21-30 % (n) 
20.4   (2.9) 
68.5    (76) 
31.5    (35) 
 20.7 
54.8 
45.2 
  (2.8) 
   (92) 
   (76) 
 1.12 
5.24 
0.263 
0.022 
 
Treatment group % (n) 
       
    FA 55.9   (62)  45.8     (77)  2.68 0.101 
    AO 44.1   (49)  54.2     (91)    
 
Anthropometric changes were modest in the 111 participants for which data was available, 
mean Δ weight = 0.83 kg, SD = 3.75, mean Δ BMI = 0.28 kg/m2, SD = 1.29. Sphericity was 
investigated with Mauchly’s test, and results were not significant, indicating that variances of 
differences were equal.  Weight change over time was not significant, F (1, 566) = 0.14, p = 
0.700; neither was the Treatment Group*Time interaction F (1, 566) = 0.57, p = 0.451, 
indicating equal weight change in both groups over the year.  These results did not change 
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once covariates (age, gender) were added to the model F time (1, 105) = 0.30, p = 0.864, F 
Treat*Time (1, 105) = 0.50, p = 0.500. Main effects for covariates were not significant.  
 
Differences between groups in 5% weight gain 
Because weight naturally fluctuates as discussed in the previous chapter, and it is difficult to 
determine whether weight fluctuations are meaningful, we decided to also explore whether 
the intervention had an influence on 5% weight gain in the sample.   
 
Out of the 111 participants for whom data were available, 25 (9.0%) gained at least 5% of their 
body weight. Gainers were younger than non-gainers (t (1, 109) = 2.0, p = 0.045) but were 
otherwise no different from non-gainers  with no significant differences in baseline BMI (t (1, 
109) = 1.73, p = 0.85), baseline body weight (t (1, 109) = 0.07, p = 0.942, proportion of those 
classified as overweight (χ2 (1) = 0.16, p = 0.692, or gender (χ2 (1) = 2.56, p = 0.209). Binary 
logistic regression analyses revealed that treatment group allocation was not a significant 
predictor of 5% weight gain, OR = 0.64, 95%CI = 0.25-1.62, p = 0.353. This remained 
unchanged once covariates were added, OR = 0.73, 95%CI = 0.27-1.91, p = 0.523. Younger age 
remained the only significant predictor of 5% weight gain, OR = 0.21, 95% CI = 0.05-0.85, p = 
0.029.  
 
8.5.5 Potential Harms 
We were not made aware that the intervention caused any harm; in fact, we got many 
positive comments, suggesting that it was well received.  
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However, we were aware that the topic of body weight is very sensitive and personal; 
especially for young adults or those struggling with weight control (REF).  Therefore, I trained 
all researchers assisting with data collection to be sensitive to the individual participant and to 
be careful to avoid discriminating against anyone based on their weight (high or low) because 
it might impair help seeking.  Everyone who opted to receive their body composition 
assessment got brief, personal recommendations with it.  Furthermore, we decided to offer 
brief, general advice on available resources regarding concerns about body weight or eating 
(GP, student services) to all participants, so that those who wished to find help could do so.  In 
case any of the participants had become distressed by their genetic test result, Jane Wardle 
would have been available for support.  However, none of the participants required support.   
 
As discussed in Chapter 2, there is a possibility that receiving genetic test feedback causes 
transient negative affect and fatalistic reactions. Therefore, we assessed psychological 
reactions immediately after participants received FTO feedback and these findings will be 
discussed in the next chapter.  Participants were once again provided with my contact details 
at that stage and were encouraged to get in touch with any questions or concerns, but none of 
them did.   
 
8.6 Discussion 
 
To our knowledge, this is the first study that investigated the utility of FTO genetic test 
feedback to motivate young, healthy individuals to engage with weight gain prevention. In line 
with our hypothesis, returning weight control advice in conjunction with FTO genetic test 
feedback successfully increased individuals’ motivation to engage in weight control behaviours 
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in comparison with receiving weight control advice without genetic test feedback. As 
hypothesised, receiving higher risk genetic test feedback (AT/AA) resulted in increased 
motivation to engage with weight control relative to receiving no feedback, in line with 
predictions from traditional models of health behaviour (Rosenstock, 1974).  Importantly, 
receiving lower risk FTO feedback did not decrease individuals’ motivation to engage with 
weight control, with effects being equivalent to receiving no genetic test feedback; lending no 
support to the concern that genetic test feedback may result in false reassurance and 
complacency.  However, contrary to hypotheses, effects on motivation did not translate into 
behaviour change; individuals receiving genetic test feedback and weight control advice 
showed no more engagement with the weight control advice provided and gained equal 
amounts of weight compared to those receiving only weight control advice.  
 
8.6.1 Study limitations 
However, the study had many limitations. First, baseline weight control intentions were not 
assessed, so that no inferences about change in motivation as a result of genetic test feedback 
can be made.  Secondly, although the weight control leaflet was evidence-based, it was not 
piloted in students.  It is therefore not possible to discern whether the leaflet would have been 
effective at changing behaviour without genetic test feedback, and this may explain our lack of 
behavioural effects. It is possible that the intervention was not intense enough to engage this 
particularly unmotivated population.  It would have been preferable to pilot the leaflet in 
students before administering it to the larger sample, but this was unfortunately not possible 
because of time constraints. Furthermore, participants were not specifically encouraged to 
engage with the tips on the leaflet, because we were interested to explore whether genetic 
test feedback would be sufficient to prompt participants to seek out information and initiate 
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weight control without additional support.  In the original ‘Ten Top Tips’ study, participants 
were motivated to engage with weight loss and were given additional materials (booklets) to 
record their progress daily.  It is also possible that participants engaged in alternative weight 
control behaviours which were not mentioned in the tips.  However, differences in weight gain 
between the groups were non-significant, and therefore, this explanation appears unlikely.  
 
Randomization procedures leave also potential for bias.  Because all relevant procedures were 
conducted by me (enrolment, group allocation, and data analysis) there was considerable 
potential for data manipulation.  Even with keeping the constraints of the PhD in mind, in 
hindsight, it would have been desirable to involve a third party at least with group allocation 
to minimise the risk of data manipulation.  However, several steps were taken to ensure that 
data was safe from manipulation: Data was anonymised immediately after data collection and 
group allocation occurred as soon as data collection for each wave was complete and before 
genetic test results became available.  Furthermore, all outcome data was collected 
electronically and print-outs of anthropometric data were kept to ensure that all data are 
verifiable.  
 
The study suffered from high drop-out rates and poor follow-up, despite making every effort 
to retain participants (i.e. personal emails, several email reminders, reimbursement).  
Although this was anticipated (because we chose a population which was not particularly 
interested) and we chose our sample size accordingly, it nonetheless limits the generalizability 
of findings.  Participants were more likely to enrol if they were normal weight, and less likely 
to return if they had a higher BMI at baseline which limited opportunities for exploring effects 
of FTO test feedback in individuals who were already overweight.  
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Lastly, although the study population was chosen to reflect levels of interest in disease 
prevention in young adults, results cannot be assumed to apply to the wider population.  
Students are commonly of higher SES, better educated and have higher literacy levels than 
young adults in the general population which may have affected the interpretation of their 
results (i.e. they may hold less deterministic beliefs than the general population).  Therefore, it 
might be beneficial to explore effects of genetic test feedback for risk of weight gain in a 
sample more reflective of the general population.  
 
8.7 Conclusion 
 
The current study provides evidence that returning FTO genetic test feedback can successfully 
increase motivation to engage with weight control in a young, healthy population with low 
perceived risk and little interest to do so.  However, FTO genetic test feedback was not 
sufficient to impact actual behaviour; although it also did not worsen any motivational or 
behavioural outcomes.  These findings provide further evidence that returning genetic test 
results has transient motivational effects, but does not lead to actual behaviour change. 
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Chapter 9:  Study 4b – Psychological reactions to receiving FTO genetic 
test feedback  
 
9.1 Background 
 
The previous chapter investigated motivational effects of adding FTO feedback to generic 
weight control advice.  Results showed that receiving FTO feedback increased motivation to 
engage with weight control; receiving higher risk FTO feedback was more motivating than 
receiving lower risk, or no feedback; consistent with traditional psychological theories 
(Rosenstock, 1974). 
 
However, as discussed in Chapter 2, one concern of using genetic test feedback to engage 
healthy individuals with disease prevention is the potential for adverse psychological reactions 
caused by genetic determinism; possibly resulting in fatalism (with a higher risk result) and 
false reassurance (with a lower risk result).  Either reaction would be detrimental for obesity 
prevention and treatment because recommendations are primarily based on behaviour 
change.   
 
Results from the vignette study (Study 1) suggested that a small proportion of participants 
anticipated mild adverse reactions to a higher risk genetic test result Furthermore, Study 2b 
showed that lower (and not higher) risk FTO feedback may lead to transient negative affect in 
individuals struggling with weight control; although genetic test feedback had no negative 
outcomes in the qualitative study with predominantly normal weight individuals (Study 2).  
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However, because in both qualitative studies samples were small and highly selected, the 
psychological impact of ‘real’ FTO genetic test required further investigation in a larger 
sample.  Furthermore, no study to date has investigated affective reactions of genetic testing 
for obesity risk in a sample of young, healthy individuals with low interest to engage in weight 
control behaviours. However, if genetic test feedback for disease prevention was introduced 
on a large scale, the target group would be most likely young, healthy individuals unaware of 
their genetic risk.  
 
9.2 Study aims and contribution to the literature 
 
Therefore, the aim of the study was to investigate the short-term psychological reactions to 
‘real’ FTO feedback in the student sample to begin answering the question whether FTO 
feedback is ‘safe’ to administer in this population.  All analyses were exploratory because of 
the modest sample size.  
 
Based on findings from Study 1, I hypothesised that participants receiving a higher risk genetic 
test result would show higher negative affect but not higher fatalism in response to their 
genetic test result compared with those receiving a lower risk genetic test result.  Based on 
findings from Studies 1 and 2b, I also predicted that overweight/obese participants receiving a 
higher risk FTO result would value having an explanation for their weight more than those with 
normal weight, but that they would also show higher negative affect in response to receiving a 
lower risk (TT) result.   
 
 
Chapter 9: Psychological reactions 
 
220 
 
9.3 Methods and Procedure 
 
9.3.1 Sampling and recruitment 
This study used data collected in all waves (and not just from participants in the trial).  All 
participants received an email with the link to a questionnaire assessing psychological 
reactions from me the day after they received their genetic test result, irrespective of wave in 
which the data was collected or group allocation (for participants in waves 2 and 3). Therefore, 
these data are analysed together to increase power.  
Details of the recruitment process and sampling are described in the relevant sections 
(Chapter 7: p. 147; Chapter 7: p.179). Participant flow through the study is shown in Figure 9.1  
 
9.3.2 Measures 
9.3.2.1 Participant characteristics 
Age, gender and family history of obesity were assessed as part of the questionnaire.  Family 
history was included because having overweight family members could increase perceived risk 
and potentially modify reactions to FTO test feedback.  Effects could be positive if participants 
had seen family members cope with weight and therefore perceived it as less threatening or 
severe, or they could be negative if participants were more concerned about weight gain 
because of previous exposure (Wang, 2010; Acheson, 2010).   
Participants were asked ‘are/were any of your family members overweight?’ and a list of 
relatives consisting of mother, father, sister and brother (here participants were asked how 
many brothers/sisters they had and how many are/were overweight), grandmother on 
mother’s side, grandfather on mother’s side, grandmother of father’s side and grandfather on 
father’s side was provided . Response options of ‘yes’, ‘no’, and ‘don’t know’ were given for 
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each relative.  Family history of obesity was coded as ‘yes’ if at least one parent or 
grandparent was reported to have been overweight/obese. BMI was calculated from height 
and weight measurements taken at baseline as described in Chapter 4 (pp.146).  
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Figure 9.1 Flowchart of study procedures 
 
 
 
 
Chapter 9: Psychological reactions 
 
223 
 
9.3.2.2 Psychological reactions to FTO feedback 
A copy of the full questionnaire is included in Appendix 11.  Constructs investigated were 
identical to those used in the hypothetical study (Study 1): Fatalism, Negative Affect, 
Explanatory value of the FTO result and Information Seeking.  Motivation to engage with 
weight control was not included because it was the focus of the trial (Chapter 8).  Agreement 
with each statement was rated on a 5-point Likert Scale, ranging from strongly disagree to 
strongly agree. 
 
Question items of each construct are shown in Table 9.1.  Question wording was adapted to 
capture responses to actual feedback but to remain as close as possible to the original items 
used in Study 1.  Also, like in Study 1, scores of individual items in each construct were 
summed and their mean was calculated to obtain a composite score that was comparable 
across categories (referring to responses on a 5-point scale from strongly disagree to strongly 
agree).  
 
Four items were newly developed based on review of the literature (‘knowing my FTO gene 
result is useful’, ‘knowing my FTO gene test result is important for me’, ‘knowing my FTO gene 
result makes me think about my future health’, ‘knowing my FTO gene result will not change 
anything at all’) to explore potential benefits of genetic test feedback in more detail.  These 
items remained individually assessed because they did not fall into any of the other 
constructs. Like the other items, responses were rated on a 5-point Likert Scale, with response 
options ranging from strongly disagree to strongly agree.  
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Table 9.1 Statements used to assess psychological reactions to FTO feedback 
 
Scale items 
Fatalism 
      Knowing my FTO gene test result makes me think that there is nothing I can do to prevent 
      weight gain 
Negative Affect  
      Knowing my FTO gene test result makes me regret having taken the test 
      Knowing my FTO gene test result makes me glad  (reversed) 
      Knowing my FTO gene test result makes me feel angry 
      Knowing my FTO gene test result makes me feel disappointed 
      Knowing my FTO gene test result makes me feel depressed 
Explanation for body weight 
      Knowing my FTO gene test result provides me with an explanation for my body weight 
      Knowing my FTO gene test result confirms what I have always thought of as the reason for 
      my weight 
Information seeking 
      Knowing my FTO gene test result makes me want to discuss my result with a health   
      professional 
      Knowing my FTO gene test result makes me go to the Internet to find out more about what 
      the result means 
      Knowing my FTO gene test result makes me want to know more about how the gene acts 
Novel items (individually assessed) 
      Knowing my FTO gene test result is useful 
      Knowing my FTO gene test result is important for me 
      Knowing my FTO gene test result makes me think about my future health 
      Knowing my FTO gene test result does not change anything at all 
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9.3.2.3 Correct recall of FTO genetic test result 
Correct recall of the FTO test result was assessed with two items because recall may also affect 
subsequent reactions.  The first asked ‘my FTO test result was…’ with response options being 
‘AA’, ‘AT’, ‘TT’ and ‘don’t remember’.  The second question asked ‘My FTO test result puts 
me...’ with response options being ‘at lower risk for gaining weight’, ‘at average risk for 
gaining weight’, ‘at higher risk for gaining weight’ and ‘don’t remember’ to determine whether 
participants understood the meaning of the genetic test result.  Recall was coded as ‘correct’ if 
participants’ answers to both questions matched their actual genetic test result.  
 
9.4 Statistical Analyses 
 
Analyses were carried out using the Statistical Package for Social Sciences (SPSS) version 20.0.  
Descriptive information was based on frequency tables and cross-tabulation.  All data were 
tested for assumptions of normality (Skewness, Kurtosis, Levene’s Test) and results are only 
reported if these were violated.  For Skewness and Kurtosis, values between -1 and + 1 were 
acceptable.   
 
Differences between completers and non-completers of the follow-up questionnaire were 
assessed with chi-square tests for categorical variables and t-tests for continuous variables.  
Differences between participants who correctly recalled their genetic test result and those 
who did not were assessed with chi-square tests for categorical variables and t-tests for 
continuous variables.  
 
Chapter 9: Psychological reactions 
 
226 
 
FTO risk status was not dichotomized into higher (AT/AA) and lower risk (TT) for the current 
analyses because visual inspection of means suggested that effects differed according to each 
risk group; therefore, grouping variables together would not have been appropriate.  
 
First, one-way ANOVAs, including only FTO status were run to examine short-term reactions to 
genetic test feedback for outcomes described above.  These were followed by one-way 
ANCOVAs including age, gender, family history of obesity, BMI, correct recall and Treatment 
group to adjust for effects associated with trial participation.  At first, analyses investigated 
only main effects. Thereafter, analyses were repeated for all outcome variables including 
FTO*Gender and FTO*BMI interactions.  For all analyses, age was dichotomized into younger 
(aged 18-20 years) and older (aged 21 and over) and BMI was dichotomized into ‘normal 
weight’ and ‘overweight/obese’.  Where main effects or interactions were significant, post-hoc 
pairwise comparisons were carried out to investigate these further.  Trends were analysed 
using polynomial contrasts.  Bonferroni corrections were employed in all analyses.  
 
9.5 Results 
 
9.5.1 Participant characteristics 
Out of 1518 participants who enrolled in the study, 94.2% (n = 1426) were invited to complete 
the questionnaire and 15.8% (n = 225) completed it.  Participants whose genotype could not 
be determined (5.8%, n = 89) did not receive an invitation.  Table 9.2 shows differences at 
baseline between completers and non-completers of the questionnaire.  Completers were 
more likely to be female (χ2 (1) = 16.0, p < 0.001), and to have a slightly lower BMI at baseline 
(t BMIBL (1424) = 2.12, p = 0.034) than non-completers; although proportions of those classified 
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as normal weight and overweight/obese did not differ (χ2 (1) = 2.14, p = 0.143).  Mean age was 
similar between completers and non-completers, t (1424) = -0.78, p =0.434); although a 
greater proportion of older participants completed the questionnaire (χ2 (1) = 4.30, p = 0.042). 
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Table 9.2 Baseline differences of questionnaire completers and non-completers 
 
    N = 1426 Completers 
(n = 225) 
 Non-completers 
(n = 1201) 
χ2 /t  Sig 
Gender male % (n) 36.9    (83)  51.4   (610)   16.0 <0.001 
BMI kg/m
2
 mean (SD) 
    Normal  % (n) 
    Overweight/obese % (n)  
22.0   (2.9) 
89.3  (201) 
10.7     (24) 
 21.5 
84.6 
15.4     
   (2.8) 
(1016) 
   (185) 
 
 
2.12 
2.14 
 
0.034 
0.143 
 
   
        
Age years mean (SD) 
    Age 18-20 % (n) 
    Age 21-30 % (n) 
20.6    (2.9) 
56.4   (127) 
43.6      (98) 
 20.3 
63.7 
37.1 
   (2.4) 
  (756) 
   (445) 
 -1.81 
 4.30 
  0.069 
  0.042 
 
Treatment group % (n) 
       
    Control 
    FA 
32.4     (73) 
40.4     (91) 
 34.4 
32.5 
  (413) 
  (391) 
   5.19   0.075 
    AO 27.1     (61)  33.1   (397)    
        
 
FTO test result % (n) 
       
    TT 
    AT 
  40.9   (92) 
  44.4 (101) 
 42.2 
45.4 
  (507) 
  (546) 
    0.86   0.649 
    AA   14.7   (32)  12.3   (148)    
Family history overweight 
    Yes % (n) 
    No  % (n) 
 
68.4   (154) 
31.6     (71) 
  
--- 
--- 
 
      --- 
      --- 
   
Recall FTO result 
    Correct    % (n) 
    Incorrect % (n) 
 
79.6   (179) 
20.4     (46) 
  
--- 
--- 
 
      --- 
      --- 
   
 
 
FTO genotype was in Hardy-Weinberg equilibrium, χ2 = 1.57, p = 0.454.  Genotype status was 
unrelated to questionnaire completion (χ2 = 0.86, p = 0.649) and so was treatment group 
allocation (χ2 (1) = 5.19, p = 0.075).  The majority of participants had a family history of 
overweight (68.4%, n = 154), defined as having at least one overweight parent or grandparent.   
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9.5.2 Recall of the FTO result 
Overall, accurate recall of the FTO test result was high.  Nearly 80% of participants (n = 179) 
could remember their test result accurately, and a slightly fewer (76%, n = 170) could correctly 
explain its meaning.  Participants who recalled their FTO result incorrectly (20.4%, n = 46), 
most commonly misreported a lower risk result as higher risk (37%, n = 17), followed by 
participants who could not remember their FTO result (34.8%, n = 16).   
 
9.5.3 Psychological outcomes 
Results of all ANCOVAs (main effects only), including means and standard deviations are 
shown in Table 9.3.  Age was not significantly associated with any of the outcomes, so it is not 
further reported.  
  
Chapter 9: Psychological reactions 
 
230 
 
 
Table 9.3 ANCOVA results of psychological reactions to FTO genetic test feedback 
 
Outcome 
(range 1-5) 
Risk status (N = 225) 
F (df, error) Sig. TT ( n = 92) 
mean ± sd 
AT (n = 101) 
mean ± sd 
AA ( n = 32) 
mean ± sd 
Fatalism 1.73 ± 0.72 1.71 ± 0.78 2.03 ± 0.86    2.19 (2, 214)   0.217 
Negative 
Affect 
1.71 ± 0.55a 1.89 ± 0.77a,b 2.34 ± 0.75c 14.30 (2, 214) <0.001 
Information 
Seeking 
3.08 ± 0.67 2.97 ± 0.82 3.20 ± 0.76   0.92 (2, 214)   0.397 
Explanation 2.94 ± 1.01a 2.45 ± 0.93b 2.71 ± 1.07a,b   5.66 (2, 214)   0.004 
Future Health 3.50 ± 0.80 3.46 ± 0.89 3.94 ± 0.50   2.85 (2, 214)   0.060 
Personal 
utility 
3.79 ± 0.79 3.56 ± 0.84 3.81 ± 0.73   2.37 (2, 214)   0.100 
Personal 
importance 
3.29 ± 0.90a 2.94 ± 0.97b 3.03 ± 0.78a,b   4.39 (2, 214)   0.015 
Not change 
anything 
3.26 ± 1.12a 3.47 ± 1.12a,c 2.63 ± 0.83b    5.77 (2,214)   0.004 
 
Notes: Results are adjusted for age, gender, BMI, Family history, correct recall and Treatment Group.  
Means that do not share superscripts differ by p <0.05.  
 
 
Fatalism Fatalism did not differ by FTO risk status (F (2, 222) = 2.19, p = 0.113) and this 
remained unchanged when covariates were included in the analysis (p = 0.217).  Gender was 
significantly associated with fatalistic attitudes to weight gain, with women being slightly more 
inclined than men to endorse the belief that there is nothing they could do to prevent it (F (1, 
214) = 6.71, p = 0.010), although the very low mean (1.88) and the lack of scores at the 
extreme end of the scale (nobody scored 5) still reflects overall disagreement with this 
statement.  Other covariates were not significant.  Interactions of FTO status and gender or 
BMI were also not significant (p FTO*gender = 0.452; p FTO*BMI = 0.234).  
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Negative Affect Negative Affect differed significantly by FTO status (F (2, 222) = 14.26, p < 
0.001) and this effect was maintained in the ANCOVAs (F (2, 214) = 14.30, p <0.001).  AA 
participants reported significantly higher negative affect than AT or TT participants (p AT = 
0.002, p TT <0.001). There was a trend for AT participants to report slightly higher negative 
affect than TT participants (p = 0.053); overall reflecting a linear increase in negative affect 
according to risk. The effect of gender was also significant, with women reporting significantly 
higher negative affect than men (F (1, 214) = 4.69, p = 0.031); although the low mean (2.03) 
indicates modest effects. Main effects of other covariates, including BMI were not significant 
(F (1, 214) = 0.01, p = 0.985); neither was the FTO*gender interaction.   
 
However, the FTO*BMI interaction was significant (F (2, 212) = 5.78, p = 0.004). As shown in 
Figure 9.2, normal weight individuals reported to be most negatively affected receiving an AA 
result in comparison with those either receiving an AT or TT result (p AT = 0.001, p TT < 0.001); 
whereas there was only a trend for normal weight AT participants to report higher negative 
affect than TT individuals (p = 0.083); although, once again, low means and only a small 
percentage of individuals scoring at the extreme end of the scale (only two participants had a 
composite score of four and one participant of five) indicated that these effects were mild.   
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Information seeking Associations of FTO status with information seeking were not significant; 
neither in the univariate analysis (F (2,222) = 1.31, p = 0.270) nor in the ANCOVA (p = 0.397). 
However, the main effect of BMI was borderline significant, indicating a trend for overweight 
or obese participants to be slightly more inclined to seek information about FTO than those of 
normal weight (F (2, 214) = 3.86, p = 0.051).  Other main effects were not significant.  
Interactions between FTO status and gender or BMI were also not significant (p FTO *gender = 
0.487; p FTO*BMI = 0.126), indicating similar reactions for both genders and weight groups within 
each type of FTO result.  
 
Explanation There was a significant association of FTO status with the perceived explanatory 
value of the result (F (2, 222) = 6.05, p = 0.003) and this effect remained significant in the 
ANCOVA (p = 0.004). Other main effects were not significant; neither was the FTO*gender 
interaction (p = 0.260).  However, interactions between FTO status and BMI were significant (F 
(2, 214) = 4.84, p = 0.009).  As shown in Figure 9.3, unexpectedly, normal weight TT 
Figure 9.2 Differences in Negative Affect by FTO- and weight status 
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participants reported to be most glad about having an explanation for their body weight 
compared with normal weight AT, but not normal weight AA participants (p AT < 0.001; p AA = 
0.490).  Differences between AT and AA participants were not significant (p = 0.217).  Effects 
were not significant in overweight participants; although means indicated a trend towards a 
linear pattern in the opposite direction, with TT participants being least glad about having an 
explanation and AA participants reporting to be most glad to have an explanation for their 
weight status.  However, the small sample size (n = 4) has to be taken into account when 
interpreting these findings.  
 
 
 
Future health considerations Differences by FTO status in thoughts about future health were 
significant in the univariate analysis (F (2, 222) = 4.50, p = 0.012), but this was not maintained 
once covariates were added (p = 0.060). The effect of gender was significant with women 
Figure 9.3 Explanatory value of the FTO result by weight status 
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being more likely to think about their future health in response to the FTO result (F (1,214) = 
5.30, p = 0.022).  Furthermore, correct recall of the genetic test result was associated with 
future health considerations (F (1, 214) = 5.05, p = 0.026), with individuals who recalled their 
genetic test result correctly being more likely to think about their future health; although 
these differences were modest.  Other covariates were not significantly associated with future 
health considerations; neither were interactions with gender or BMI (p FTO*gender = 0.290; p 
FTO*BMI = 0.186).  
 
Perceived personal utility Perceptions of personal utility did not differ by FTO status (p = 
0.095).  This did not change when the analysis included covariates (p = 0.100) and there were 
no other significant main effects.  Interactions of FTO status with gender or BMI were also not 
significant (p FTO*gender = 0.317; p FTO*BMI = 0.293).  
 
Perceived personal importance However, perceptions of personal importance differed by FTO 
status in univariate analyses (F (2, 222) = 3.68, p = 0.027) which was maintained in the 
ANCOVA (F 2, 214) = 4.39, p = 0.014).  Participants receiving a TT result found it more 
important than those receiving an AT result (p = 0.015), but not more important than those 
receiving an AA result (p = 0.204). There was no difference in perceived importance of the 
result between participants receiving AT vs. AA genetic feedback (p = 1.000). Family history of 
obesity was borderline significantly associated with perceived personal importance, with 
participants who had a family history of obesity attaching more personal importance to the 
FTO result than participants who had no family history of overweight (F (1, 214) = 3.84, p = 
0.051). Other covariates were not significantly associated with perceived personal importance; 
neither were interactions with gender or BMI (F = 0.55, p FTO*gender = 0.576; p FTO*BMI = 0.852).  
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Perceived lack of impact Beliefs that awareness of FTO status would not change anything at all 
differed significantly by FTO status (F (2, 222) = 7.31, p = 0.001) and this effect was maintained 
in the multivariate analysis (F (2, 214) = 5.77, p = 0.004). Participants receiving TT feedback 
were more likely to agree that it would not change anything at all compared with AA but not 
AT participants (p AA = 0.032; p AT = 0.843) and AT participants were more likely to agree that it 
would not change anything at all compared with AA participants (p = 0.003).  Main effect of 
gender was also significant with men being more likely to agree that the result would not 
change anything at all (F (1, 214) = 3.88, p = 0.050). Family history was also associated with the 
belief that awareness of FTO status would not change anything (F (1, 214) = 8.02, p = 0.005), 
with participants without family history of obesity being more likely to agree with this 
statement than individuals with family history.  Other main effects were not significant; 
neither were interactions with gender or BMI (p FTO*gender = 0.123; p FTO*BMI = 0.689).  
 
9.6 Discussion 
 
This study investigated the short-term psychological reactions to FTO genetic test feedback in 
a sample of young, healthy individuals.  In line with hypotheses, participants showed no 
evidence of fatalistic reactions in response to FTO genetic test feedback, regardless of FTO 
status.  Although participants receiving a higher risk FTO result (AA) were more negatively 
affected than individuals receiving a lower risk (TT) result low overall means and a lack of 
scores at the extreme ends of the scale suggest that these effects were modest.  Further 
investigation revealed that individuals of normal weight were more negatively affected 
receiving a higher risk AA result than overweight individuals, with a trend for the reverse 
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pattern in individuals receiving a TT result (overweight individuals were more negatively 
affected than normal weight individuals).  In line with traditional health behaviour theories 
(Rosenstock, 1974), individuals anticipated that the knowledge of FTO status would lead only 
to change if it conferred a higher risk AA result.  FTO status was not associated with 
information seeking, perceived personal utility or future health considerations.  However, 
contrary to our hypothesis, overweight and obese participants were no more likely than 
normal weight participants to report that they were glad to have an explanation for their body 
weight.   
 
9.6.1 A conceptual model of how genetic test feedback may influence psychological and 
behavioural reactions 
 
Findings from all the studies in this thesis indicate that the impact of genetic test feedback for 
obesity risk may influence psychological and behavioural outcomes in the following manner 
(Figure 9.4):  Demographic characteristics such as age, gender and education may impact on 
the decision to enrol for testing; in addition to perceived risk of the condition and existing 
diagnosis.  If genetic test results are as expected (i.e. congruent with the participant’s 
perceived risk or phenotype), I hypothesis that this will lead to acceptance of the result and 
perhaps some relief of stigma by providing a confirmation of private assumptions or a causal 
explanation, which will in turn impact on motivation to change behaviour (which is also 
influenced by perceived risk or an existing diagnosis).  Ultimately these should result in actual 
behaviour change, although my study was as unsuccessful as those that have gone before in 
finding evidence for behaviour change.   
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If the result is unexpected to the participant (i.e. incongruent with their expectations, either 
because of prior perceived risk or current phenotype), this could result in cognitive dissonance 
and an increase in perceived risk, and potentially, negative affect.  In my study, negative 
affective reactions were reported by some respondents but the reaction was transient, 
probably because coping mechanisms led to acceptance of the result, relief, confirmation and 
a causal explanation resulting in the increase in motivation to change behaviour as discussed 
above.   
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Figure 9.4 Proposed model of the mechanisms whereby genetic test feedback 
influences psychological and behavioural reactions 
 
9.6.2 Study limitations 
However, this study had several limitations.  First, several constructs that may be important 
contributors to either testing decisions or psychological and behavioural reactions were not 
investigated (e.g. self-efficacy, tolerance of uncertainty, information avoidance) because it was 
beyond the scope of this thesis.  However, these elements could be investigated in future 
research.  
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Secondly, the low overall response rate (15.8%) limits any conclusions that could be drawn for 
the student population at large.  The long delay between providing saliva for analysis and 
receiving the genetic test result (either because of group allocation or because of delays in 
processing by the Institute of Metabolic Sciences) may have resulted in students being 
disinclined to return the questionnaire.  Furthermore, it is possible that spamfilters and some 
results being returned near the holiday period (during which students may not check their 
university emails) precluded emails from reaching recipients.  It is unlikely that questionnaire 
length contributed to the low response rate, because only two participants terminated the 
questionnaire before completion.   
 
In addition, because of the observed differences between questionnaire responders and non-
responders, particularly in the low number of overweight and obese individuals (n = 4) who 
returned the questionnaire; results from this group have to be interpreted with caution.  It is 
possible that individuals who were more negatively affected by their genetic test result did not 
return the questionnaire.  
 
Lastly, findings may also have limited application to the wider population because students 
tend to be better educated and have higher SES and literacy levels than the general 
population, as described in the previous chapter.  Future research could explore reactions to 
obesity genetic testing in the wider population to allow for drawing more general conclusions.  
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9.7 Conclusion 
 
Despite its limitations, findings from this study lend little support to concerns about fatalistic 
or complacent reactions in response to FTO genetic test feedback for the risk of weight gain in 
this young, healthy population;  matching results from hypothetical and earlier small-scale 
studies.  These findings are encouraging for aims of integrating predictive genetic testing into 
mainstream medicine.  
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Chapter 10:  General discussion and Conclusions 
The aim of the studies described in this thesis was to examine the emotional, motivational and 
behavioural effects of FTO genetic test feedback first in vignette studies, then in smaller scale 
qualitative research, then in a larger scale study, and finally to examine its contribution to 
promoting weight management.  The key concern in all studies was psychological safety, with 
positive emotional, motivational and behavioural effects as a secondary focus.   
 
10.1 Psychological impact of FTO genetic test feedback 
The first set of research questions I tried to answer was:  ‘What is the psychological impact of 
anticipated and ‘real’ genetic test feedback for risk of weight gain? Will genetic test feedback 
cause fatalism (with a higher-risk result) or false reassurance (with a lower-risk result)? Will 
responses differ by weight status?’ 
 
Results from the vignette study (Study 1) showed that the idea of a higher risk genetic test 
result did not result in a fatalistic attitude or false reassurance.  Although fatalism increased 
slightly in the student sample, the increase was small, with the mean response increasing from 
‘strongly disagree’ to ‘disagree’; and only a very small percentage of students thought that 
they were destined to gain weight if their result showed the higher risk FTO variant.  Vignette 
studies really only tell us what people think that they might feel, and they may not engage 
very hard in the thinking process.  However, this reassuring result made it possible to move on 
to studies concerned with ‘real’ FTO feedback (Studies 2a, 2b and 4b).  Results from these 
three studies confirmed that real genetic test feedback did not increase negative attitudes; 
regardless of risk status.  In fact, far from fatalism, awareness of FTO status was perceived as 
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helpful and motivating; particularly for individuals who had difficulties at weight control.  
These findings contrast with some of the earlier work on smoking cessation (Sanderson & 
Wardle, 2005) and susceptibility to heart disease (Senior & Marteau, 1999).  It is possible that 
causal attributions of obesity incorporate biological and environmental causes; whereas those 
for smoking or familial hypercholesterolemia are drawing predominantly on biological 
explanations (Senior, 1999) which may explain the discrepancy in findings. 
 
Results from both my qualitative studies suggested that individuals’ cognitive constructs of the 
causes of weight gain correctly incorporate multiple causes; so adding information about one 
gene that evidently only contributes very modestly to obesity development understandably 
had had little effect on altering obesity-related beliefs.  Lock and colleagues (2006) discovered 
in interviews with 40 participants from the REVEAL study (Green et al., 2009) that personal 
beliefs about disease aetiology are resistant to change, and that new information encountered 
is made to ‘fit’ with previously held beliefs; a finding similar to that by Michie and colleagues 
(2005) about Familial adenomatous polyposis (FAP) aetiology, which remained wrongly 
perceived as multifaceted even after education sessions informing about dominant 
inheritance patterns.  Alternatively, it is possible that only participants who anticipated not 
being negatively affected participated in the studies giving ‘real’ genetic feedback, as proposed 
in the self-selection hypothesis by Sanderson & Wardle (2005).  Given that people are unlikely 
to get genetic feedback unless they volunteer, these results suggest that access to FTO genetic 
test feedback is not likely to contribute to fatalism.   
 
This finding fits well with the current literature investigating fatalistic attitudes to genetic test 
feedback.  As discussed in Chapter 1, on the whole, most studies have not found evidence that 
Chapter 10: Discussion and Conclusion 
 
243 
 
awareness of genetic risk results in fatalistic attitudes (e.g. Marteau et al., 2004; Bloss et al., 
2011), even for severe conditions, such as Alzheimer’s or Huntington’s Disease where to date 
no cure exists (Green et al., 2009; Wiggins et al., 1992).  However, the low uptake rates of 
genetic testing in the population affected by Huntington’s Disease (~ 30%) suggests that the 
self-selection argument has probably some validity and needs to be kept in mind when 
interpreting findings from any study on genetic test feedback.   
 
The limitations inherent in self-report measures have also to be considered.  Although survey 
items were based on a review of the literature, they did not stem from validated scales and 
may therefore be inadequate to correctly assess fatalistic responses.  For example, Likert 
scales may not have been sensitive enough to account for any nuanced responses from 
individuals.  I considered using visual analogue scales, as they have been found to have good 
ecological validity (Fields, 2005), but because they were not used in any other study, and 
coding them for statistical purposes can be challenging, I decided to use Likert scales in this 
thesis.  However, despite including several items which were grouped into overarching scales 
by means of Principal Component Analysis to improve validity, fatalism remained assessed 
through a single item.  Single item measures have been shown to have lower validity and 
reliability than composite scales (Fields, 2005).  However, in the few other quantitative studies 
in the area (Sanderson & Wardle, 2005, Marteau et al., 2004), fatalism was also assessed 
through a single item, so that findings could at least be compared across studies.  
 
Some increase in negative affect was anticipated in a small proportion of participants in the 
vignette study, and this was also observed the studies giving ‘real’ FTO genetic test feedback, 
with a small linear increase per higher risk allele.  In contrast to the vignette study, results 
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from Studies 2b and 4b revealed that negative affect varied by risk-and weight status: normal 
weight participants showed mildly elevated negative affect in response to a higher risk genetic 
test result, but overweight and obese individuals reported increases in negative affect in 
response to a lower risk (TT) genetic test result.   
 
Although these findings may be somewhat puzzling in isolation, when interpreted alongside 
the data for the perceived ‘explanatory value’ of FTO feedback, they are less surprising.  
Individuals struggling with weight control, appeared to benefit from receiving an ‘explanation’ 
for their weight status in the form of a higher risk result by reduced self-blame and a shift of 
focus towards taking action; suggesting that genetic feedback may have value beyond 
‘objective’ clinical utility in participants struggling with weight control.  In this respect, 
motivation to participate may have differed from those without difficulties at weight control.  
As shown in the qualitative studies, most normal weight individuals took part out of curiosity; 
whereas among individuals struggling with weight control, participation was unanimously 
driven by the desire to find an explanation for one’s own ‘battle’ with weight.  Therefore, a 
lower risk genetic test result led to disappointment because it lacked the anticipated ‘genomic 
confirmation’ of their weight problems.  Alternatively, it is possible that slightly elevated 
negative affect is a necessary intermediate for shifting individuals towards taking action.  
Either way, it appears that coping mechanisms were relatively efficient because individuals in 
the qualitative studies insisted that negative effects were transient and nobody contacted us 
for advice in any of the studies.  These findings are in line with the review by Heshka and 
colleagues (2008) who investigated responses to genetic feedback for more severe conditions 
and found that negative affect in response to genetic test feedback may be elevated in the 
short-term, but not the longer-term.  Furthermore, humans have generally a high capacity to 
Chapter 10: Discussion and Conclusion 
 
245 
 
adjust to adverse life experiences (Bonnano, 2004), and the response to genetic risk 
information appears to be no exception. 
 
However, as these findings were obtained from qualitative work, which is limited by the small 
sample size and the potential for social desirability or researcher bias, they have to be viewed 
with caution and further quantitative work is needed to test the hypotheses that they 
generated.  
 
A further limitation common to all studies in this thesis was that samples were self-selected 
and therefore, only individuals who had positive attitudes towards genetics and who 
anticipated no negative outcomes may have taken part which may have influenced reactions 
to genetic feedback.  The small sample sizes in the qualitative studies (studies 2 and 2b)  – 
which is usual with this methodology – primarily allows us to develop hypotheses for further 
research and cannot be generalised to other/larger populations.  It would have been desirable 
to include a larger number of participants in the qualitative studies to improve validity; 
especially because I did not observe differences in explanatory value by weight status in Study 
4b which investigated the psychological impact of FTO feedback quantitatively.  However, 
trends were in the same direction as those from the qualitative studies and the discrepancy 
may be due to the small sample overall which meant that the power may not have been 
sufficient to detect differences in responses between participants.   
 
The numbers of overweight and obese individuals in study 4b were low (n = 34); making it 
difficult to draw conclusions.  Problems with participant retention had been expected because 
the study population was not particularly motivated, but this was made worse by the delays in 
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genotyping that were not in my control.  The delay meant that students were not reachable 
anymore, so personal reminders were also ineffective.  Furthermore, it may have caused 
individuals to be less cooperative when required to return the final questionnaire, contributing 
to the low response rates, as discussed in Chapter 7.  It would have been desirable to build on 
findings from the qualitative studies with a quantitative study with a larger number of 
overweight/obese individuals to investigate the ‘genetic confirmation’ hypothesis further.  If 
the search for ‘genetic confirmation’ was a motivation to seek testing that applies to a larger 
segment of the population, it would change the purpose of the genetic test from being 
‘predictive’ to ‘aetiological’ in terms of its interpretation by the individual, which might need 
to be considered in the debate about clinical utility of genetic testing for common complex 
conditions.  
 
It would have also been desirable to also include participants from different socioeconomic 
and ethnic groups. All the participants in my studies were highly educated and predominantly 
white, but attitudes towards genetic testing may differ among ethnic groups and across 
socioeconomic strata (Kaphingst et al., 2012).  The generalisability of my findings would have 
been improved if a wider variety of participants had been included.  Although the current 
findings replicate those from earlier studies and other areas of genetic testing (Bloss, Schork, 
& Topol, 2011b; Heshka, Palleschi, Howley, Wilson, & Wells, 2008; Conradt et al., 2009; 
Harvey-Berino, 2001), participants in these studies were also likely to have been ‘early 
adopters’ and therefore wealthier, better educated and with higher literacy levels than the 
general population (McGowan et al., 2010).  Few studies have investigated effects of genetic 
test feedback in more varied population groups (e.g.McBride et al., 2002; Lipkus et al., 2004), 
and although findings are comparable to others (e.g. improvements in smoking cessation rates 
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in the short-but not the longer-term), the limitations of self-selection/early adopters may also 
apply in these samples.   
 
The studies in this thesis concerned with genetic test feedback were all cross-sectional, so that 
inferences about longer-term impact cannot be made.  Ideally, participants would have been 
followed up over a longer period of time to explore whether reactions to their result changed, 
but this was not possible because of the time constraints of the PhD. 
 
10.2 Motivational and behavioural impact of FTO genetic test feedback 
The second set of questions I tried to answer was ‘What is the impact of genetic test feedback 
for weight gain susceptibility on motivation to avoid weight gain or to lose weight? Does it 
enhance or decrease motivation to control weight? Does the effect depend on genetic risk 
status? Does the effect depend on current body weight?’ 
 
The results of the vignette study had indicated that motivation to prevent weight gain or to 
initiate weight loss in response to receiving FTO feedback would be high regardless of weight 
status, but would be higher in response to a higher risk result.  These findings were supported 
in the studies giving ‘real’ feedback.  In particular, results of the RCT (Study 4) showed that 
adding genetic test feedback to weight control advice increased weight control intentions in 
participants who received feedback and advice, compared with those receiving weight control 
advice alone.  Within the feedback group, receiving higher risk genetic test feedback was more 
motivating than receiving lower risk, or no feedback; matching predictions from traditional 
Health Behaviour Models (Rosenstock, 1974) rather than those of illness perception models 
(Leventhal, 1997).  Although the effects in response to the feedback were overall modest, and 
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smaller than anticipated in the vignette study, this may be due to people overestimating the 
impact of events in hypothetical scenarios; expecting generally a stronger emotional reaction 
than they will actually have (Persky et al., 2008; Armor et al., 2006;Ajzen et al., 2004).  
Furthermore, most students who participated in the RCT had very low motivation to control 
weight (because most of them were normal weight), which may have contributed to the small 
effect size.   
 
Importantly, findings from the RCT showed that receiving lower risk TT feedback did not result 
in a decrease in motivation to avoid weight gain, with weight control intentions identical to 
those of receiving no genetic feedback.  These findings further support the idea that lay beliefs 
about disease onset are multifactorial, and less genetically deterministic than predicted by 
some; although it is important to note that the information provided to participants clearly 
outlined the multifactorial causes of unhealthy weight gain and was reiterated at various time 
points throughout the study which may have influenced participants’ deterministic beliefs.  
However, because findings from the studies presented here are in agreement with previous 
studies (e.g. Hollands et al., 2012; Bloss et al., 2011; Sanderson et al., 2008), they are likely to 
have some validity.  Furthermore, there was no indication that overweight/obese individuals 
would disengage with efforts at weight control in response to a higher risk genetic test result 
(which might have been assumed following deterministic predictions).  As discussed earlier, 
findings indicated that public confirmation of private assumptions about weight from a source 
perceived as ‘objective’ helped to alleviate some of the internalized stigma of obesity and 
shifted individuals’ focus toward taking action.  Considering that individuals did not enrol 
specifically in a weight loss intervention this is encouraging; although the small sample size of 
overweight and obese individuals limits any general conclusions.  
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The motivational effect of FTO genetic test feedback described here cannot be viewed in 
isolation, but has to be interpreted in conjunction with my third and fourth set of research 
questions: Is FTO status associated with weight gain at university? Will returning genetic test 
feedback alongside weight control advice be effective at diminishing weight gain during this 
time period? Will awareness of genetic risk status result in behaviour change? 
 
I found that, despite low follow-up rates and a highly selected sample, FTO status is associated 
with clinically significant weight gain at university, which would warrant risk-stratified 
intervention at this time.  However, unfortunately, the answer to the question of whether or 
not gene test feedback had a behavioural effect was ‘No’.  Although the intervention was 
successful in increasing weight control intentions, it had no impact on actual behaviour, or on 
weight change.   There may be several reasons for these negative findings.  First, behaviour 
change is complex and results from a multitude of factors, some of which are still not very well 
understood (Michie et al., 2009).  Therefore, it would have been surprising if adding a single 
piece of information would have had enough impact to alter behaviour to any great extent; 
particularly, if disease representations are multifactorial.  However, if there is a ‘tipping point’ 
for  action, it is reasonable to aim at ‘edging’ people to that tipping point and Study 4 has 
shown that returning genetic test feedback for risk of weight gain may be one way of 
achieving this.   
 
A second reason is that the participants in this study were young, healthy individuals not 
particularly concerned about weight gain, and therefore they may have seen little need to take 
immediate action at weight control; hence no effects on actual behaviour change.  It is 
Chapter 10: Discussion and Conclusion 
 
250 
 
possible that people will keep their result in mind and take action quicker than they would 
have otherwise once they begin gaining weight, as participants also reported in Study 4b that 
higher risk FTO feedback would make them think about their future health. However, the one-
year follow-up results from Bloss and colleagues’ study which recently became available 
(Bloss, Wineinger, Darst, Schork & Topol, 2013), found no differences in anxiety, diet or 
exercise behaviours between baseline and follow-up.  The only effect was that participants 
were more likely to have shared their results with a physician, which resulted in more 
screening tests than reported in the short-term; especially in participants over 40 years old.  
This suggests that people may act on their test results once they feel it necessary, but as these 
are findings from a single study, results have to be viewed with caution.  In the present study, 
it would have been valuable if I had been able to follow up participants for an extended period 
of time to ascertain whether awareness of FTO status would prompt earlier action.  
 
One issue discussed in relation to Study 4 (p. 215), is that it is possible that the weight control 
leaflet was ineffective.  As the students in the study did not specifically enrol in a ‘weight 
control intervention’, nor were they explicitly encouraged to follow the tips, the intensity of 
the intervention might not have been sufficient.  Weight gain prevention studies in this age 
group have usually only been effective if they are very time- and resource intensive (e.g. 
weekly courses), as discussed in Chapter 2.  It would have been interesting to offer an 
intervention with proven efficacy, but in that case, participation would have depended on 
interest in weight loss, and the potential value of a‘light touch’ prevention would be lost.  I 
was also able to explore the effects of ‘self-motivation’ in response to FTO genetic feedback, 
which would not have been possible with a more structured intervention.   
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One limitation of all studies in this thesis was that genetic test feedback was given for a single 
gene implicated in a complex condition.  As discussed above, any significant reaction (positive 
or negative) could be deemed inappropriate as the effect size is so small.  This scenario is 
highly unlikely in clinical practice because steadily falling sequencing costs now allow for 
sequencing of gene panels, and most likely, whole genome sequencing in the foreseeable 
future, so that participants may assign a different meaning to these results. However, when 
this study was conceived (2008) the dramatic fall of sequencing costs was not predicted; 
therefore, studies presented here only focused on FTO and therefore, can only serve as a 
proof-of-principle investigation.  A further shortcoming is that we did not provide participants 
with much specific information on how to counteract FTO’s effects, as there have been no 
tests of the type of advice that would help to counteract the probable behavioural 
mechanisms of low satiety sensitivity and high food responsiveness.  Advice tailored to the 
individual genotype result may have had a greater impact than generic weight control advice, 
but this hypothesis remains to be explored in further research.   
 
10.3 Implications for clinical practice 
Findings from the current thesis may have some implications for clinical practice; bearing in 
mind the many limitations discussed above; particularly, that studies in this thesis used only a 
single marker with modest effect size to assess weight gain susceptibility and the highly 
selected samples.   
 
Results of the studies presented here showed that knowledge of genetic risk may be beneficial 
for individuals who have difficulties with weight control by diminishing negative emotions 
associated with this problem.  The ‘scientifically objective’ genetic test result was perceived as 
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removing some of the stigma and shame attached to weight gain, permitting dialogue about 
the ‘condition’.  Therefore, it might be useful to include genetic test feedback as one 
component of weight loss intervention packages.  However, if genetic feedback was offered in 
a clinical context, it would be crucial to determine beliefs about risk status beforehand to 
avoid negative impact.  
 
Secondly, as demonstrated in the studies presented here, and in all other studies concerned 
with the psychological and behavioural effects of genetic test feedback, impact (positive or 
negative) appears to be much less than anticipated; suggesting that deterministic beliefs about 
disease development are not widespread and most people are unlikely to overestimate the 
predictive value of genetic tests; especially when feedback is concerned with a single gene 
implicated in the development of a complex condition.  However, instead of dismissing genetic 
test feedback for behaviour change because these early studies have had little impact, we 
need to continue improving our understanding of how individuals make sense of and use their 
genetic data to discover how to best harness the potential of this new and exciting technology.  
 
10.4 . Conclusion 
Results from this thesis indicate that FTO genetic test feedback for weight gain susceptibility 
has little adverse psychological impact and may be beneficial for overweight and obese 
individuals by diminishing stigma and self-blame.  Furthermore, normal weight individuals 
appreciated the information about their risk of weight gain, and FTO feedback was successful 
in increasing their readiness to change behaviour.  Based on results of the current thesis it 
would also be expected that FTO feedback is be especially useful for normal weight women 
with a family history of obesity who receive AA feedback; although the studies here were not 
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sufficiently powered to draw firm conclusions. However, although FTO feedback was effective 
in increasing weight control intentions, it had no impact on behaviour change.  Although the 
many limitations of the studies presented here have to be kept in mind, in particular the often 
small and highly selected sample sizes and the cross-sectional nature, findings are in 
agreement with those obtained from other studies in the field which increases confidence.  
With whole genome sequencing on the horizon, we need to continue to improve our 
understanding of how individuals ‘make sense’ of genetic risk to successfully harness the 
potential of genomic medicine to influence health behaviour change.  
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Chapter 12:  Appendices 
12.1 Appendix 1: Tables of studies discussed in the Literature reviews  
Literature Table FTO review, Chapter 1 
Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
FTO and measured 
food intake 
     
Cecil et al (2008) Measured ad-
libitum food intake 
at a test meal 
containing a 
selection of sweet 
and savoury foods 
after preloads of 
varying energy 
density 
Foods weighed 
before and after 
consumption, 
caloric value 
calculated 
Children with at 
least one higher risk 
FTO allele ingested 
food with 
significantly higher 
energy density, but 
not higher weight, 
than children with 
the lower risk 
genotype after 
receiving the no 
energy and low 
energy preload, 
with a similar trend 
for the high energy 
preload.  This effect 
remained significant 
76 schoolchildren 
aged 4-10 years 
Experimental 
Preload conditions 
high-energy (389kcals), low 
energy (187 kcals), no 
energy (water)  
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Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
after controlling for 
age and BMI.  
 
Wardle, Llewellyn, 
Sanderson & Plomin 
(2008) 
Association of FTO 
and eating in the 
absence of hunger 
Biscuits consumed 1 
hour after a meal.  
Plate weighed 
before and after 
consumption 
Food intake was 
significantly higher 
in children carrying 
one or two higher 
risk alleles than in 
children 
homozygous for the 
lower risk allele; 
following a linear 
trend.  Results 
remained significant 
after adjusting for 
BMI.  
 
131 children aged 4-
5 years 
Experimental 
Home-based 
Children could eat as much 
as they liked for 10 min. 
Dougkas, Yaqoob, 
Givens, Reynolds & 
Minihane (2013) 
Measured ad 
libitum food intake 
after preload (201 
kcal or water)in 
overweight 
individuals 
Appetite and 
hunger rated on 
VAS; foods weighed 
before and after 
lunch; KJ calculated.  
Significantly lower 
reports of fullness 
and higher hunger 
after preload in 
carriers of at least 1 
A allele, but no 
difference in energy 
intake 
40 overweight men 
from gen pop, mean 
BMI 32.1, SD = 9.1 
Randomised with-in subject 
experimental cross-over 
design 
Preload: 3 types of different 
dairy snack, given to each 
participant one wk apart 
 
 
FTO and -self-reported 
food intake 
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Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
Children and adolescents      
Liu (2010) Assoc of FTO with 
insulin resistance, 
energy intake, PA 
Up to 7 24h diet 
recalls , PA self-
report, fat, BMI w 
DXA 
No significant 
association w FTO 
and energy intake, 
PA, no insulin 
resistance and 
%body fat 
1978 youth (mean 
age 16.5 y) ,  
Cross-sectional 
Johnson et al (2009) Assoc of FTO and 
dietary energy 
density 
3-day unweighed 
diet diaries, 
completed by 
children w parental 
help when aged 10 
No evidence for 
assoc of FTO w 
dietary energy 
density at age 10 w 
fat mass at 13 
2275 children from 
ALSPAC 
Cross -sectional 
Timpson et al. (2008) Association of FTO 
and dietary intake  
Detailed 3-day 
parent completed 
dietary records 
Per higher risk allele 
significantly higher 
consumption of 
total fat (1.5g 
higher/day) and 
energy (25kj/day).  
Difference persisted 
after adjusting for 
BMI 
3641 children from 
ALSPAC 
Diet diaries 3 day unweighed 
food records, incl portion 
sizes, and preparation 
methods 
Adults      
Park et al. (2013) FTO and energy 
intake in multiple 
racial/ethnic 
populations 
FFQ, 180 items, incl. 
portion size for 
MEC, EAGLE:24 
hour 24 hour 
dietary recall 
Sig higher intake of 
calories from fat, 
but no assoc w 
energy intake 
36973 adults from 
the MEC,  EAGLE-
NHANES III and 
PAGE studies, BMI 
~26.1 
Cross-sectional 
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Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
Brunkwall et al (2013) FTO and food 
preferences  
7-day menu book, 
168 item FFQ and 
Interview-based 
diet history, 7-day 
self-report 
Sig higher intake of 
protein in AA 
carriers, sig higher 
intake of cals in AA 
28098 adults, mean 
BMI ~25.6.  
Cross-sectional 
Interview and menu book 
incl portion size, calculate 
daily calorie consumption 
McCaffery et al (2012) Discover assoc of 
obesity 
susceptibility loci 
(incl FTO) and 
dietary intake 
FFQ, 134 main 
items, 20 line items 
can be added 
Sig higher intake of 
calories in AT/AA 
carriers and more 
eating episodes/day 
but diminished after 
adjustment for 
weight 
2075 participants in 
the LOOK AHEAD 
trial, all overweight 
or obese (mean BMI 
= 36, SD = 5.9) Mean 
intake 2000 kcals 
over 4.7 meals 
Assesses food intake over 
previous 6 months portion 
size included (small, 
medium, large) 
Hasselbalch et al (2010) Investigated assoc 
of FTO and MC4R 
and dietary intake 
247 item FFQ 1 
month recall  
No association of 
FTO with habitual 
dietary intake 
756 adult twins from 
the GMINAKAR 
study cohort, mean 
BMI 27  
Cross-sectional, FFQ 
validated against 2-d 
weighed food records  
 
Holzapfel at al. (2010) Associations of 
obesity genes with 
lifestyle factors (diet 
and PA) 
FFQ with focus on 
fat and carbs, self-
reported physical 
activity 
No association for a 
direct lifestyle SNP 
association 
12462 adults from 
the MOINICA/KORA 
study, , mean BMI 
26.9.4.9  
Cross-sectional 
 
Bauer et al. (2009) Association of 
obesity genes and 
energy-and 
macronutrient 
intake 
178-item FFQ daily 
consumption during 
year preceding 
enrolment; portion 
sizes included 
No association of 
FTO and food intake 
1700 adults from the 
EPIC-DUTCH cohort, 
BMI 25.9, SD = 4.02 
Cross-sectional Portion sizes 
assessed w pictures, 
calculate average daily 
calorie consumption  
Sonestedt et al (2009) Investigate whether 
FTO assoc with 
dietary factors and 
7-day menu book 
and 168-item FFQ, 
PA: Minnesota 
FTO higher risk 
allele effect on BMI 
only observed in 
4839 adults from the 
Malmö study, mean 
BMI ~25.8.  
Cross-sectional 
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Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
PA Leisure Time 
Physical Activity 
Instrument 
individuals w higher 
fat diet and lower 
carb intake and 
restricted to those 
w low leisure time 
PA 
 
Speakman, Rance & 
Johnstone (2008) 
Discover whether 
FTO associated w 
variations in energy 
intake or 
expenditure 
7-day diary, 
weighed food 
records and kept 
packaging; BMR and 
VO2 max for energy 
expenditure 
FTO genotype sig 
assoc w variation in 
energy intake TT: 
9.0MJ/day; AT: 
10.2MJ/day; AA: 
9.5MJ/day. No 
variation in energy 
expenditure 
150 White adults , 
BMI from 16.7-49.3 
Cross-sectional 
 
 
 
 
     
FTO and eating 
behaviours 
     
Satiety sensitivity 
 
     
Karra et al (2013) Link between FTO, 
ghrelin, BMI 
Test meal protocol, 
appetite assessed 
with VAS before, 
20, 30 min after 
AA homozygotes 
failed to suppress 
circulating levels of 
acetyl-ghrelin 
359 males aged 18-
35, normal weight 
(BMI 22.5, SD = 0.1)  
10 were selected, 
experimental 
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Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
meal ingestion and 
every 30 min after 
until 180min after 
appropriately in 
response to the test 
meal and levels 
remained elevated 
for the duration of 
the study period.  
Correspondingly, AA 
participants also 
reported 
significantly higher 
levels of hunger 
after meal 
termination and for 
the remainder of 
the study period 
than TT 
homozygotes.   
 
 
matched and 
consumed test meal 
Ibba et al (2013) Assess influence of 
FTO on satiety 
sensitivity 
CEBQ No sig assoc of 
CEBQ Satiety 
Sensitivity scale and 
FTO genotype 
412 obese Sardinian 
children and 
adolescents aged 4-
20 years 
Cross-sectional 
Den Hoed, Westerterp-
Plantenga, Bouwman, 
Mariman, & Westerterp, 
2009; 
Assess FTO and 
satiety 
responsiveness 
Rate hunger and 
satiety on VAS 
before and after 
consumption of a 
fixed meal 
Carriers of at least 1 
A allele significantly 
higher hunger and 
reduced satiety 
after meal 
103 adults, mean 
age 31, BMI 25  
Experimental  
Fixed meal protocol 
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Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
consumption 
 
 
Wardle et al., 2008 Assoc of FTO with 
habitual appetitive 
behaviour 
CEBQ AA sig reduced 
satiety 
responsiveness 
scores 
3337 children aged 
8-11 from TEDS 
Cross-sectional 
Tanofsky-Kraff (2009) FTO and eating 
behaviours (incl. 
binge eating) 
Ad libitum lunch 
after 6 hr fast, EDE, 
rate hunger and 
satiety on VAS 
No sig differences in 
satiety 
responsiveness at 
ad libitum, lunch but 
sig higher rates of 
LOC eating episodes 
in carriers of at least 
1 A allele 
Also select foods 
higher in fat, no diff 
in cals 
 
289 children and 
adolescents aged 6-
19 years , normal 
weight , 190 
participated in the 
ad libitum lunch 
Experimental 
Aberrant eating 
behaviour 
     
Cornelis et al (2013) Assoc of FTO and 
other obesity susc 
loci w with 
uncontrolled eating, 
emotional eating 
and eating restraint 
TFEQ FTO sig assoc with 
all three aberrant 
eating behaviours, 
with each higher 
risk allele resulting 
in modestly 
increased scores 
3852 adults in mid-
sixties slightly 
overweight (mean 
BMI women: 25.9, 
SD: 5.1; mean BMI 
men: 25.3, SD = 3.1). 
Cross-sectional 
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Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
(~0.12-0.33) on each 
TEFQ subscale.  
However, only the 
association with 
cognitive restraint 
remained sig after 
adjustment with 
BMI and none of the 
associations 
survived 
adjustments for 
multiple testing. 
also the case for 
assoc of the gen risk 
score w aberrant 
eating and for any 
of the other SNPs 
investigated.  
 
Jonassaint et al (2011) Assoc of FTO and 
eating disorders 
SIAB and clinical 
interviews 
No sig assoc w AN 
irrespective of 
subtype 
1085 AN patients, 
677 HC, from 3 large 
clinical cohort 
studies 
Cross-sectional 
Mueller et al (2012) Assoc of FTO with 
eating disorders 
Clinical interviews, 
CIDI questionnaire 
Sig assoc of FTO 
with Bulimia 
Nervosa (BN) 
although only 
evident in 
477 participants 
with BN, 689 with 
AN, 984 non-
population healthy 
controls and a 
Cross-sectional 
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Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
comparison with the 
non-population 
based sample of 
controls.  
 
population sample 
of 3951 control 
participants 
FTO and physical 
activity 
     
Kilpeläinen et al (2011) Investigate 
influence of PA on 
FTO activity 
41 published 
studies, 13 
unpublished 
PA dic into ‘inactive’ 
vs.’active  
categorical: inactive 
< 1 hr. leisure time 
or commute + 
sedentary 
occupation; 
continuous: bottom 
20% ‘inactive’ 
PA sig attenuated 
the association of 
FTO with BMI, with 
the effect being 
reduced by 30% in 
physically active 
adults; odds of 
being overweight or 
obese were also 
significantly reduced 
in physically active 
individuals with the 
higher risk alleles 
(27% and 26%, 
respectively) 
218.166 adults and 
19.268 children 
Meta-analysis 
 
 
 
Appendix 1: FTO Information Leaflet 
 
306 
 
Review of psychological and behavioural outcomes of FTO genetic test feedback, Chapter 2 
Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
Psychological 
outcomes 
     
Fatalism      
Senior et al (1999) to describe parents' 
perceptions of familial 
hypercholesterolaemia 
(FH), an  
inherited 
predisposition to heart 
disease, following 
population-based 
neonatal screening 
Qualitative interviews 
questions about beliefs 
about high cholesterol 
in children; based on 
the self-regulation 
model of illness 
perceptions As the 
interview was designed 
to elicit perceptions of 
the screening test, 
rather than elicit 
perceptions of genetic 
testing, perceptions of 
genes were only 
explored if participants 
raised them first. 
found that parents felt 
the condition was 
more dangerous and 
less controllable when 
they thought of the 
result as genetic 
rather than related to 
the mother’s diet 
during pregnancy.   
24 parents of infants 
aged 15-30 months 
qualitative 
 
Wiggins et al (1992) To investigate psych 
effects of testing for 
Huntington’s disease 
Standardised 
questionnaires 
assessing distress, 
depression, well-being 
Decreased risk lower 
scores for distress 
than before testing 
increased risk, no 
change at first, but 
over the year small 
linear declines in 
135 participants longitudinal  
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Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
distress and increases 
in well-being.  At 12 
mo. Both increased 
and decreased risk 
group had lower 
scores on depression 
and higher scores for 
well-being than no-
change group. 
 
  
Heshka et al (2008) Psychological 
outcomes of genetic 
testing for 
nonpolyposis 
colorectal carcinoma, 
hereditary breast and 
ovarian cancer, and 
Alzheimer’s disease 
5 databases searched, 
terms related to genes, 
testing psych impact  
No long-term impact 
on affect, increased 
screening for breast 
and crc, no impact on 
risk perceptions 
35 articles, 30 studies Review  
 
False reassurance 
     
Sanderson & Wardle 
(2005) 
explored factors 
associated with a 
motivated or a 
complacent reaction 
to genetic testing for 
risk of heart disease or 
cancer 
Vignette study  
Single statement for 
each reaction of 
interest (motivation, 
complacency, and 
depression),  perceived 
family history, 
majority of smokers 
anticipated to find a 
high-risk result more 
motivating for 
smoking cessation 
than a result showing 
no increased risk.  
186 smokers Cross-sectional 
survery 
Appendix 1: FTO Information Leaflet 
 
308 
 
Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
dispositional 
pessimism, desire to 
quit smoking, level of 
nicotine addiction, and 
understanding of 
genetic testing. 
Over one third of the 
sample (39%) thought 
it safe to carry on 
smoking if they 
received a negative 
result.  Out of those 
participants who 
thought that it was 
safe to carry on 
smoking, a higher 
percentage had less 
formal education and 
less understanding of 
genetic testing, in 
addition to a lower 
desire to quit and not 
falling into the middle-
age category.  
However, in 
multivariate analyses, 
only age and level of 
education were 
maintained. 
Frosch et al (2005) assess anticipated 
consequences of 
genetic test feedback 
for obesity risk 
Vignette study two 
(hormone test vs. 
genetic test) by two 
(high-risk vs. low-risk) 
design; participants 
High-risk feedback led 
to increased 
intentions to eat a 
healthy diet, 
regardless of feedback 
249 Cross-sectional 
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Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
received one of the 
four vignettes in 
random order.  
Measures: intentions 
to eat a healthy diet, 
attitudes, perceived 
behavioural control, 
perceived social norms, 
and expectations about 
benefits of eating a 
healthy diet 
type.  Individuals 
receiving high-risk 
genetic feedback felt 
less in control than 
those receiving 
average feedback, 
whereas in hormone 
group: opposite 
pattern. Intentions to 
eat a healthy diet high 
when perceived 
control high, 
independently of risk 
status or feedback 
type.  Having higher 
BMI was not related 
to feedback status 
although intentions to 
eat a healthy diet 
were relatively low. 
Individuals who 
scored low on 
perceived behavioural 
control imagining not 
having the high-risk 
gene combination for 
obesity reported less 
intention to eat a 
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Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
healthy diet.   
Stigma      
Conradt et al (2007) Impact of gen 
feedback in weight 
loss programme 
Measurements 
included restraint 
eating, body 
acceptance, feelings of 
guilt, self-efficacy, and 
affect.   
The inclusion of 
genetic information 
led to a significant 
increase in genetic 
causal attributions of 
obesity in individuals, 
and those who also 
had a family history of 
obesity suffered from 
less negative affect 
after six months.  
Feelings of guilt were 
also reduced in the 
short-term, although 
this had disappeared 
at follow-up. 
 
147 obese individuals 
who took part in a 
weight loss 
programme 
Longitudinal, 6 mo 1 
yr FU 
Behaviour change      
Smoking cessation      
Lerman et al (1997) 
Audrain et al (1997) 
impact of genetic test 
feedback on smoking 
cessation 
assigned to receive 
counselling only, 
counselling and 
biomarker feedback or 
counselling, biomarker 
feedback and genetic 
test feedback 
Feedback was 
successful in elevating 
perceived risk, 
perceived quitting 
benefits but also 
increased worry about 
lung cancer.  No 
427 smokers Longitudinal, 2 mo, 6 
mo, 12 mo FU 
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Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
differences between 
groups in cessation 
rates and number of 
cigarettes smoked per 
day.at two-month 
follow-up  After one 
year, however, 
participants receiving 
genetic test feedback 
in addition to 
counselling had made 
more quit attempts 
and were more 
motivated to quit than 
those only receiving 
counselling, although 
no differences in 
actual quit rates 
emerged 
McBride et al (2002) Whether gene 
feedback could 
motivate smoking 
cessation 
used genetic feedback 
in addition to a 
smoking cessation 
intervention 
quit rates were nearly 
doubled at the six-
month follow-up.  19% 
versus 10%, 
respectively; at 6 
months but not at 12 
months There were no 
increases in perceived 
risk or distress among 
316 African-American 
smokers 
Longitudinal, 6 mo 
and 12 mo FU 
Appendix 1: FTO Information Leaflet 
 
312 
 
Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
participants.  
However, quit rates 
were high regardless 
of ‘high-risk’ or ‘low-
risk’ genetic status for 
the GSTM1 gene. 
Sanderson et al 
(2008) 
Gene feedback 
motivates smoking 
cessation? 
smoking related 
outcomes, perceived 
risk and self-efficacy 
were also assessed 
smoking cessation 
rates increased 
significantly one week 
after providing 
individuals with 
feedback for the 
GSTM1 gene, 
compared with 
control participants 
(35 % vs. 0%).  
However, the effect 
was no longer evident 
after the two-month 
follow-up 
61 smokers RCT, 2 mo FU 
 
Hishida et al (2006) 
 
Gene feedback to 
motivate smoking 
cessation? 
 
Workplace 
intervention feedback 
vs. not 
 
At one-year follow-up 
fewer people in the 
intervention arm had 
quit than in the 
control group (15 vs. 
22 participants).  
However, negative 
 
562 smokers 
 
RCT, 1 y FU 
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Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
outcomes of gene 
feedback were also 
not reported.  
 
 
Ito et al (2006) 
 
Gene feedback to 
motivate smoking 
cessation? 
 
Attendees of a cancer 
centre, assess smoking 
status 
 
There were no 
significant differences 
in quit rates between 
the groups; neither at 
three-, nor at nine 
months; although 
there was a trend for 
quit rates to be higher 
in participants 
receiving gene 
feedback.   
 
 
617 smokers 
 
RCT, 3 mo and 9 mo 
FU 
Diet and exercise 
behaviours 
     
Harvey Berino et al 
(2001) 
whether genetic 
testing would diminish 
self-efficacy and 
feelings of control 
over eating 
Diet self-efficacy was 
measured with the 
Eating Self Efficacy 
Scale (Poston, 1997), 
and four statements 
assessed potential 
responses and beliefs 
about the effect of 
having an ‘obesity 
Feedback status had 
no impact on diet self-
efficacy, confidence in 
the ability to lose 
weight, or attitudinal 
variables.  Contrary to 
expectations, 
individuals who tested 
positive for the b3AR 
30 postmenopausal 
obese women 
Cross-sectional 
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Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
gene’.  Diet and weight 
history were assessed 
via self-report. 
gene reported more 
confidence in the 
ability to overcome 
genetic 
predispositions with 
the right lifestyle 
choices 
Hicken and Tucker 
(2002) 
whether a positive test 
result for the fictitious 
‘Asch syndrome’ 
would affect 
individuals’ dietary 
behaviour. 
‘family history’ assessm 
ent, health behaviours, 
perceived risk for 
getting ‘Ash 
syndrome’, told soy 
would make it better 
no differences 
between the groups 
emerged in intended 
soy consumption or 
dietary fat reduction 
115 participants, 
particpants whose 
‘family history’ 
supported Ash 
syndrome, 2 groups 
higher and lower risk 
gene feedback 
RCT  
Marteau et al (2004)  Impact of gene 
feedback for FH on 
health behaviours 
randomly assigned to 
receive either a routine 
clinical diagnosis or the 
routine diagnosis and 
genetic test results.  
perceptions of control 
over FH, cholesterol 
and heart disease, and 
fatalism about FH, 
which were assessed 
with the respective 
scales of the Illness 
Perception 
Questionnaire-Revised 
No effect of feedback 
was observed on 
perceived control on 
any of the tested 
variables, and neither 
was there an increase 
in fatalism. 
341 individuals w FH, 
128 affected relatives  
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Study Summary Outcome measures 
and how assessed 
Main findings Sample description Design 
(Moss Morris, 2002), 
Grant et al (2013) whether returning 
genetic feedback 
about diabetes would 
improve outcomes in a 
12-week validated 
diabetes prevention 
programme 
self-reported attitudes, 
program attendance, 
and weight loss, 
separately comparing 
higher-risk and lower-
risk result recipients 
with control 
participants. 
No significant diff 
between either 
higher-or lower risk 
participants with 
control participants in 
any of the outcome 
variables  
102 overweight adults 
at high risk of diabetes 
Longitudinal, 12 wkFU 
Hollands et al (2012) Whether genetic 
susceptibility feedback 
and FH assessment for 
Crohn’s would 
motivate smoking 
cessation in a sample 
of individuals with first 
degree reslatives with 
Chrohn’s disease more 
than receiving only FH 
assessment  
The primary outcome 
was smoking cessation 
for 24 hours or longer, 
assessed at six months 
No effect on smoking 
cessation, or quit 
attempts  
497 smokers, relatives 
of individuals w 
Chrohn’s 
RCT 
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12.3 Appendix 3: Ethics approval letters 
 
Approval letter Study 2 
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Ethics approval letter Amendment for Study 2b 
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Ethics Approval letter Study 3 
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Ethics Approval letter Study 4 
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12.4 Appendix 4: Information sheets and Consent Forms 
 
Information sheet and Consent Form for Studies 2 and 2b – these were identical 
 
Information Sheet for Participants in Research Studies 
 
You will be given a copy of this information sheet. 
 
Title of Project in lay terms:   
Reactions to Genetic Testing for Risk of 
Overweight 
This study has been approved by the UCL Research Ethics 
Committee [Project ID Number 2471/001]:  
Health Behaviour Research 
Centre 
Department of Epidemiology 
and Public Health 
University College London 
1-19 Torrington Place, Room 
203 
London WC1E 6BT 
 
T:+44 (0)20 7679 8306 
F:+44 (0)20 7679 8354 
Email:  
 
Susanne Meisel 
PhD Student 
Health Behaviour Research Centre 
Department of Epidemiology and Public Health 
University College London 
1-19 Torrington Place, Room 208 
London WC1E 6BT 
 
T: +44 (0) 20 7679 1723 (direct line) 
F: +44 (0) 20 7679 8354 
Email:  
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Aims of the research and possible benefits 
 There is considerable evidence that becoming overweight has a genetic 
component. The aim of the study is to explore reactions to genetic test feedback 
for risk of overweight. 
 Results from this study will help inform the debate about psychological effects of 
genetic tests. Furthermore, the results will help us to determine whether genetic 
testing for risk of overweight can be useful in combination with weight control 
advice.  
 
What will be involved if you decide to participate? 
 We will determine your genetic susceptibility to overweight by analysing DNA 
taken from saliva (by spitting into a test tube). We will then ask you some 
questions about your thoughts and your feelings after you receive your test result 
in a recorded telephone interview. The interview will last about 20 minutes, 
depending on your availability, and on how much information you would like to 
provide us with.  
 It is important to note that genetic testing will only be done for one gene that 
makes a small contribution towards your susceptibility to overweight; it will not 
look at genetic markers for other diseases (such as Alzheimer’s or breast cancer).  
 
Are there any risks involved if you choose to participate? 
 Some people could be upset by the test result, although in other studies related 
to genetic test feedback and cancer this was not the case. If you were upset, 
Susanne Meisel and Professor Wardle, who is also a clinical Psychologist, will be 
available to support you.  
 
What are possible benefits for you as a participant? 
 One possible benefit for you as a participant is knowledge of your genetic status 
on the FTO gene which is linked to overweight. 
 You will receive detailed information from the charity Weight Concern on how to 
keep a healthy weight. 
 You will also receive a copy of the final research report.  
 
Arrangements for ensuring anonymity and confidentiality  
 We will hold your demographic information, such as date of birth, and your test 
result which will be stored anonymously. In the transcripts we will use initials, so 
you will not be identifiable; this will also be the case for any statements that will 
be included in the final report.  
 With your consent, recorded interviews will be transcribed (written up) and the 
tape will then be wiped clear  
 Your saliva sample will be discarded after DNA analysis.  
 Only the researchers immediately involved in the research (Susanne Meisel and 
Professor Wardle) will have access to the full results.  
 All data will be kept confidential and stored in accordance with the Data 
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Protection Act.  
 
 It is up to you to decide whether to take part or not. If you decide to take part 
you are still free to withdraw at any time and without giving a reason.   
 
 A decision to withdraw at any time, or a decision not to take part, will not affect 
the standard of education you receive. 
 You may withdraw your data from the project at any time up until it is 
transcribed for use in the final report by October 2013. 
 If you agree to take part, you will be asked whether you are happy to be 
contacted about participation in future studies. Your participation in this study 
will not be affected should you choose not be re-contacted. 
 If you decide to take part, you will be given this information sheet to keep and be 
asked to sign a consent form. 
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Informed Consent Form for Students in Research Studies 
Please complete this form after you have read the Information Sheet and/or listened to an 
explanation about the research.  
 
Title of Project:   
Interest and attitudes towards genetic testing for obesity 
risk- an interview study 
This study has been approved by the UCL Research Ethics Committee [Project ID 
Number: 2471/001 ] 
 
 
Thank you for your interest in taking part in this research. Before you agree to take 
part the person organising the research must explain the project to you. 
 
If you have any questions arising from the Information Sheet or explanation already 
given to you, please ask the researcher before you to decide whether to join in.  You 
will be given a copy of this Consent Form to keep and refer to at any time.  
 
 
Participant’s Statement  
 
I ……………………………………………………………. 
 
• I have read the notes written above and the Information Sheet, and understand 
what the study involves.  
 
• I understand that participation involves taking a DNA test exclusively for the risk 
of becoming overweight.  
 
• I understand that if I decide at any time that I no longer wish to take part in this 
project, I can notify the researchers involved and withdraw immediately.   
 
• I consent to the processing of my personal information for the purposes of this 
research study.  
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• I understand that such information will be treated as strictly confidential and 
handled in accordance with the provisions of the Data Protection Act 1998.  
 
• I understand that my participation will be taped/video recorded and I am aware 
of and consent to, any use you intend to make of the recordings after the end of 
the project.  
 
• I agree that my non-personal research data may be used by others for future 
research. I am assured that the confidentiality of my personal data will be upheld 
through the removal of identifiers.  
 
• I agree that the research project named above has been explained to me to my 
satisfaction and I agree to take part in this study.  
 
• I agree to be contacted in the future by UCL researchers who would like to invite 
me to participate in follow-up studies.  
 
 Signed: Date: 
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Information sheet and Consent form for Study 3 
C10 
Information Sheets And Consent Forms 
 
 
 
Information Sheet for Students in Research Studies 
 
You will be given a copy of this information sheet. 
 
Title of Project in lay 
terms:   
Associations between genes and body fat at the first 
year of college 
This study has been approved by the 
UCL Research Ethics Committee [Project 
ID Number 2471/001]:  
Professor Jane Wardle 
HBRC, UCL Epidemiology & 
Public Health, 
UCL, Gower Street 
London 
WC1E 6BT, UK 
Office: Room 203, 1-19 
Torrington Place, London 
WC1E 6BT 
Telephone: 
+44 (0)20 7679 8306 
Internal: x48306 
Fax: 
+44 (0)20 7679 8354 
Email:  
 
Susanne Meisel 
PhD Student 
Health Behaviour Research Centre 
Department of Epidemiology and Public Health 
University College London 
1-19 Torrington Place, Room 208 
London WC1E 6BT 
 
T: +44 (0) 20 7679 1723 (direct line) 
F: +44 (0) 20 7679 8354 
Email:  
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important to read the following information carefully and discuss it with others if you 
wish.  Ask us if anything is not clear or if you would like more information.  
 
Aims of the research and possible benefits 
 There is evidence that body fat is in part genetically determined, and one gene in 
particular – the FTO gene – has been linked with slightly higher body fat (equivalent 
to 5 lbs in weight) 
 When young people go to university, some of them increase their body fat 
 We are interested in testing a large sample of new students for the FTO gene and 
another gene with smaller effect to see if these genes are related to the tendency 
to gain body fat when people move into this new environment 
 The results from this study may help identify health advice to reduce risk of body 
fat gain 
 
What will be involved if you decide to participate? 
 Participation will involve four things: i) assessment of body fat, ii) DNA collection 
and analysis, iii) filling out a questionnaire now and iiii) in 6 months time. 
 
Assessment of body fat:  
 Body fat is measured with a special scale. You will be asked to remove heavy 
garments (coat, belt) as well as your shoes and socks, but stay otherwise fully 
clothed.  You will stand on the Tanita body fat scale for a few minutes. The scale 
will have an antibacterial gel in the area you place your feet.  It works through 
bioelectrical impedance which involves a very low, safe current being sent through 
your body.  Most people don’t feel anything, although a few a slight tingling in 
hands and feet; but it is not painful or harmful in any way. This method is 
considered the most convenient way of assessing body fat and versions of the 
Tanita body fat scales are available in shops. 
DNA Collection  
 DNA for analysis of genes is collected with a saliva sample. This involves ‘drooling’ 
1.5-2.0 ml of saliva into a plastic collection tube.  This is painless.  
 It is important that you don’t eat, drink (except water), smoke, or brush your 
teeth for one hour before saliva collection.  
 The DNA will be extracted from the saliva in the laboratory and we will carry out 
genetic testing for genes related to body fat.  The samples will not be used to test 
for genetic markers for any other diseases such as Alzheimer’s or breast cancer.  
You will be able to receive your result after 6 months if you wish, but you can also 
choose not to know.  
 
Questionnaire 
 We will ask you some questions on a computer about your eating habits, stress 
levels, physical activity levels and family history of overweight.  Filling out the 
questionnaire should take no longer than 20 minutes.  You can do it now, or if you 
don’t have time, we can email you the link to the questionnaire, and you can fill it 
out when it suits you.  
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Follow-up 
 After 6 months, we will email you another questionnaire to complete which will 
cover some of the same issues and we will invite you for a repeat assessment of 
body fat. The email will also remind you that your DNA results are ready for 
collection should you wish to know them.  
 
Your test result 
 You will be able to receive your test result either by email or over the phone as you 
choose, so that you have the opportunity to ask any questions. You will also receive 
the contact details of the researcher, should you have questions at a later stage. 
 
 
Are there any risks involved if you choose to participate? 
 During the assessment of body fat you might feel slight tingling in your hands or 
feet. Should that distress you, please let the researcher know, and we will 
terminate the assessment without any consequences for you.  
 Some people could be upset by the test result, although in other studies related to 
genetic test feedback for genes that only confer a low risk, this was not the case. If 
you are upset, Susanne Meisel and Professor Wardle (who is a Clinical 
Psychologist), will be available to support you.  
 
What are possible benefits for you as a participant? 
 One possible benefit for you is knowledge of your genetic status on certain genes 
involved in body fat development (FTO and SNP rs 17782313 near the MC4R gene) 
 You will receive an accurate assessment of your body fat percentage. 
 You will also receive a copy of the final research report.  
 
Arrangements for ensuring anonymity and confidentiality  
 We will store any information about you and your test result anonymously. We will 
store your email address separately from other information for future contacts.  
 Your saliva sample will be discarded after DNA analysis.  
 Only the researchers immediately involved in the research (Susanne Meisel and 
Professor Wardle) will have access to the full results.  
 All data will be kept confidential and stored in accordance with the Data Protection 
Act.  
 It is up to you to decide whether to take part or not. If you decide to take part you are still 
free to withdraw at any time and without giving a reason.   
 A decision to withdraw at any time, or a decision not to take part, will not affect the 
standard of education you receive. 
 You may withdraw your data from the project at any time up until it is transcribed 
for use in the final report by October 2011. 
 If you agree to take part, you will be asked whether you are happy to be contacted 
about participation in future studies. Your participation in this study will not be 
affected should you choose not be re-contacted. 
 
If you decide to take part in this study, you will be given this information sheet to keep 
and invited to sign a consent form. 
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Informed Consent Form for Students in Research Studies 
Please complete this form after you have read the Information Sheet and/or 
listened to an explanation about the research.  
 
Title of Project:   Interest and attitudes towards genetic testing for obesity 
risk- an interview study 
This study has been approved by the UCL Research Ethics Committee [Project ID 
Number: 2471/001 ] 
 
 
Thank you for your interest in taking part in this research. Before you agree to take 
part the person organising the research must explain the project to you. 
 
If you have any questions arising from the Information Sheet or explanation already 
given to you, please ask the researcher before you to decide whether to join in.  You 
will be given a copy of this Consent Form to keep and refer to at any time.  
 
Participant’s Statement  
 
I ……………………………………………………………. 
 
• I have read the notes written above and the Information Sheet, and understand 
what the study involves.  
 
• I understand that participation involves taking a DNA test exclusively for the risk 
of becoming overweight.  
 
• I understand that if I decide at any time that I no longer wish to take part in this 
project, I can notify the researchers involved and withdraw immediately.   
 
• I consent to the processing of my personal information for the purposes of this 
research study.  
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• I understand that such information will be treated as strictly confidential and 
handled in accordance with the provisions of the Data Protection Act 1998.  
 
• I understand that my participation will be taped/video recorded and I am aware 
of and consent to, any use you intend to make of the recordings after the end of 
the project.  
 
• I agree that my non-personal research data may be used by others for future 
research. I am assured that the confidentiality of my personal data will be upheld 
through the removal of identifiers.  
 
• I agree that the research project named above has been explained to me to my 
satisfaction and I agree to take part in this study.  
 
• I agree to be contacted in the future by UCL researchers who would like to invite 
me to participate in follow-up studies.  
 
 Signed: Date: 
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Information Sheet and Consent form Study 4 
C10 Information Sheets And Consent Forms 
  
 
Information Sheet for Students in Research Studies 
 
You will be given a copy of this information sheet. 
 
Title of Project in lay terms:   
Psychological and behavioural effects of genetic test 
feedback for weight gain prevention in first year university 
students-a randomized controlled trial 
This study has been approved by the UCL Research 
Ethics Committee [Project ID Number 2471/003]:  
Professor Jane Wardle 
HBRC, UCL Epidemiology & Public Health, 
UCL, Gower Street 
London 
WC1E 6BT, UK 
Office: Room 203, 1-19 Torrington Place, 
London 
WC1E 6BT 
 Telephone: 
+44 (0)20 7679 8306 
Internal: x48306 
Fax: 
+44 (0)20 7679 8354 
Email:  
 
Susanne Meisel 
PhD Student 
Health Behaviour Research Centre 
Department of Epidemiology and Public Health 
University College London 
1-19 Torrington Place, Room 208 
London WC1E 6BT 
 
T: +44 (0) 20 7679 1723 (direct line) 
F: +44 (0) 20 7679 8354 
Email:  
 
We would like to invite you, as a UCL Student, to participate in this research project.  
 
You should only participate if you want to; choosing not to take part will not disadvantage you in any way. 
Before you decide whether you want to take part, it is important to read the following information carefully 
and discuss it with others if you wish.  Ask us if anything is not clear or if you would like more information.  
 
Aims of the research and possible benefits 
 There is evidence that body fat is in part genetically determined, and one gene in particular – the FTO 
gene – has been linked with slightly higher body fat (equivalent to 5 lbs in weight) 
 When young people go to university, some of them increase their body fat 
 It is possible to test for the FTO gene 
 We are interested in testing a large sample of new students for the FTO gene to see whether  
 knowing genetic risk status for weight gain will help to prevent weight gain in the first year of university 
 We are also interested whether receiving an information leaflet with tips on weight management tailored 
to counteract the effects of FTO will be helpful in keeping a healthy weight 
 The results from this study may help identify health advice to reduce risk of body fat gain 
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What will be involved if you decide to participate? 
 Participation will involve five things: i) assessment of body fat, ii) DNA collection and analysis, iii) reading 
an information leaflet with tips on how to avoid weight gain iv)filling out a questionnaire now and v) in 8 
month’s time.  
 You will be randomly allocated to receive your genetic test result either shortly after initial participation 
or at the 8 months follow-up.  
 
Assessment of body fat:  
 Body fat is measured with a special scale. You will be asked to remove heavy garments (coat, belt) as well 
as your shoes and socks, but stay otherwise fully clothed.  You will stand on the Tanita body fat scale for a 
few minutes. The scale will have an antibacterial gel in the area you place your feet.  It works through 
bioelectrical impedance which involves a very low, safe current being sent through your body.  Most 
people don’t feel anything, although a few a slight tingling in hands and feet; but it is not painful or 
harmful in any way. This method is considered the most convenient way of assessing body fat and 
versions of the Tanita body fat scales are available in shops. 
DNA Collection  
 DNA for analysis of genes is collected with a saliva sample. This involves ‘drooling’ 1.5-2.0 ml of saliva 
into a plastic collection tube.  This is painless.  
 It is important that you don’t eat, drink (except water), smoke, or brush your teeth for one hour before 
saliva collection.  
 The DNA will be extracted from the saliva in the laboratory and we will carry out genetic testing for one 
gene related to body fat.  The samples will not be used to test for genetic markers for any other diseases 
such as Alzheimer’s or breast cancer.   
 
Your test result 
 You will randomly be allocated to receive your test result shortly after enrolment, or at the end of the 
year. You can also choose not to know.  
 You will be able to receive your test result either by email or over the phone as you choose, and you will 
have the opportunity to ask any questions. You will also receive the contact details of the researcher, 
should you have questions at a later stage.  
 
Information leaflet 
 You will receive an information leaflet with tips on how to keep a healthy weight. These tips are useful for 
anyone, but will be especially useful for you if you have the ‘AA’ or ‘AT’ FTO genotype. ‘AA’ and ‘AT’ 
genotypes have been linked with lower satiety sensitivity.  
 
Questionnaire 
 We will ask you some questions on a computer about your eating habits, stress levels, physical activity 
levels and family history of overweight.  Filling out the questionnaire should take no longer than 20 
minutes.  You can do it now, or if you don’t have time, we can email you the link to the questionnaire, and 
you can fill it out when it suits you.  
 
Follow-up 
 After 8 months, we will email you another questionnaire to complete which will cover some of the same 
issues and we will invite you for a repeat assessment of body fat. If you have not received your test result 
shortly after initial enrolment, you will now have the option to collect your test result.  
 
 
Are there any risks involved if you choose to participate? 
 During the assessment of body fat you might feel slight tingling in your hands or feet. Should that distress 
you, please let the researcher know, and we will terminate the assessment without any consequences for 
you.  
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 Some people could be upset by the test result, although in other studies related to genetic test feedback 
for genes that only confer a low risk, this was not the case. If you are upset, Susanne Meisel and Professor 
Wardle (who is a Clinical Psychologist), will be available to support you.  
 
What are possible benefits for you as a participant? 
 One possible benefit for you is knowledge of your genetic status on the FTO gene involved in body fat 
development  
 You will receive an accurate assessment of your body fat percentage. 
 You will also receive a copy of the final research report.  
 
Arrangements for ensuring anonymity and confidentiality  
 We will store any information about you and your test result anonymously. We will store your email 
address separately from other information for future contacts.  
 Your saliva sample will be discarded after DNA analysis.  
 Only the researchers immediately involved in the research (Susanne Meisel and Professor Wardle) will 
have access to the full results.  
 All data will be kept confidential and stored in accordance with the Data Protection Act.  
 It is up to you to decide whether to take part or not. If you decide to take part you are still free to 
withdraw at any time and without giving a reason.   
 A decision to withdraw at any time, or a decision not to take part, will not affect the standard of 
education you receive. 
 You may withdraw your data from the project at any time up until it is transcribed for use in the final 
report by October 2013. 
 If you agree to take part, you will be asked whether you are happy to be contacted about participation in 
future studies. Your participation in this study will not be affected should you choose not be re-contacted. 
 
If you decide to take part in this study, you will be given this information sheet to keep and invited to sign a 
consent form. 
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12.5 Appendix 5: Recruitment materials  
 
Email invitation for Study 2 
Title: Genetic test feedback for weight gain – opportunity for participation 
Dear Student, 
 
 I know I am writing to you very late, however i just wanted to inform you that a new 
opportunity has arisen to take part in the FTO study. 
 
It is slightly different from the previous one in that you would be tested about your FTO status 
and then talk to me about your experience once you receive your result. 
 
 All interviews will be confidential, and you will not be able to be identified in any write -up. 
 
The advantage of this study is that you would receive your result quite soon after you gave me 
your saliva, however talking to me might take a bit of time. 
 
Please let me know if you are interested so I can send you further details. 
 
Best Wishes, 
 
 Susie 
 
Email invitation for Study 2b 
Subject line: Big panel research – reactions to genetic test feedback for risk of overweight 
 
 
Dear Big Panel Members, 
 
You may remember taking part in a survey about attitudes towards genetic testing for risk of 
obesity that we organised last year.  We have now moved on to the next stage of this research 
and are inviting a small number of people from the Big Panel for a genetic test of one of the 
genes  that has been associated with increased risk for overweight. This gene is called the FTO 
gene. There would of course be no cost, but we are looking for participants who would be 
willing to take part in a short phone interview after the test to give us their views about the 
experience.  
 
Please find an information sheet with further details about the study attached.  If you are 
interested in the study, please contact me (Susanne.meisel.09@ucl.ac.uk) for further details. 
 
Thank you very much for your time. 
 
Kind Regards, 
 
Susanne  
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Email invitation for studies 3 and 4 
Subject line: how fat are your genes?-find out here! 
Dear Student, 
 
Are you a first year student at UCL aged between 18 and 25 years?  If the answer is yes, we 
should like to invite you to participate in a study investigating the association of the FTO gene 
and the tendency to gain body fat in the first year of college. 
  
Many Freshers already agreed to take part when they attended the Freshers’ Fayre.  
 
Those of you who didn’t attend the Fayre, or were put off by the queue at our stall, now have 
the opportunity to help us find out more about how genes influence body fat gain. 
 
What does participation involve?  
Participation involves assessing your level of body fat, taking a saliva sample for DNA, and 
filling out a questionnaire now and in 6 months time.   
 
These procedures are painless and should take in total no longer than 30mins.  
 
Your DNA will be used solely to test for two genes associated with body fat gain, but not for 
any other condition or disease.  Samples will be discarded after analysis.  Results will be 
treated with strict confidentiality.  
 
What are the benefits for me as a participant? 
You will receive an accurate measurement of your body fat percentage, and see how it 
changes over time 
 
You will receive feedback on your genet status for the two genes we test for 
 
You will receive a copy of the final research report 
 
Of course, you are under no obligation to participate; and if you did, you are free to withdraw 
at any time. 
 
Please contact me by email (susanne.meisel.09@ucl.ac.uk) or on the phone number below if 
you would like to receive further information or discuss the study.  
 
I look forward to hearing from you. 
 
Susanne Meisel 
 
 
 
 
Example of an advert distributed around campus for study 3 (Contact details were attached 
below) 
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12.6 Appendix 6: Instructions for Saliva Collection Study 2b 
        
Health Behaviour Research Centre  
University College London 
1-19 Torrington Place 
London, WC1E 6BT 
Tel: 0207 679 1736 
November 28th 2011 
 
Dear panel participant, 
 
Thank you very much for your interest in the study.  
 
Instructions on how to collect the saliva sample for the genetic analysis are on the 
back of this letter.  Should you have any queries, please do not hesitate to contact me.  
 
After you have posted your sample back to us, it will be analysed at the Institute for 
Metabolic Sciences in Cambridge.  Although we are aiming for a speedy turnover, 
analysis may take a few weeks, but we will give you the result as soon as we can.  
 
I will contact you by email as soon as your result is available.  Then we will also make 
an appointment for the phone interview.  
 
Meanwhile, please could you follow the link below, to fill out a brief baseline 
questionnaire. 
www.attitudestohealth.co.uk/genesint 
 
With best wishes, 
 
Yours sincerely, 
Susanne Meisel 
Tel: 020 7679 1736 
Email:   
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A guide to collecting your saliva sample 
 
Before collecting your sample it is advisable not to eat, drink (except water), smoke, 
chew gum or brush your teeth 30 minutes before.  Collection time is unimportant.  
 
For collection, you will need:  
• The salivette and about ¼ teaspoon of sugar/ sweetener.   
• The sugar helps stimulate saliva flow.  You will spit the sugar into the tube with 
the saliva. (Note for diabetics: you don’t swallow the sugar but spit it into the 
tube, so it should not affect your blood glucose levels). 
  
1. Open the salivette by pulling top and bottom half apart (as shown in the 
picture). You spit into the empty outer tube.  Ignore the screw-cap that gives 
access to the cotton wool – you will NOT need the cotton wool to collect your 
sample.  
 
 
2. Put the sugar onto your tongue and let it dissolve.  Do not swallow for a few 
minutes. 
 
3. When you feel saliva building up in your mouth, spit it into the test-tube.  
 
4. The tube needs to be filled to at least the 1 ml mark, more is preferable.  If you 
need to, repeat steps 2 and 3.  Using sugar for each ‘go’ helps.  Avoid ‘frothy’ 
saliva that is generated when you try and ‘suck’ saliva out of your cheeks.  Do 
not drink water as it will dilute saliva.  
 
5. Firmly close the lid (you should hear it ‘click’).  Wipe the tube, if necessary.  
 
6.  Write forename, last name and DOB on the label and stick it on to the tube 
(using a normal pen is fine). Sign and date the consent form.   
 
7. Put the sample and the signed consent form in the prepaid envelope.  Post it 
back as soon as you can, but you can store in your home fridge/freezer if you 
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are unable to post it the same day.  This will not affect the result.  The sample 
does not need to be frozen for transport.   
 
8. Please do not forget to fill out the short questionnaire at 
www.attituedestohealth.co.uk/genesint  
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12.7 Appendix 7: Saliva Extraction Protocol 
 
 
Saliva Spin Protocol 
 
Notes: 
• Equilibrate samples to room temperature. 
• Heat a water bath or heating block to 56°C for use in step 4. 
• Equilibrate Buffer AE or water to room temperature for elution in step 10. 
• Ensure that Buffer AW1, Buffer AW2, and QIAGEN Protease have been prepared 
according to the instructions on page 24. 
• If a precipitate has formed in Buffer AL, dissolve by incubating at 56°C. 
• All centrifugation steps should be carried out at room temperature. 
 
1. Add 4mls PBS (phosphate buffered saline) to 1ml sample. Centrifuge @ RT for 5mins 3000g. 
Resuspend the pellet in 180 PBS and 20 ul RNASE A (20mg/ul) 
2. Add 200 μl sample to Eppendorf 1.5ml tube. 
3. Add 200 μl Buffer AL to the sample. Mix by pulse-vortexing for 15 s. 
 
4. Incubate at 56°C for 10 min. 
 
5. Briefly centrifuge the 1.5 ml microcentrifuge tube to remove drops from the inside of the 
lid. 
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6. Add 200 μl ethanol (96–100%) to the sample, and mix again by pulse-vortexing for 15 s. 
After mixing, briefly centrifuge the 1.5 ml microcentrifuge tube to remove drops from the 
inside of the lid. 
 
7. Carefully apply the mixture from step 6 to the QIAamp spin column (in a 2 ml collection 
tube) without wetting the rim, close the cap, and centrifuge at 6000 x g (8000 rpm) for 1 min. 
Place the QIAamp spin column in a clean 2 ml collection tube (provided), and discard the tube 
containing the filtrate. 
 
8. Carefully open the QIAamp spin column and add 500 μl Buffer AW1 without wetting the 
rim. Close the cap and centrifuge at 6000 x g (8000 rpm) for 1 min. Place the QIAamp spin 
column in a clean 2 ml collection tube (provided), and discard the collection tube containing 
the filtrate. 
 
9. Carefully open the QIAamp spin column and add 500 μl Buffer AW2 without wetting the 
rim. Close the cap and centrifuge at full speed (20,000 x g; 14,000 rpm) for 3 min. Continue 
directly with step 10, or to eliminate any chance of possible Buffer AW2 carryover, perform 
step 9a, and then continue with step 10. 
 
9a. (Optional): Place the QIAamp spin column in a new 2 ml collection tube (not provided) and 
discard the collection tube with the filtrate. Centrifuge at full speed for 1 min. 
 
10. Place the QIAamp spin column in a clean 1.5 ml microcentrifuge tube (not provided), and 
discard the collection tube containing the filtrate. Carefully open the QIAamp spin column and 
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add 50 μl Buffer AE or distilled water. Incubate at room temperature for 1 min, and then 
centrifuge at 6000 x g (8000 rpm) for 1 min. 
 
For long-term storage of DNA, eluting in Buffer AE and storing at –20°C is recommended, since 
DNA stored in water is subject to acid hydrolysis. 
. 
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Isolation of genomic DNA from Saliva 
 
• Add isopropanol and ethanol to Wash Solution 1 Concentrate and Wash 
Solution 2 Concentrate respectively. See the reagent bottles for preparation instructions. Store 
the solutions at room temperature. 
• Prepare sufficient DNA Binding Bead Mix for your sample extraction and store at room 
temperature. If you are preparing multiple samples, prepare 5% excess to account for error. 
• Confirm that your MagMAX™ Express-96 Deep Well Magnetic Particle 
Processor has installed the 4413021 DW tissues protocol.  
 
1. Add 1ml sample to 4mls PBS (phosphate buffered saline). Centrifuge @ RT for 5mins 3000g. 
Resuspend the pellet in 200 μL of Multi-Sample DNA Lysis Buffer 
 
Disrupt the samples 1. For each sample: 
a. Move samples into deep well plate. 
2. Shake the plate on a plate shaker. 
 
Perform the DNA extraction and elution 
1. Add 160 μL of 100% isopropanol to each sample on the plate. 
2. Seal the plate, shake for 3 minutes at on a plate shaker. 
3. Remove the plate from the shaker, carefully remove the cover, add 20 μL 
DNA Binding Bead Mix to each lysate on the plate. Seal then shake for a further 3 minutes 
Appendix 7: Saliva extraction Protocol 
 
345 
 
4. While the plate is shaking, prepare sufficient RNase A mix for the number of samples you 
are preparing. IMPORTANT! Prepare the RNase A mix just before use. Prolonged storage 
atroom temperature can reduce its efficiency. 
5. Prepare the plates for the MagMAX instrument. 
6. Start the protocol. 
 
Component     Volume (μL) 
1 well 96-well plateRNase A    5  505 
Water, nuclease-free     95  9595 
Total (RNase A mix)     100  10100 
 
Plate      Reagent Volume per well (μL)   
ID Position 
Binding  1  Lysate, isopropanol, and beads (from steps 1 to 3) 180 to 380  
Wash 1   2  Wash Buffer 1       150 
Wash 2   3  Wash Buffer 2       150 
RNase   4  RNase A mixture (5 μL RNase + 95 μL water per well)  100 
Wash 3  5  Wash Buffer 2       150 
Wash 4  6  Wash Buffer 2       150 
Elution   7  DNA Elution Buffer 1 for initial heated and elution  75  
Load the plates into the loading station as prompted by the instrument. 
Press start after loading each plate. 
After the run is started, load the following reagents into the plates at the loading stations 
listed in the following table when prompted by the instrument. 
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ID Position Reagent Volume per well (μL) RNase  4 Multi-Sample 
DNA Lysis Buffer and isopropanol 220 
 
Note: The instrument prompts you to add 100 μL lysis buffer and 120 μL isopropanol after the 
RNase digestion is complete. 
  
Eluron‡ 7 DNA Eluron Buﬀer 2 for equilibration 75§  
Unload the instrument 1. When the instrument has completed the protocol, remove all plates 
from the loading station as prompted by the instrument. Press start after removing each plate. 
IMPORTANT! After removing the elution plate (the first plate removed) from the MagMAX™ 
instrument, which contains the purified DNA, cover the plate immediately. To prevent 
evaporation, do not allow the sample to sit uncovered at room temperature for an extended 
time. 
If precipitated DNA is visible in the samples, pipet up/down 5 to 10 times before covering the 
plate to ensure complete resuspension. Precipitate is common when preparing tissues that 
have a large amount of DNA (such as spleen or thymus). 
2. When the MagMAX™ instrument displays END_OF_RUN, press stop. 
3. Power off the MagMAX™ instrument. 
 
STOPPING POINT. Use the purified samples immediately, or store the elution plate for later 
use at 2 to 6 °C for up to 24 hours or at − 20 to − 80 °C for prolonged storage. 
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12.8 Appendix 8: Result letters 
Result letter AA 
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Result letter AT 
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Result letter TT 
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Questionnaire Study 1 
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Baseline Questionnaire Study 4 
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1-month follow-up questionnaire Study 4 
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Reactions to genetic test feedback questionnaire Study 4 
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